id	sid	tid	token	lemma	pos
dpc-3884	1	1	dermatology	dermatology	NOUN
dpc-3884	1	2	:	:	PUNCT
dpc-3884	1	3	practical	practical	ADJ
dpc-3884	1	4	and	and	CCONJ
dpc-3884	1	5	conceptual	conceptual	ADJ
dpc-3884	1	6	original	original	ADJ
dpc-3884	1	7	article	article	NOUN
dpc-3884	1	8	|	|	ADV
dpc-3884	1	9	dermatol	dermatol	ADJ
dpc-3884	1	10	pract	pract	NOUN
dpc-3884	1	11	concept	concept	NOUN
dpc-3884	1	12	.	.	PUNCT
dpc-3884	2	1	2024;14(3):e2024118	2024;14(3):e2024118	NUM
dpc-3884	2	2	1	1	NUM
dpc-3884	2	3	the	the	DET
dpc-3884	2	4	impact	impact	NOUN
dpc-3884	2	5	of	of	ADP
dpc-3884	2	6	immune	immune	ADJ
dpc-3884	2	7	checkpoint	checkpoint	NOUN
dpc-3884	2	8	inhibitorsinduced	inhibitorsinduce	VERB
dpc-3884	2	9	skin	skin	NOUN
dpc-3884	2	10	toxicity	toxicity	NOUN
dpc-3884	2	11	on	on	ADP
dpc-3884	2	12	patients	patient	NOUN
dpc-3884	2	13	quality	quality	NOUN
dpc-3884	2	14	of	of	ADP
dpc-3884	2	15	life	life	NOUN
dpc-3884	2	16	and	and	CCONJ
dpc-3884	2	17	the	the	DET
dpc-3884	2	18	role	role	NOUN
dpc-3884	2	19	of	of	ADP
dpc-3884	2	20	dermatologic	dermatologic	ADJ
dpc-3884	2	21	intervention	intervention	NOUN
dpc-3884	2	22	christina	christina	PROPN
dpc-3884	2	23	kemanetzi1	kemanetzi1	PROPN
dpc-3884	2	24	,	,	PUNCT
dpc-3884	2	25	konstantinos	konstantinos	PROPN
dpc-3884	2	26	lallas2	lallas2	PROPN
dpc-3884	2	27	,	,	PUNCT
dpc-3884	2	28	elizavet	elizavet	ADJ
dpc-3884	2	29	lazaridou1	lazaridou1	PROPN
dpc-3884	2	30	,	,	PUNCT
dpc-3884	2	31	chrysoula	chrysoula	NOUN
dpc-3884	2	32	papageorgiou1	papageorgiou1	NOUN
dpc-3884	2	33	,	,	PUNCT
dpc-3884	2	34	aimilios	aimilios	PROPN
dpc-3884	2	35	lallas3	lallas3	NOUN
dpc-3884	2	36	,	,	PUNCT
dpc-3884	2	37	alexandros	alexandros	PROPN
dpc-3884	2	38	stratigos4	stratigos4	PROPN
dpc-3884	2	39	,	,	PUNCT
dpc-3884	2	40	eleni	eleni	PROPN
dpc-3884	2	41	timotheadou2	timotheadou2	PROPN
dpc-3884	2	42	,	,	PUNCT
dpc-3884	2	43	george	george	PROPN
dpc-3884	2	44	lazaridis2	lazaridis2	PROPN
dpc-3884	2	45	,	,	PUNCT
dpc-3884	2	46	dimitrios	dimitrios	ADJ
dpc-3884	2	47	dionysopoulos2	dionysopoulos2	NOUN
dpc-3884	2	48	,	,	PUNCT
dpc-3884	2	49	kalliopi	kalliopi	PROPN
dpc-3884	2	50	kalaitzi5	kalaitzi5	PROPN
dpc-3884	2	51	,	,	PUNCT
dpc-3884	2	52	antonios	antonios	PROPN
dpc-3884	2	53	tsimpidakis4	tsimpidakis4	PROPN
dpc-3884	2	54	,	,	PUNCT
dpc-3884	2	55	myrto	myrto	PROPN
dpc-3884	2	56	trakatelli1	trakatelli1	PROPN
dpc-3884	2	57	,	,	PUNCT
dpc-3884	2	58	aikaterini	aikaterini	PROPN
dpc-3884	2	59	patsatsi1	patsatsi1	PROPN
dpc-3884	2	60	,	,	PUNCT
dpc-3884	2	61	vasiliki	vasiliki	PROPN
dpc-3884	2	62	nikolao4	nikolao4	PROPN
dpc-3884	2	63	,	,	PUNCT
dpc-3884	2	64	zoe	zoe	PROPN
dpc-3884	2	65	apalla1	apalla1	NOUN
dpc-3884	2	66	1	1	NUM
dpc-3884	2	67	second	second	ADJ
dpc-3884	2	68	department	department	NOUN
dpc-3884	2	69	of	of	ADP
dpc-3884	2	70	dermatology	dermatology	NOUN
dpc-3884	2	71	,	,	PUNCT
dpc-3884	2	72	school	school	NOUN
dpc-3884	2	73	of	of	ADP
dpc-3884	2	74	health	health	NOUN
dpc-3884	2	75	sciences	sciences	PROPN
dpc-3884	2	76	,	,	PUNCT
dpc-3884	2	77	aristotle	aristotle	PROPN
dpc-3884	2	78	university	university	PROPN
dpc-3884	2	79	of	of	ADP
dpc-3884	2	80	thessaloniki	thessaloniki	PROPN
dpc-3884	2	81	,	,	PUNCT
dpc-3884	2	82	papageorgiou	papageorgiou	PROPN
dpc-3884	2	83	general	general	ADJ
dpc-3884	2	84	hospital	hospital	PROPN
dpc-3884	2	85	,	,	PUNCT
dpc-3884	2	86	thessaloniki	thessaloniki	PROPN
dpc-3884	2	87	,	,	PUNCT
dpc-3884	2	88	greece	greece	PROPN
dpc-3884	2	89	2	2	NUM
dpc-3884	2	90	oncology	oncology	NOUN
dpc-3884	2	91	department	department	NOUN
dpc-3884	2	92	,	,	PUNCT
dpc-3884	2	93	school	school	NOUN
dpc-3884	2	94	of	of	ADP
dpc-3884	2	95	health	health	NOUN
dpc-3884	2	96	sciences	sciences	PROPN
dpc-3884	2	97	,	,	PUNCT
dpc-3884	2	98	aristotle	aristotle	PROPN
dpc-3884	2	99	university	university	PROPN
dpc-3884	2	100	of	of	ADP
dpc-3884	2	101	thessaloniki	thessaloniki	PROPN
dpc-3884	2	102	,	,	PUNCT
dpc-3884	2	103	papageorgiou	papageorgiou	PROPN
dpc-3884	2	104	general	general	ADJ
dpc-3884	2	105	hospital	hospital	PROPN
dpc-3884	2	106	,	,	PUNCT
dpc-3884	2	107	thessaloniki	thessaloniki	PROPN
dpc-3884	2	108	,	,	PUNCT
dpc-3884	2	109	greece	greece	PROPN
dpc-3884	2	110	3	3	NUM
dpc-3884	2	111	first	first	PROPN
dpc-3884	2	112	department	department	NOUN
dpc-3884	2	113	of	of	ADP
dpc-3884	2	114	dermatology	dermatology	NOUN
dpc-3884	2	115	,	,	PUNCT
dpc-3884	2	116	school	school	NOUN
dpc-3884	2	117	of	of	ADP
dpc-3884	2	118	health	health	NOUN
dpc-3884	2	119	sciences	sciences	PROPN
dpc-3884	2	120	,	,	PUNCT
dpc-3884	2	121	aristotle	aristotle	PROPN
dpc-3884	2	122	university	university	PROPN
dpc-3884	2	123	of	of	ADP
dpc-3884	2	124	thessaloniki	thessaloniki	PROPN
dpc-3884	2	125	,	,	PUNCT
dpc-3884	2	126	thessaloniki	thessaloniki	PROPN
dpc-3884	2	127	,	,	PUNCT
dpc-3884	2	128	greece	greece	PROPN
dpc-3884	2	129	4	4	NUM
dpc-3884	2	130	first	first	ADJ
dpc-3884	2	131	department	department	NOUN
dpc-3884	2	132	of	of	ADP
dpc-3884	2	133	dermatology	dermatology	NOUN
dpc-3884	2	134	-	-	PUNCT
dpc-3884	2	135	venereology	venereology	NOUN
dpc-3884	2	136	,	,	PUNCT
dpc-3884	2	137	national	national	ADJ
dpc-3884	2	138	and	and	CCONJ
dpc-3884	2	139	kapodistrian	kapodistrian	ADJ
dpc-3884	2	140	university	university	PROPN
dpc-3884	2	141	of	of	ADP
dpc-3884	2	142	athens	athens	PROPN
dpc-3884	2	143	,	,	PUNCT
dpc-3884	2	144	school	school	NOUN
dpc-3884	2	145	of	of	ADP
dpc-3884	2	146	medicine	medicine	NOUN
dpc-3884	2	147	,	,	PUNCT
dpc-3884	2	148	andreas	andreas	PROPN
dpc-3884	2	149	sygros	sygros	PROPN
dpc-3884	2	150	hospital	hospital	PROPN
dpc-3884	2	151	,	,	PUNCT
dpc-3884	2	152	athens	athens	PROPN
dpc-3884	2	153	,	,	PUNCT
dpc-3884	2	154	greece	greece	PROPN
dpc-3884	2	155	5	5	NUM
dpc-3884	2	156	attikon	attikon	ADJ
dpc-3884	2	157	hospital	hospital	NOUN
dpc-3884	2	158	,	,	PUNCT
dpc-3884	2	159	athens	athens	PROPN
dpc-3884	2	160	medical	medical	PROPN
dpc-3884	2	161	school	school	PROPN
dpc-3884	2	162	,	,	PUNCT
dpc-3884	2	163	athens	athens	PROPN
dpc-3884	2	164	,	,	PUNCT
dpc-3884	2	165	greece	greece	PROPN
dpc-3884	2	166	key	key	ADJ
dpc-3884	2	167	words	word	NOUN
dpc-3884	2	168	:	:	PUNCT
dpc-3884	2	169	checkpoint	checkpoint	NOUN
dpc-3884	2	170	inhibitors	inhibitor	NOUN
dpc-3884	2	171	,	,	PUNCT
dpc-3884	2	172	skin	skin	NOUN
dpc-3884	2	173	toxicity	toxicity	NOUN
dpc-3884	2	174	,	,	PUNCT
dpc-3884	2	175	skin	skin	NOUN
dpc-3884	2	176	rash	rash	NOUN
dpc-3884	2	177	,	,	PUNCT
dpc-3884	2	178	quality	quality	NOUN
dpc-3884	2	179	of	of	ADP
dpc-3884	2	180	life	life	NOUN
dpc-3884	2	181	,	,	PUNCT
dpc-3884	2	182	patient	patient	NOUN
dpc-3884	2	183	reported	report	VERB
dpc-3884	2	184	outcomes	outcome	NOUN
dpc-3884	2	185	citation	citation	NOUN
dpc-3884	2	186	:	:	PUNCT
dpc-3884	2	187	kemanetzi	kemanetzi	PROPN
dpc-3884	2	188	c	c	NOUN
dpc-3884	2	189	,	,	PUNCT
dpc-3884	2	190	lallas	lallas	PROPN
dpc-3884	2	191	k	k	PROPN
dpc-3884	2	192	,	,	PUNCT
dpc-3884	2	193	lazaridou	lazaridou	PROPN
dpc-3884	2	194	e	e	NOUN
dpc-3884	2	195	,	,	PUNCT
dpc-3884	2	196	et	et	NOUN
dpc-3884	2	197	al.the	al.the	PROPN
dpc-3884	2	198	impact	impact	NOUN
dpc-3884	2	199	of	of	ADP
dpc-3884	2	200	immune	immune	ADJ
dpc-3884	2	201	checkpoint	checkpoint	NOUN
dpc-3884	2	202	inhibitors	inhibitor	NOUN
dpc-3884	2	203	-	-	PUNCT
dpc-3884	2	204	induced	induce	VERB
dpc-3884	2	205	skin	skin	NOUN
dpc-3884	2	206	toxicity	toxicity	NOUN
dpc-3884	2	207	on	on	ADP
dpc-3884	2	208	patients	patient	NOUN
dpc-3884	2	209	quality	quality	NOUN
dpc-3884	2	210	of	of	ADP
dpc-3884	2	211	life	life	NOUN
dpc-3884	2	212	and	and	CCONJ
dpc-3884	2	213	the	the	DET
dpc-3884	2	214	role	role	NOUN
dpc-3884	2	215	of	of	ADP
dpc-3884	2	216	dermatologic	dermatologic	ADJ
dpc-3884	2	217	intervention	intervention	NOUN
dpc-3884	2	218	.	.	PUNCT
dpc-3884	3	1	dermatol	dermatol	NOUN
dpc-3884	3	2	pract	pract	PROPN
dpc-3884	3	3	concept	concept	NOUN
dpc-3884	3	4	.	.	PUNCT
dpc-3884	4	1	2024;14(3):e2024118	2024;14(3):e2024118	X
dpc-3884	4	2	.	.	PUNCT
dpc-3884	5	1	doi	doi	PROPN
dpc-3884	5	2	:	:	PUNCT
dpc-3884	5	3	https://doi.org/10.5826/	https://doi.org/10.5826/	PROPN
dpc-3884	5	4	dpc.1403a118	dpc.1403a118	PUNCT
dpc-3884	5	5	accepted	accept	VERB
dpc-3884	5	6	:	:	PUNCT
dpc-3884	5	7	january	january	PROPN
dpc-3884	5	8	14	14	NUM
dpc-3884	5	9	,	,	PUNCT
dpc-3884	5	10	2024	2024	NUM
dpc-3884	5	11	;	;	PUNCT
dpc-3884	5	12	published	publish	VERB
dpc-3884	5	13	:	:	PUNCT
dpc-3884	6	1	july	july	PROPN
dpc-3884	6	2	2024	2024	NUM
dpc-3884	6	3	copyright	copyright	NOUN
dpc-3884	6	4	:	:	PUNCT
dpc-3884	6	5	©	©	PROPN
dpc-3884	6	6	2024	2024	NUM
dpc-3884	6	7	kemanetzi	kemanetzi	NOUN
dpc-3884	6	8	et	et	PROPN
dpc-3884	6	9	al	al	PROPN
dpc-3884	6	10	.	.	PUNCT
dpc-3884	7	1	this	this	PRON
dpc-3884	7	2	is	be	AUX
dpc-3884	7	3	an	an	DET
dpc-3884	7	4	open	open	ADJ
dpc-3884	7	5	-	-	PUNCT
dpc-3884	7	6	access	access	NOUN
dpc-3884	7	7	article	article	NOUN
dpc-3884	7	8	distributed	distribute	VERB
dpc-3884	7	9	under	under	ADP
dpc-3884	7	10	the	the	DET
dpc-3884	7	11	terms	term	NOUN
dpc-3884	7	12	of	of	ADP
dpc-3884	7	13	the	the	DET
dpc-3884	7	14	creative	creative	ADJ
dpc-3884	7	15	commons	common	NOUN
dpc-3884	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3884	7	17	license	license	NOUN
dpc-3884	7	18	(	(	PUNCT
dpc-3884	7	19	by	by	ADP
dpc-3884	7	20	-	-	PUNCT
dpc-3884	7	21	nc-4.0	nc-4.0	NOUN
dpc-3884	7	22	)	)	PUNCT
dpc-3884	7	23	,	,	PUNCT
dpc-3884	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3884	7	25	,	,	PUNCT
dpc-3884	7	26	which	which	PRON
dpc-3884	7	27	permits	permit	VERB
dpc-3884	7	28	unrestricted	unrestricted	ADJ
dpc-3884	7	29	noncommercial	noncommercial	ADJ
dpc-3884	7	30	use	use	NOUN
dpc-3884	7	31	,	,	PUNCT
dpc-3884	7	32	distribution	distribution	NOUN
dpc-3884	7	33	,	,	PUNCT
dpc-3884	7	34	and	and	CCONJ
dpc-3884	7	35	reproduction	reproduction	NOUN
dpc-3884	7	36	in	in	ADP
dpc-3884	7	37	any	any	DET
dpc-3884	7	38	medium	medium	NOUN
dpc-3884	7	39	,	,	PUNCT
dpc-3884	7	40	provided	provide	VERB
dpc-3884	7	41	the	the	DET
dpc-3884	7	42	original	original	ADJ
dpc-3884	7	43	authors	author	NOUN
dpc-3884	7	44	and	and	CCONJ
dpc-3884	7	45	source	source	NOUN
dpc-3884	7	46	are	be	AUX
dpc-3884	7	47	credited	credit	VERB
dpc-3884	7	48	.	.	PUNCT
dpc-3884	8	1	funding	funding	NOUN
dpc-3884	8	2	:	:	PUNCT
dpc-3884	8	3	none	none	NOUN
dpc-3884	8	4	.	.	PUNCT
dpc-3884	9	1	competing	compete	VERB
dpc-3884	9	2	interests	interest	NOUN
dpc-3884	9	3	:	:	PUNCT
dpc-3884	9	4	none	none	NOUN
dpc-3884	9	5	.	.	PUNCT
dpc-3884	10	1	authorship	authorship	NOUN
dpc-3884	10	2	:	:	PUNCT
dpc-3884	10	3	all	all	DET
dpc-3884	10	4	authors	author	NOUN
dpc-3884	10	5	have	have	AUX
dpc-3884	10	6	contributed	contribute	VERB
dpc-3884	10	7	significantly	significantly	ADV
dpc-3884	10	8	to	to	ADP
dpc-3884	10	9	this	this	DET
dpc-3884	10	10	publication	publication	NOUN
dpc-3884	10	11	.	.	PUNCT
dpc-3884	11	1	corresponding	correspond	VERB
dpc-3884	11	2	author	author	NOUN
dpc-3884	11	3	:	:	PUNCT
dpc-3884	11	4	zoe	zoe	NOUN
dpc-3884	11	5	apalla	apalla	PROPN
dpc-3884	11	6	,	,	PUNCT
dpc-3884	11	7	phd	phd	NOUN
dpc-3884	11	8	,	,	PUNCT
dpc-3884	11	9	associate	associate	ADJ
dpc-3884	11	10	professor	professor	NOUN
dpc-3884	11	11	of	of	ADP
dpc-3884	11	12	dermatology	dermatology	NOUN
dpc-3884	11	13	,	,	PUNCT
dpc-3884	11	14	aristotle	aristotle	PROPN
dpc-3884	11	15	university	university	PROPN
dpc-3884	11	16	of	of	ADP
dpc-3884	11	17	thessaloniki	thessaloniki	PROPN
dpc-3884	11	18	.	.	PUNCT
dpc-3884	12	1	address	address	NOUN
dpc-3884	12	2	:	:	PUNCT
dpc-3884	12	3	anatolis	anatolis	PROPN
dpc-3884	12	4	5	5	NUM
dpc-3884	12	5	,	,	PUNCT
dpc-3884	12	6	55535	55535	NUM
dpc-3884	12	7	,	,	PUNCT
dpc-3884	12	8	thessaloniki	thessaloniki	PROPN
dpc-3884	12	9	,	,	PUNCT
dpc-3884	12	10	greece	greece	PROPN
dpc-3884	12	11	,	,	PUNCT
dpc-3884	12	12	tel	tel	PROPN
dpc-3884	12	13	.	.	PUNCT
dpc-3884	12	14	+306972916729	+306972916729	PROPN
dpc-3884	12	15	,	,	PUNCT
dpc-3884	12	16	email	email	NOUN
dpc-3884	12	17	:	:	PUNCT
dpc-3884	12	18	zoimd@yahoo.gr	zoimd@yahoo.gr	NOUN
dpc-3884	12	19	introduction	introduction	NOUN
dpc-3884	12	20	:	:	PUNCT
dpc-3884	12	21	data	datum	NOUN
dpc-3884	12	22	regarding	regard	VERB
dpc-3884	12	23	quality	quality	NOUN
dpc-3884	12	24	of	of	ADP
dpc-3884	12	25	life	life	NOUN
dpc-3884	12	26	(	(	PUNCT
dpc-3884	12	27	qol	qol	NOUN
dpc-3884	12	28	)	)	PUNCT
dpc-3884	12	29	of	of	ADP
dpc-3884	12	30	oncologic	oncologic	NOUN
dpc-3884	12	31	patients	patient	NOUN
dpc-3884	12	32	experiencing	experience	VERB
dpc-3884	12	33	dermatologic	dermatologic	ADJ
dpc-3884	12	34	immune	immune	NOUN
dpc-3884	12	35	-	-	PUNCT
dpc-3884	12	36	related	relate	VERB
dpc-3884	12	37	adverse	adverse	ADJ
dpc-3884	12	38	events	event	NOUN
dpc-3884	12	39	(	(	PUNCT
dpc-3884	12	40	diraes	diraes	NOUN
dpc-3884	12	41	)	)	PUNCT
dpc-3884	12	42	and	and	CCONJ
dpc-3884	12	43	their	their	PRON
dpc-3884	12	44	course	course	NOUN
dpc-3884	12	45	after	after	ADP
dpc-3884	12	46	dermatologic	dermatologic	ADJ
dpc-3884	12	47	intervention	intervention	NOUN
dpc-3884	12	48	are	be	AUX
dpc-3884	12	49	scarce	scarce	ADJ
dpc-3884	12	50	.	.	PUNCT
dpc-3884	13	1	objectives	objective	NOUN
dpc-3884	13	2	:	:	PUNCT
dpc-3884	13	3	to	to	PART
dpc-3884	13	4	assess	assess	VERB
dpc-3884	13	5	the	the	DET
dpc-3884	13	6	impact	impact	NOUN
dpc-3884	13	7	of	of	ADP
dpc-3884	13	8	diraes	diraes	NOUN
dpc-3884	13	9	on	on	ADP
dpc-3884	13	10	patients	patient	NOUN
dpc-3884	13	11	qol	qol	VERB
dpc-3884	13	12	and	and	CCONJ
dpc-3884	13	13	to	to	PART
dpc-3884	13	14	investigate	investigate	VERB
dpc-3884	13	15	the	the	DET
dpc-3884	13	16	correlation	correlation	NOUN
dpc-3884	13	17	between	between	ADP
dpc-3884	13	18	dermatologic	dermatologic	ADJ
dpc-3884	13	19	and	and	CCONJ
dpc-3884	13	20	oncologic	oncologic	ADJ
dpc-3884	13	21	indexes	index	NOUN
dpc-3884	13	22	used	use	VERB
dpc-3884	13	23	for	for	ADP
dpc-3884	13	24	estimating	estimate	VERB
dpc-3884	13	25	qol	qol	NOUN
dpc-3884	14	1	.	.	PUNCT
dpc-3884	14	2	methods	method	NOUN
dpc-3884	14	3	:	:	PUNCT
dpc-3884	14	4	we	we	PRON
dpc-3884	14	5	enrolled	enrol	VERB
dpc-3884	14	6	oncologic	oncologic	ADJ
dpc-3884	14	7	patients	patient	NOUN
dpc-3884	14	8	with	with	ADP
dpc-3884	14	9	diraes	dirae	NOUN
dpc-3884	14	10	managed	manage	VERB
dpc-3884	14	11	in	in	ADP
dpc-3884	14	12	two	two	NUM
dpc-3884	14	13	supportive	supportive	ADJ
dpc-3884	14	14	oncodermatology	oncodermatology	NOUN
dpc-3884	14	15	outpatient	outpatient	NOUN
dpc-3884	14	16	clinics	clinic	NOUN
dpc-3884	14	17	in	in	ADP
dpc-3884	14	18	greece	greece	PROPN
dpc-3884	14	19	.	.	PUNCT
dpc-3884	15	1	patient	patient	NOUN
dpc-3884	15	2	-	-	PUNCT
dpc-3884	15	3	reported	report	VERB
dpc-3884	15	4	outcomes	outcome	NOUN
dpc-3884	15	5	included	include	VERB
dpc-3884	15	6	dlqi	dlqi	NOUN
dpc-3884	15	7	,	,	PUNCT
dpc-3884	15	8	eortc	eortc	VERB
dpc-3884	15	9	-	-	PUNCT
dpc-3884	15	10	qlq	qlq	NOUN
dpc-3884	15	11	-	-	PUNCT
dpc-3884	15	12	c30	c30	NOUN
dpc-3884	15	13	and	and	CCONJ
dpc-3884	15	14	numerical	numerical	ADJ
dpc-3884	15	15	rating	rating	NOUN
dpc-3884	15	16	scale	scale	NOUN
dpc-3884	15	17	for	for	ADP
dpc-3884	15	18	pruritus	pruritus	PROPN
dpc-3884	15	19	(	(	PUNCT
dpc-3884	15	20	pnrs	pnrs	NOUN
dpc-3884	15	21	)	)	PUNCT
dpc-3884	15	22	.	.	PUNCT
dpc-3884	16	1	abstract	abstract	ADJ
dpc-3884	16	2	2	2	NUM
dpc-3884	16	3	original	original	ADJ
dpc-3884	16	4	article	article	NOUN
dpc-3884	16	5	|	|	ADV
dpc-3884	16	6	dermatol	dermatol	ADJ
dpc-3884	16	7	pract	pract	NOUN
dpc-3884	16	8	concept	concept	NOUN
dpc-3884	16	9	.	.	PUNCT
dpc-3884	17	1	2024;14(3):e2024118	2024;14(3):e2024118	NUM
dpc-3884	17	2	introduction	introduction	NOUN
dpc-3884	17	3	the	the	DET
dpc-3884	17	4	introduction	introduction	NOUN
dpc-3884	17	5	of	of	ADP
dpc-3884	17	6	immune	immune	ADJ
dpc-3884	17	7	checkpoint	checkpoint	NOUN
dpc-3884	17	8	inhibitors	inhibitor	NOUN
dpc-3884	17	9	(	(	PUNCT
dpc-3884	17	10	icis	icis	NOUN
dpc-3884	17	11	)	)	PUNCT
dpc-3884	17	12	(	(	PUNCT
dpc-3884	17	13	ctla-4	ctla-4	NOUN
dpc-3884	17	14	,	,	PUNCT
dpc-3884	17	15	pd-1	pd-1	ADV
dpc-3884	17	16	,	,	PUNCT
dpc-3884	17	17	pd	pd	PROPN
dpc-3884	17	18	-	-	PUNCT
dpc-3884	17	19	l1	l1	PROPN
dpc-3884	17	20	)	)	PUNCT
dpc-3884	17	21	in	in	ADP
dpc-3884	17	22	the	the	DET
dpc-3884	17	23	therapeutic	therapeutic	ADJ
dpc-3884	17	24	armamentarium	armamentarium	NOUN
dpc-3884	17	25	of	of	ADP
dpc-3884	17	26	oncologists	oncologist	NOUN
dpc-3884	17	27	wasa	wasa	VERB
dpc-3884	17	28	major	major	ADJ
dpc-3884	17	29	breakthrough	breakthrough	NOUN
dpc-3884	17	30	in	in	ADP
dpc-3884	17	31	cancer	cancer	NOUN
dpc-3884	17	32	therapy	therapy	NOUN
dpc-3884	17	33	.	.	PUNCT
dpc-3884	18	1	due	due	ADP
dpc-3884	18	2	to	to	ADP
dpc-3884	18	3	their	their	PRON
dpc-3884	18	4	unique	unique	ADJ
dpc-3884	18	5	mechanism	mechanism	NOUN
dpc-3884	18	6	,	,	PUNCT
dpc-3884	18	7	icis	icis	PROPN
dpc-3884	18	8	induce	induce	VERB
dpc-3884	18	9	a	a	DET
dpc-3884	18	10	new	new	ADJ
dpc-3884	18	11	spectrum	spectrum	NOUN
dpc-3884	18	12	of	of	ADP
dpc-3884	18	13	adverse	adverse	ADJ
dpc-3884	18	14	events	event	NOUN
dpc-3884	18	15	that	that	PRON
dpc-3884	18	16	are	be	AUX
dpc-3884	18	17	described	describe	VERB
dpc-3884	18	18	with	with	ADP
dpc-3884	18	19	the	the	DET
dpc-3884	18	20	term	term	NOUN
dpc-3884	18	21	immune	immune	ADJ
dpc-3884	18	22	related	relate	VERB
dpc-3884	18	23	adverse	adverse	ADJ
dpc-3884	18	24	events	event	NOUN
dpc-3884	18	25	(	(	PUNCT
dpc-3884	18	26	iraes	iraes	NOUN
dpc-3884	18	27	)	)	PUNCT
dpc-3884	18	28	and	and	CCONJ
dpc-3884	18	29	practically	practically	ADV
dpc-3884	18	30	represent	represent	VERB
dpc-3884	18	31	a	a	DET
dpc-3884	18	32	class	class	NOUN
dpc-3884	18	33	effect	effect	NOUN
dpc-3884	18	34	of	of	ADP
dpc-3884	18	35	these	these	DET
dpc-3884	18	36	drugs	drug	NOUN
dpc-3884	18	37	.	.	PUNCT
dpc-3884	19	1	among	among	ADP
dpc-3884	19	2	them	they	PRON
dpc-3884	19	3	,	,	PUNCT
dpc-3884	19	4	dermatologic	dermatologic	ADJ
dpc-3884	19	5	iraes	iraes	NOUN
dpc-3884	19	6	(	(	PUNCT
dpc-3884	19	7	diraes	diraes	PROPN
dpc-3884	19	8	)	)	PUNCT
dpc-3884	19	9	are	be	AUX
dpc-3884	19	10	the	the	DET
dpc-3884	19	11	most	most	ADV
dpc-3884	19	12	common	common	ADJ
dpc-3884	19	13	,	,	PUNCT
dpc-3884	19	14	affecting	affect	VERB
dpc-3884	19	15	up	up	ADP
dpc-3884	19	16	to	to	PART
dpc-3884	19	17	50	50	NUM
dpc-3884	19	18	%	%	NOUN
dpc-3884	19	19	of	of	ADP
dpc-3884	19	20	treated	treat	VERB
dpc-3884	19	21	patients	patient	NOUN
dpc-3884	19	22	[	[	X
dpc-3884	19	23	1	1	NUM
dpc-3884	19	24	-	-	SYM
dpc-3884	19	25	5	5	NUM
dpc-3884	19	26	]	]	PUNCT
dpc-3884	19	27	.	.	PUNCT
dpc-3884	20	1	diraes	dirae	NOUN
dpc-3884	20	2	include	include	VERB
dpc-3884	20	3	eczematous	eczematous	ADJ
dpc-3884	20	4	,	,	PUNCT
dpc-3884	20	5	lichenoid	lichenoid	PROPN
dpc-3884	20	6	and	and	CCONJ
dpc-3884	20	7	psoriasiformrashes	psoriasiformrashe	NOUN
dpc-3884	20	8	,	,	PUNCT
dpc-3884	20	9	pruritus	pruritus	PROPN
dpc-3884	20	10	,	,	PUNCT
dpc-3884	20	11	vitiligo	vitiligo	NOUN
dpc-3884	20	12	-	-	PUNCT
dpc-3884	20	13	like	like	ADJ
dpc-3884	20	14	rash	rash	NOUN
dpc-3884	20	15	,	,	PUNCT
dpc-3884	20	16	auto	auto	NOUN
dpc-3884	20	17	-	-	PUNCT
dpc-3884	20	18	immune	immune	ADJ
dpc-3884	20	19	bullous	bullous	ADJ
dpc-3884	20	20	diseases	disease	NOUN
dpc-3884	20	21	-	-	PUNCT
dpc-3884	20	22	like	like	ADJ
dpc-3884	20	23	rash	rash	NOUN
dpc-3884	20	24	,	,	PUNCT
dpc-3884	20	25	as	as	ADV
dpc-3884	20	26	well	well	ADV
dpc-3884	20	27	as	as	ADP
dpc-3884	20	28	other	other	ADJ
dpc-3884	20	29	less	less	ADV
dpc-3884	20	30	common	common	ADJ
dpc-3884	20	31	skin	skin	NOUN
dpc-3884	20	32	toxicities	toxicity	NOUN
dpc-3884	20	33	[	[	X
dpc-3884	20	34	2,3,5	2,3,5	NUM
dpc-3884	20	35	-	-	SYM
dpc-3884	20	36	7	7	NUM
dpc-3884	20	37	]	]	PUNCT
dpc-3884	20	38	.	.	PUNCT
dpc-3884	21	1	importantly	importantly	ADV
dpc-3884	21	2	,	,	PUNCT
dpc-3884	21	3	cumulative	cumulative	ADJ
dpc-3884	21	4	data	datum	NOUN
dpc-3884	21	5	suggest	suggest	VERB
dpc-3884	21	6	that	that	SCONJ
dpc-3884	21	7	development	development	NOUN
dpc-3884	21	8	of	of	ADP
dpc-3884	21	9	certain	certain	ADJ
dpc-3884	21	10	skin	skin	NOUN
dpc-3884	21	11	toxicities	toxicity	NOUN
dpc-3884	21	12	linked	link	VERB
dpc-3884	21	13	to	to	ADP
dpc-3884	21	14	a	a	DET
dpc-3884	21	15	better	well	ADJ
dpc-3884	21	16	oncologic	oncologic	ADJ
dpc-3884	21	17	outcome	outcome	NOUN
dpc-3884	21	18	,	,	PUNCT
dpc-3884	21	19	as	as	SCONJ
dpc-3884	21	20	indicated	indicate	VERB
dpc-3884	21	21	by	by	ADP
dpc-3884	21	22	the	the	DET
dpc-3884	21	23	longer	long	ADJ
dpc-3884	21	24	progression	progression	NOUN
dpc-3884	21	25	-	-	PUNCT
dpc-3884	21	26	free	free	ADJ
dpc-3884	21	27	and	and	CCONJ
dpc-3884	21	28	overall	overall	ADJ
dpc-3884	21	29	survival	survival	NOUN
dpc-3884	21	30	in	in	ADP
dpc-3884	21	31	these	these	DET
dpc-3884	21	32	patients	patient	NOUN
dpc-3884	21	33	[	[	X
dpc-3884	21	34	8	8	NUM
dpc-3884	21	35	-	-	SYM
dpc-3884	21	36	10	10	NUM
dpc-3884	21	37	]	]	PUNCT
dpc-3884	21	38	.	.	PUNCT
dpc-3884	22	1	the	the	DET
dpc-3884	22	2	quality	quality	NOUN
dpc-3884	22	3	-	-	PUNCT
dpc-3884	22	4	of	of	ADP
dpc-3884	22	5	-	-	PUNCT
dpc-3884	22	6	life	life	NOUN
dpc-3884	22	7	(	(	PUNCT
dpc-3884	22	8	qol	qol	NOUN
dpc-3884	22	9	)	)	PUNCT
dpc-3884	22	10	index	index	NOUN
dpc-3884	22	11	is	be	AUX
dpc-3884	22	12	a	a	DET
dpc-3884	22	13	multidimensional	multidimensional	ADJ
dpc-3884	22	14	concept	concept	NOUN
dpc-3884	22	15	that	that	PRON
dpc-3884	22	16	describes	describe	VERB
dpc-3884	22	17	the	the	DET
dpc-3884	22	18	impact	impact	NOUN
dpc-3884	22	19	of	of	ADP
dpc-3884	22	20	a	a	DET
dpc-3884	22	21	person	person	NOUN
dpc-3884	22	22	health	health	NOUN
dpc-3884	22	23	status	status	NOUN
dpc-3884	22	24	on	on	ADP
dpc-3884	22	25	qol	qol	PROPN
dpc-3884	22	26	.	.	PUNCT
dpc-3884	23	1	it	it	PRON
dpc-3884	23	2	involves	involve	VERB
dpc-3884	23	3	many	many	ADJ
dpc-3884	23	4	aspects	aspect	NOUN
dpc-3884	23	5	of	of	ADP
dpc-3884	23	6	life	life	NOUN
dpc-3884	23	7	,	,	PUNCT
dpc-3884	23	8	including	include	VERB
dpc-3884	23	9	physical	physical	ADJ
dpc-3884	23	10	and	and	CCONJ
dpc-3884	23	11	mental	mental	ADJ
dpc-3884	23	12	health	health	NOUN
dpc-3884	24	1	[	[	X
dpc-3884	24	2	11,12	11,12	NOUN
dpc-3884	24	3	]	]	PUNCT
dpc-3884	24	4	.	.	PUNCT
dpc-3884	25	1	from	from	ADP
dpc-3884	25	2	the	the	DET
dpc-3884	25	3	limited	limited	ADJ
dpc-3884	25	4	available	available	PROPN
dpc-3884	25	5	literature	literature	PROPN
dpc-3884	25	6	data	datum	NOUN
dpc-3884	25	7	,	,	PUNCT
dpc-3884	25	8	it	it	PRON
dpc-3884	25	9	appears	appear	VERB
dpc-3884	25	10	that	that	SCONJ
dpc-3884	25	11	skin	skin	NOUN
dpc-3884	25	12	toxicities	toxicity	NOUN
dpc-3884	25	13	triggered	trigger	VERB
dpc-3884	25	14	by	by	ADP
dpc-3884	25	15	icis	icis	PROPN
dpc-3884	25	16	have	have	VERB
dpc-3884	25	17	a	a	DET
dpc-3884	25	18	significant	significant	ADJ
dpc-3884	25	19	impact	impact	NOUN
dpc-3884	25	20	on	on	ADP
dpc-3884	25	21	patients	patient	NOUN
dpc-3884	25	22	qol	qol	VERB
dpc-3884	25	23	.	.	PUNCT
dpc-3884	26	1	the	the	DET
dpc-3884	26	2	use	use	NOUN
dpc-3884	26	3	of	of	ADP
dpc-3884	26	4	tools	tool	NOUN
dpc-3884	26	5	evaluating	evaluate	VERB
dpc-3884	26	6	qol	qol	NOUN
dpc-3884	26	7	and	and	CCONJ
dpc-3884	26	8	the	the	DET
dpc-3884	26	9	collection	collection	NOUN
dpc-3884	26	10	of	of	ADP
dpc-3884	26	11	patient	patient	NOUN
dpc-3884	26	12	-	-	PUNCT
dpc-3884	26	13	reported	report	VERB
dpc-3884	26	14	outcomes	outcome	NOUN
dpc-3884	26	15	(	(	PUNCT
dpc-3884	26	16	pros	pro	NOUN
dpc-3884	26	17	)	)	PUNCT
dpc-3884	26	18	before	before	ADP
dpc-3884	26	19	and	and	CCONJ
dpc-3884	26	20	after	after	ADP
dpc-3884	26	21	therapeutic	therapeutic	ADJ
dpc-3884	26	22	interventions	intervention	NOUN
dpc-3884	26	23	,	,	PUNCT
dpc-3884	26	24	is	be	AUX
dpc-3884	26	25	of	of	ADP
dpc-3884	26	26	paramount	paramount	ADJ
dpc-3884	26	27	importance	importance	NOUN
dpc-3884	26	28	in	in	ADP
dpc-3884	26	29	modern	modern	ADJ
dpc-3884	26	30	medicine	medicine	NOUN
dpc-3884	26	31	.	.	PUNCT
dpc-3884	27	1	pros	pro	NOUN
dpc-3884	27	2	reflect	reflect	VERB
dpc-3884	27	3	patients	patient	NOUN
dpc-3884	27	4	needs	need	VERB
dpc-3884	27	5	and	and	CCONJ
dpc-3884	27	6	their	their	PRON
dpc-3884	27	7	perspective	perspective	NOUN
dpc-3884	27	8	regarding	regard	VERB
dpc-3884	27	9	treatment	treatment	NOUN
dpc-3884	27	10	outcome	outcome	NOUN
dpc-3884	27	11	and	and	CCONJ
dpc-3884	27	12	should	should	AUX
dpc-3884	27	13	be	be	AUX
dpc-3884	27	14	considered	consider	VERB
dpc-3884	27	15	in	in	ADP
dpc-3884	27	16	treatment	treatment	NOUN
dpc-3884	27	17	decision	decision	NOUN
dpc-3884	27	18	making	make	VERB
dpc-3884	27	19	[	[	X
dpc-3884	27	20	13	13	NUM
dpc-3884	27	21	]	]	PUNCT
dpc-3884	27	22	.	.	PUNCT
dpc-3884	28	1	the	the	DET
dpc-3884	28	2	dermatology	dermatology	NOUN
dpc-3884	28	3	life	life	NOUN
dpc-3884	28	4	quality	quality	NOUN
dpc-3884	28	5	index	index	NOUN
dpc-3884	28	6	(	(	PUNCT
dpc-3884	28	7	dlqi	dlqi	PROPN
dpc-3884	28	8	)	)	PUNCT
dpc-3884	28	9	is	be	AUX
dpc-3884	28	10	a	a	DET
dpc-3884	28	11	10	10	NUM
dpc-3884	28	12	-	-	PUNCT
dpc-3884	28	13	question	question	NOUN
dpc-3884	28	14	questionnaire	questionnaire	NOUN
dpc-3884	28	15	used	use	VERB
dpc-3884	28	16	to	to	PART
dpc-3884	28	17	gauge	gauge	VERB
dpc-3884	28	18	the	the	DET
dpc-3884	28	19	impact	impact	NOUN
dpc-3884	28	20	of	of	ADP
dpc-3884	28	21	skin	skin	NOUN
dpc-3884	28	22	diseases	disease	NOUN
dpc-3884	28	23	on	on	ADP
dpc-3884	28	24	the	the	DET
dpc-3884	28	25	patients	patient	NOUN
dpc-3884	28	26	qol	qol	VERB
dpc-3884	28	27	.	.	PUNCT
dpc-3884	29	1	each	each	DET
dpc-3884	29	2	question	question	NOUN
dpc-3884	29	3	receives	receive	VERB
dpc-3884	29	4	a	a	DET
dpc-3884	29	5	score	score	NOUN
dpc-3884	29	6	from	from	ADP
dpc-3884	29	7	0	0	NUM
dpc-3884	29	8	(	(	PUNCT
dpc-3884	29	9	“	"	PUNCT
dpc-3884	29	10	not	not	PART
dpc-3884	29	11	at	at	ADV
dpc-3884	29	12	all	all	ADV
dpc-3884	29	13	”	"	PUNCT
dpc-3884	29	14	)	)	PUNCT
dpc-3884	29	15	to	to	ADP
dpc-3884	29	16	3	3	NUM
dpc-3884	29	17	(	(	PUNCT
dpc-3884	29	18	“	"	PUNCT
dpc-3884	29	19	very	very	ADV
dpc-3884	29	20	much	much	ADJ
dpc-3884	29	21	”	"	PUNCT
dpc-3884	29	22	)	)	PUNCT
dpc-3884	29	23	.	.	PUNCT
dpc-3884	30	1	the	the	DET
dpc-3884	30	2	sum	sum	NOUN
dpc-3884	30	3	gives	give	VERB
dpc-3884	30	4	the	the	DET
dpc-3884	30	5	total	total	ADJ
dpc-3884	30	6	score	score	NOUN
dpc-3884	30	7	that	that	PRON
dpc-3884	30	8	ranges	range	VERB
dpc-3884	30	9	from	from	ADP
dpc-3884	30	10	0	0	NUM
dpc-3884	30	11	-	-	SYM
dpc-3884	30	12	30	30	NUM
dpc-3884	30	13	.	.	PUNCT
dpc-3884	31	1	a	a	DET
dpc-3884	31	2	score	score	NOUN
dpc-3884	31	3	over	over	ADP
dpc-3884	31	4	10	10	NUM
dpc-3884	31	5	indicates	indicate	VERB
dpc-3884	31	6	that	that	SCONJ
dpc-3884	31	7	the	the	DET
dpc-3884	31	8	patient	patient	NOUN
dpc-3884	31	9	qol	qol	NOUN
dpc-3884	31	10	is	be	AUX
dpc-3884	31	11	being	be	AUX
dpc-3884	31	12	severely	severely	ADV
dpc-3884	31	13	affected	affect	VERB
dpc-3884	31	14	by	by	ADP
dpc-3884	31	15	the	the	DET
dpc-3884	31	16	skin	skin	NOUN
dpc-3884	31	17	disease	disease	NOUN
dpc-3884	31	18	[	[	X
dpc-3884	31	19	14	14	NUM
dpc-3884	31	20	-	-	SYM
dpc-3884	31	21	15	15	NUM
dpc-3884	31	22	]	]	PUNCT
dpc-3884	31	23	.	.	PUNCT
dpc-3884	32	1	the	the	DET
dpc-3884	32	2	numerical	numerical	ADJ
dpc-3884	32	3	rating	rating	NOUN
dpc-3884	32	4	scale	scale	NOUN
dpc-3884	32	5	for	for	ADP
dpc-3884	32	6	pruritus	pruritus	PROPN
dpc-3884	32	7	(	(	PUNCT
dpc-3884	32	8	pnrs	pnrs	NOUN
dpc-3884	32	9	)	)	PUNCT
dpc-3884	32	10	is	be	AUX
dpc-3884	32	11	a	a	DET
dpc-3884	32	12	widely	widely	ADV
dpc-3884	32	13	used	use	VERB
dpc-3884	32	14	ten	ten	NUM
dpc-3884	32	15	-	-	PUNCT
dpc-3884	32	16	point	point	NOUN
dpc-3884	32	17	numerical	numerical	ADJ
dpc-3884	32	18	scale	scale	NOUN
dpc-3884	32	19	,	,	PUNCT
dpc-3884	32	20	in	in	ADP
dpc-3884	32	21	which	which	PRON
dpc-3884	32	22	0	0	NUM
dpc-3884	32	23	represents	represent	VERB
dpc-3884	32	24	“	"	PUNCT
dpc-3884	32	25	no	no	DET
dpc-3884	32	26	”	"	PUNCT
dpc-3884	32	27	itch	itch	NOUN
dpc-3884	32	28	and	and	CCONJ
dpc-3884	32	29	10	10	NUM
dpc-3884	32	30	represents	represent	VERB
dpc-3884	32	31	“	"	PUNCT
dpc-3884	32	32	maximum	maximum	ADJ
dpc-3884	32	33	”	"	PUNCT
dpc-3884	32	34	itch	itch	NOUN
dpc-3884	32	35	.	.	PUNCT
dpc-3884	33	1	the	the	DET
dpc-3884	33	2	eortc	eortc	VERB
dpc-3884	33	3	-	-	PUNCT
dpc-3884	33	4	qlq	qlq	NOUN
dpc-3884	33	5	-	-	PUNCT
dpc-3884	33	6	c30	c30	NOUN
dpc-3884	33	7	is	be	AUX
dpc-3884	33	8	a	a	DET
dpc-3884	33	9	specialized	specialized	ADJ
dpc-3884	33	10	questionnaire	questionnaire	NOUN
dpc-3884	33	11	,	,	PUNCT
dpc-3884	33	12	developed	develop	VERB
dpc-3884	33	13	in	in	ADP
dpc-3884	33	14	1988	1988	NUM
dpc-3884	33	15	to	to	PART
dpc-3884	33	16	capture	capture	VERB
dpc-3884	33	17	the	the	DET
dpc-3884	33	18	qol	qol	NOUN
dpc-3884	33	19	of	of	ADP
dpc-3884	33	20	oncologic	oncologic	NOUN
dpc-3884	33	21	patients	patient	NOUN
dpc-3884	33	22	.	.	PUNCT
dpc-3884	34	1	it	it	PRON
dpc-3884	34	2	includes	include	VERB
dpc-3884	34	3	9	9	NUM
dpc-3884	34	4	sections	section	NOUN
dpc-3884	34	5	:	:	PUNCT
dpc-3884	34	6	5	5	NUM
dpc-3884	34	7	functional	functional	ADJ
dpc-3884	34	8	sections	section	NOUN
dpc-3884	34	9	(	(	PUNCT
dpc-3884	34	10	physical	physical	ADJ
dpc-3884	34	11	condition	condition	NOUN
dpc-3884	34	12	,	,	PUNCT
dpc-3884	34	13	posture	posture	NOUN
dpc-3884	34	14	,	,	PUNCT
dpc-3884	34	15	perceptual	perceptual	ADJ
dpc-3884	34	16	ability	ability	NOUN
dpc-3884	34	17	,	,	PUNCT
dpc-3884	34	18	emotional	emotional	ADJ
dpc-3884	34	19	and	and	CCONJ
dpc-3884	34	20	social	social	ADJ
dpc-3884	34	21	functioning	functioning	NOUN
dpc-3884	34	22	)	)	PUNCT
dpc-3884	34	23	,	,	PUNCT
dpc-3884	34	24	3	3	NUM
dpc-3884	34	25	symptom	symptom	NOUN
dpc-3884	34	26	-	-	PUNCT
dpc-3884	34	27	related	relate	VERB
dpc-3884	34	28	sections	section	NOUN
dpc-3884	34	29	(	(	PUNCT
dpc-3884	34	30	fatigue	fatigue	NOUN
dpc-3884	34	31	,	,	PUNCT
dpc-3884	34	32	pain	pain	NOUN
dpc-3884	34	33	and	and	CCONJ
dpc-3884	34	34	nausea	nausea	NOUN
dpc-3884	34	35	)	)	PUNCT
dpc-3884	34	36	and	and	CCONJ
dpc-3884	34	37	1	1	NUM
dpc-3884	34	38	section	section	NOUN
dpc-3884	34	39	regarding	regard	VERB
dpc-3884	34	40	the	the	DET
dpc-3884	34	41	patient	patient	ADJ
dpc-3884	34	42	general	general	ADJ
dpc-3884	34	43	health	health	NOUN
dpc-3884	34	44	status	status	NOUN
dpc-3884	34	45	(	(	PUNCT
dpc-3884	34	46	ghs	ghs	PROPN
dpc-3884	34	47	)	)	PUNCT
dpc-3884	35	1	[	[	X
dpc-3884	35	2	11,12	11,12	NUM
dpc-3884	35	3	]	]	PUNCT
dpc-3884	35	4	.	.	PUNCT
dpc-3884	36	1	scores	score	NOUN
dpc-3884	36	2	range	range	VERB
dpc-3884	36	3	from	from	ADP
dpc-3884	36	4	0	0	NUM
dpc-3884	36	5	to	to	ADP
dpc-3884	36	6	100	100	NUM
dpc-3884	36	7	,	,	PUNCT
dpc-3884	36	8	with	with	ADP
dpc-3884	36	9	a	a	DET
dpc-3884	36	10	10	10	NUM
dpc-3884	36	11	-	-	PUNCT
dpc-3884	36	12	point	point	NOUN
dpc-3884	36	13	score	score	NOUN
dpc-3884	36	14	shift	shift	NOUN
dpc-3884	36	15	corresponding	correspond	VERB
dpc-3884	36	16	to	to	ADP
dpc-3884	36	17	a	a	DET
dpc-3884	36	18	clinically	clinically	ADV
dpc-3884	36	19	meaningful	meaningful	ADJ
dpc-3884	36	20	change	change	NOUN
dpc-3884	36	21	[	[	X
dpc-3884	36	22	16	16	NUM
dpc-3884	36	23	]	]	PUNCT
dpc-3884	36	24	.	.	PUNCT
dpc-3884	37	1	a	a	DET
dpc-3884	37	2	high	high	ADJ
dpc-3884	37	3	score	score	NOUN
dpc-3884	37	4	in	in	ADP
dpc-3884	37	5	functional	functional	ADJ
dpc-3884	37	6	scales	scale	NOUN
dpc-3884	37	7	suggests	suggest	VERB
dpc-3884	37	8	a	a	DET
dpc-3884	37	9	high/	high/	NUM
dpc-3884	37	10	healthy	healthy	ADJ
dpc-3884	37	11	level	level	NOUN
dpc-3884	37	12	of	of	ADP
dpc-3884	37	13	functioning	functioning	NOUN
dpc-3884	37	14	,	,	PUNCT
dpc-3884	37	15	which	which	PRON
dpc-3884	37	16	translates	translate	VERB
dpc-3884	37	17	to	to	ADP
dpc-3884	37	18	a	a	DET
dpc-3884	37	19	higher	high	ADJ
dpc-3884	37	20	overall	overall	ADJ
dpc-3884	37	21	health	health	NOUN
dpc-3884	37	22	status	status	NOUN
dpc-3884	37	23	/	/	SYM
dpc-3884	37	24	qol	qol	PROPN
dpc-3884	37	25	.	.	PUNCT
dpc-3884	38	1	in	in	ADP
dpc-3884	38	2	contrast	contrast	NOUN
dpc-3884	38	3	,	,	PUNCT
dpc-3884	38	4	a	a	DET
dpc-3884	38	5	higher	high	ADJ
dpc-3884	38	6	score	score	NOUN
dpc-3884	38	7	on	on	ADP
dpc-3884	38	8	a	a	DET
dpc-3884	38	9	physical	physical	ADJ
dpc-3884	38	10	symptom	symptom	NOUN
dpc-3884	38	11	scales	scale	NOUN
dpc-3884	38	12	indicates	indicate	VERB
dpc-3884	38	13	a	a	DET
dpc-3884	38	14	higher	high	ADJ
dpc-3884	38	15	level	level	NOUN
dpc-3884	38	16	of	of	ADP
dpc-3884	38	17	problems	problem	NOUN
dpc-3884	38	18	[	[	X
dpc-3884	38	19	17	17	NUM
dpc-3884	38	20	]	]	PUNCT
dpc-3884	38	21	.	.	PUNCT
dpc-3884	39	1	objectives	objective	NOUN
dpc-3884	39	2	in	in	ADP
dpc-3884	39	3	this	this	DET
dpc-3884	39	4	study	study	NOUN
dpc-3884	39	5	we	we	PRON
dpc-3884	39	6	aimed	aim	VERB
dpc-3884	39	7	to	to	PART
dpc-3884	39	8	record	record	VERB
dpc-3884	39	9	the	the	DET
dpc-3884	39	10	impact	impact	NOUN
dpc-3884	39	11	of	of	ADP
dpc-3884	39	12	diraes	diraes	NOUN
dpc-3884	39	13	on	on	ADP
dpc-3884	39	14	patient	patient	ADJ
dpc-3884	39	15	qol	qol	PROPN
dpc-3884	39	16	,	,	PUNCT
dpc-3884	39	17	using	use	VERB
dpc-3884	39	18	dlqi	dlqi	NOUN
dpc-3884	39	19	,	,	PUNCT
dpc-3884	39	20	pnrs	pnrs	NOUN
dpc-3884	39	21	and	and	CCONJ
dpc-3884	39	22	eortc	eortc	VERB
dpc-3884	39	23	-	-	PUNCT
dpc-3884	39	24	qlq	qlq	NOUN
dpc-3884	39	25	-	-	PUNCT
dpc-3884	39	26	c30	c30	NOUN
dpc-3884	39	27	and	and	CCONJ
dpc-3884	39	28	the	the	DET
dpc-3884	39	29	modification	modification	NOUN
dpc-3884	39	30	of	of	ADP
dpc-3884	39	31	these	these	DET
dpc-3884	39	32	scores	score	NOUN
dpc-3884	39	33	after	after	ADP
dpc-3884	39	34	therapeutic	therapeutic	ADJ
dpc-3884	39	35	interventions	intervention	NOUN
dpc-3884	39	36	by	by	ADP
dpc-3884	39	37	specialized	specialized	ADJ
dpc-3884	39	38	dermatologists	dermatologist	NOUN
dpc-3884	39	39	.	.	PUNCT
dpc-3884	40	1	we	we	PRON
dpc-3884	40	2	also	also	ADV
dpc-3884	40	3	attempted	attempt	VERB
dpc-3884	40	4	to	to	PART
dpc-3884	40	5	correlate	correlate	VERB
dpc-3884	40	6	baseline	baseline	ADJ
dpc-3884	40	7	patients	patient	NOUN
dpc-3884	40	8	and	and	CCONJ
dpc-3884	40	9	toxicity	toxicity	NOUN
dpc-3884	40	10	characteristics	characteristic	NOUN
dpc-3884	40	11	with	with	ADP
dpc-3884	40	12	qol	qol	NOUN
dpc-3884	40	13	.	.	PUNCT
dpc-3884	41	1	furthermore	furthermore	ADV
dpc-3884	41	2	,	,	PUNCT
dpc-3884	41	3	we	we	PRON
dpc-3884	41	4	tested	test	VERB
dpc-3884	41	5	the	the	DET
dpc-3884	41	6	correlation	correlation	NOUN
dpc-3884	41	7	between	between	ADP
dpc-3884	41	8	the	the	DET
dpc-3884	41	9	dermatology	dermatology	NOUN
dpc-3884	41	10	qol	qol	NOUN
dpc-3884	41	11	index	index	NOUN
dpc-3884	41	12	and	and	CCONJ
dpc-3884	41	13	eortc	eortc	VERB
dpc-3884	41	14	-	-	PUNCT
dpc-3884	41	15	qlq	qlq	NOUN
dpc-3884	41	16	-	-	PUNCT
dpc-3884	41	17	c30	c30	NOUN
dpc-3884	41	18	,	,	PUNCT
dpc-3884	41	19	in	in	ADP
dpc-3884	41	20	order	order	NOUN
dpc-3884	41	21	to	to	PART
dpc-3884	41	22	clarify	clarify	VERB
dpc-3884	41	23	whether	whether	SCONJ
dpc-3884	41	24	the	the	DET
dpc-3884	41	25	latter	latter	ADJ
dpc-3884	41	26	can	can	AUX
dpc-3884	41	27	adequately	adequately	ADV
dpc-3884	41	28	capture	capture	VERB
dpc-3884	41	29	the	the	DET
dpc-3884	41	30	qol	qol	NOUN
dpc-3884	41	31	impairment	impairment	NOUN
dpc-3884	41	32	induced	induce	VERB
dpc-3884	41	33	by	by	ADP
dpc-3884	41	34	skin	skin	NOUN
dpc-3884	41	35	toxicity	toxicity	NOUN
dpc-3884	41	36	.	.	PUNCT
dpc-3884	42	1	methods	method	NOUN
dpc-3884	42	2	the	the	DET
dpc-3884	42	3	study	study	NOUN
dpc-3884	42	4	was	be	AUX
dpc-3884	42	5	conducted	conduct	VERB
dpc-3884	42	6	in	in	ADP
dpc-3884	42	7	two	two	NUM
dpc-3884	42	8	supportive	supportive	ADJ
dpc-3884	42	9	onco	onco	NOUN
dpc-3884	42	10	dermatology	dermatology	NOUN
dpc-3884	42	11	outpatient	outpatient	NOUN
dpc-3884	42	12	clinics	clinic	NOUN
dpc-3884	42	13	in	in	ADP
dpc-3884	42	14	greece	greece	PROPN
dpc-3884	42	15	.	.	PUNCT
dpc-3884	43	1	oncologic	oncologic	ADJ
dpc-3884	43	2	patients	patient	NOUN
dpc-3884	43	3	who	who	PRON
dpc-3884	43	4	developed	develop	VERB
dpc-3884	43	5	diraes	diraes	NOUN
dpc-3884	43	6	from	from	ADP
dpc-3884	43	7	july	july	PROPN
dpc-3884	43	8	2020	2020	NUM
dpc-3884	43	9	to	to	ADP
dpc-3884	43	10	july	july	PROPN
dpc-3884	43	11	2022	2022	NUM
dpc-3884	43	12	and	and	CCONJ
dpc-3884	43	13	were	be	AUX
dpc-3884	43	14	referred	refer	VERB
dpc-3884	43	15	for	for	ADP
dpc-3884	43	16	dermatologic	dermatologic	ADJ
dpc-3884	43	17	consultation	consultation	NOUN
dpc-3884	43	18	were	be	AUX
dpc-3884	43	19	enrolled	enrol	VERB
dpc-3884	43	20	for	for	ADP
dpc-3884	43	21	the	the	DET
dpc-3884	43	22	aims	aim	NOUN
dpc-3884	43	23	of	of	ADP
dpc-3884	43	24	the	the	DET
dpc-3884	43	25	study	study	NOUN
dpc-3884	43	26	.	.	PUNCT
dpc-3884	44	1	the	the	DET
dpc-3884	44	2	study	study	NOUN
dpc-3884	44	3	received	receive	VERB
dpc-3884	44	4	approval	approval	NOUN
dpc-3884	44	5	from	from	ADP
dpc-3884	44	6	the	the	DET
dpc-3884	44	7	institutional	institutional	ADJ
dpc-3884	44	8	ethical	ethical	PROPN
dpc-3884	44	9	committee	committee	NOUN
dpc-3884	44	10	(	(	PUNCT
dpc-3884	44	11	6296/01	6296/01	NOUN
dpc-3884	44	12	-	-	PUNCT
dpc-3884	44	13	jul-2020	jul-2020	NOUN
dpc-3884	44	14	)	)	PUNCT
dpc-3884	44	15	results	result	NOUN
dpc-3884	44	16	:	:	PUNCT
dpc-3884	44	17	overall	overall	ADJ
dpc-3884	44	18	,	,	PUNCT
dpc-3884	44	19	110	110	NUM
dpc-3884	44	20	patients	patient	NOUN
dpc-3884	44	21	were	be	AUX
dpc-3884	44	22	enrolled	enrol	VERB
dpc-3884	44	23	in	in	ADP
dpc-3884	44	24	the	the	DET
dpc-3884	44	25	study	study	NOUN
dpc-3884	44	26	.	.	PUNCT
dpc-3884	45	1	mean	mean	VERB
dpc-3884	45	2	(	(	PUNCT
dpc-3884	45	3	standard	standard	ADJ
dpc-3884	45	4	deviation	deviation	NOUN
dpc-3884	45	5	)	)	PUNCT
dpc-3884	45	6	dlqi	dlqi	NOUN
dpc-3884	45	7	and	and	CCONJ
dpc-3884	45	8	pnrs	pnrs	NOUN
dpc-3884	45	9	scores	score	NOUN
dpc-3884	45	10	were	be	AUX
dpc-3884	45	11	15.54	15.54	NUM
dpc-3884	45	12	(	(	PUNCT
dpc-3884	45	13	5.44	5.44	NUM
dpc-3884	45	14	)	)	PUNCT
dpc-3884	45	15	and	and	CCONJ
dpc-3884	45	16	7.25	7.25	NUM
dpc-3884	45	17	(	(	PUNCT
dpc-3884	45	18	2.95	2.95	NUM
dpc-3884	45	19	)	)	PUNCT
dpc-3884	45	20	,	,	PUNCT
dpc-3884	45	21	correspondingly	correspondingly	ADV
dpc-3884	45	22	,	,	PUNCT
dpc-3884	45	23	while	while	SCONJ
dpc-3884	45	24	functional	functional	ADJ
dpc-3884	45	25	,	,	PUNCT
dpc-3884	45	26	symptom	symptom	NOUN
dpc-3884	45	27	and	and	CCONJ
dpc-3884	45	28	summary	summary	NOUN
dpc-3884	45	29	scores	score	NOUN
dpc-3884	45	30	of	of	ADP
dpc-3884	45	31	eortc	eortc	VERB
dpc-3884	45	32	-	-	PUNCT
dpc-3884	45	33	c30	c30	NOUN
dpc-3884	45	34	were	be	AUX
dpc-3884	45	35	79.17	79.17	NUM
dpc-3884	45	36	(	(	PUNCT
dpc-3884	45	37	2.11	2.11	NUM
dpc-3884	45	38	)	)	PUNCT
dpc-3884	45	39	,	,	PUNCT
dpc-3884	45	40	17.66	17.66	NUM
dpc-3884	45	41	(	(	PUNCT
dpc-3884	45	42	3.60	3.60	NUM
dpc-3884	45	43	)	)	PUNCT
dpc-3884	45	44	and	and	CCONJ
dpc-3884	45	45	80.67	80.67	NUM
dpc-3884	45	46	(	(	PUNCT
dpc-3884	45	47	3.08	3.08	NUM
dpc-3884	45	48	)	)	PUNCT
dpc-3884	45	49	,	,	PUNCT
dpc-3884	45	50	respectively	respectively	ADV
dpc-3884	45	51	.	.	PUNCT
dpc-3884	46	1	after	after	ADP
dpc-3884	46	2	therapeutic	therapeutic	ADJ
dpc-3884	46	3	interventions	intervention	NOUN
dpc-3884	46	4	,	,	PUNCT
dpc-3884	46	5	there	there	PRON
dpc-3884	46	6	was	be	VERB
dpc-3884	46	7	a	a	DET
dpc-3884	46	8	statistically	statistically	ADV
dpc-3884	46	9	significant	significant	ADJ
dpc-3884	46	10	decrease	decrease	NOUN
dpc-3884	46	11	in	in	ADP
dpc-3884	46	12	dlqi	dlqi	ADJ
dpc-3884	46	13	scores	score	NOUN
dpc-3884	46	14	after	after	ADP
dpc-3884	46	15	first	first	ADJ
dpc-3884	46	16	intervention	intervention	NOUN
dpc-3884	46	17	compared	compare	VERB
dpc-3884	46	18	to	to	PART
dpc-3884	46	19	baseline	baseline	VERB
dpc-3884	46	20	,	,	PUNCT
dpc-3884	46	21	and	and	CCONJ
dpc-3884	46	22	second	second	ADJ
dpc-3884	46	23	intervention	intervention	NOUN
dpc-3884	46	24	compared	compare	VERB
dpc-3884	46	25	to	to	ADP
dpc-3884	46	26	first	first	ADV
dpc-3884	46	27	(	(	PUNCT
dpc-3884	46	28	mean	mean	INTJ
dpc-3884	46	29	decrease	decrease	NOUN
dpc-3884	46	30	4.38	4.38	NUM
dpc-3884	46	31	(	(	PUNCT
dpc-3884	46	32	2.91	2.91	NUM
dpc-3884	46	33	)	)	PUNCT
dpc-3884	46	34	,	,	PUNCT
dpc-3884	46	35	p	p	X
dpc-3884	46	36	<	<	X
dpc-3884	46	37	0.001	0.001	NUM
dpc-3884	46	38	and	and	CCONJ
dpc-3884	46	39	5.16	5.16	NUM
dpc-3884	46	40	(	(	PUNCT
dpc-3884	46	41	3.99	3.99	NUM
dpc-3884	46	42	)	)	PUNCT
dpc-3884	46	43	,	,	PUNCT
dpc-3884	46	44	p	p	X
dpc-3884	46	45	<	<	X
dpc-3884	46	46	0.001	0.001	NUM
dpc-3884	46	47	,	,	PUNCT
dpc-3884	46	48	respectively	respectively	ADV
dpc-3884	46	49	)	)	PUNCT
dpc-3884	46	50	.	.	PUNCT
dpc-3884	47	1	dlqi	dlqi	PROPN
dpc-3884	47	2	showed	show	VERB
dpc-3884	47	3	no	no	DET
dpc-3884	47	4	correlation	correlation	NOUN
dpc-3884	47	5	with	with	ADP
dpc-3884	47	6	global	global	ADJ
dpc-3884	47	7	health	health	NOUN
dpc-3884	47	8	status	status	NOUN
dpc-3884	47	9	/	/	SYM
dpc-3884	47	10	qols	qol	NOUN
dpc-3884	47	11	(	(	PUNCT
dpc-3884	47	12	rho	rho	NOUN
dpc-3884	47	13	0.01	0.01	NUM
dpc-3884	47	14	,	,	PUNCT
dpc-3884	47	15	p	p	X
dpc-3884	47	16	=	=	NOUN
dpc-3884	47	17	0.90	0.90	NUM
dpc-3884	47	18	)	)	PUNCT
dpc-3884	47	19	of	of	ADP
dpc-3884	47	20	eortc	eortc	VERB
dpc-3884	47	21	-	-	PUNCT
dpc-3884	47	22	c30	c30	NOUN
dpc-3884	47	23	.	.	PUNCT
dpc-3884	48	1	conclusions	conclusion	NOUN
dpc-3884	48	2	:	:	PUNCT
dpc-3884	48	3	diraes	dirae	NOUN
dpc-3884	48	4	negatively	negatively	ADV
dpc-3884	48	5	affect	affect	VERB
dpc-3884	48	6	qol	qol	PROPN
dpc-3884	48	7	.	.	PUNCT
dpc-3884	49	1	dermatologic	dermatologic	ADJ
dpc-3884	49	2	intervention	intervention	NOUN
dpc-3884	49	3	improves	improve	VERB
dpc-3884	49	4	patients	patient	NOUN
dpc-3884	49	5	qol	qol	ADV
dpc-3884	49	6	,	,	PUNCT
dpc-3884	49	7	facilitating	facilitate	VERB
dpc-3884	49	8	an	an	DET
dpc-3884	49	9	unimpaired	unimpaired	ADJ
dpc-3884	49	10	oncologic	oncologic	ADJ
dpc-3884	49	11	treatment	treatment	NOUN
dpc-3884	49	12	.	.	PUNCT
dpc-3884	50	1	poor	poor	ADJ
dpc-3884	50	2	correlation	correlation	NOUN
dpc-3884	50	3	between	between	ADP
dpc-3884	50	4	dlqi	dlqi	NOUN
dpc-3884	50	5	and	and	CCONJ
dpc-3884	50	6	eortc	eortc	VERB
dpc-3884	50	7	-	-	PUNCT
dpc-3884	50	8	qlq-30	qlq-30	NOUN
dpc-3884	50	9	highlights	highlight	NOUN
dpc-3884	50	10	the	the	DET
dpc-3884	50	11	need	need	NOUN
dpc-3884	50	12	for	for	ADP
dpc-3884	50	13	adapted	adapted	ADJ
dpc-3884	50	14	qol	qol	NOUN
dpc-3884	50	15	measurement	measurement	NOUN
dpc-3884	50	16	tools	tool	NOUN
dpc-3884	50	17	in	in	ADP
dpc-3884	50	18	the	the	DET
dpc-3884	50	19	context	context	NOUN
dpc-3884	50	20	of	of	ADP
dpc-3884	50	21	immune	immune	ADJ
dpc-3884	50	22	checkpoint	checkpoint	NOUN
dpc-3884	50	23	inhibitors	inhibitor	NOUN
dpc-3884	50	24	treatment	treatment	NOUN
dpc-3884	50	25	.	.	PUNCT
dpc-3884	51	1	original	original	ADJ
dpc-3884	51	2	article	article	NOUN
dpc-3884	51	3	|	|	ADV
dpc-3884	51	4	dermatol	dermatol	ADJ
dpc-3884	51	5	pract	pract	NOUN
dpc-3884	51	6	concept	concept	NOUN
dpc-3884	51	7	.	.	PUNCT
dpc-3884	52	1	2024;14(3):e2024118	2024;14(3):e2024118	NUM
dpc-3884	52	2	3	3	NUM
dpc-3884	53	1	and	and	CCONJ
dpc-3884	53	2	it	it	PRON
dpc-3884	53	3	was	be	AUX
dpc-3884	53	4	conducted	conduct	VERB
dpc-3884	53	5	in	in	ADP
dpc-3884	53	6	accordance	accordance	NOUN
dpc-3884	53	7	with	with	ADP
dpc-3884	53	8	the	the	DET
dpc-3884	53	9	provisions	provision	NOUN
dpc-3884	53	10	of	of	ADP
dpc-3884	53	11	helsinki	helsinki	PROPN
dpc-3884	53	12	declaration	declaration	PROPN
dpc-3884	53	13	and	and	CCONJ
dpc-3884	53	14	good	good	ADJ
dpc-3884	53	15	clinical	clinical	ADJ
dpc-3884	53	16	practice	practice	NOUN
dpc-3884	53	17	guidelines	guideline	NOUN
dpc-3884	53	18	.	.	PUNCT
dpc-3884	54	1	all	all	DET
dpc-3884	54	2	participants	participant	NOUN
dpc-3884	54	3	provided	provide	VERB
dpc-3884	54	4	written	write	VERB
dpc-3884	54	5	informed	inform	VERB
dpc-3884	54	6	consent	consent	NOUN
dpc-3884	54	7	before	before	ADP
dpc-3884	54	8	undergoing	undergo	VERB
dpc-3884	54	9	any	any	DET
dpc-3884	54	10	procedure	procedure	NOUN
dpc-3884	54	11	related	relate	VERB
dpc-3884	54	12	to	to	ADP
dpc-3884	54	13	the	the	DET
dpc-3884	54	14	study	study	NOUN
dpc-3884	54	15	.	.	PUNCT
dpc-3884	55	1	inclusion	inclusion	NOUN
dpc-3884	55	2	criteria	criterion	NOUN
dpc-3884	55	3	were	be	AUX
dpc-3884	55	4	age	age	NOUN
dpc-3884	55	5	>	>	SYM
dpc-3884	55	6	18	18	NUM
dpc-3884	55	7	years	year	NOUN
dpc-3884	55	8	and	and	CCONJ
dpc-3884	55	9	the	the	DET
dpc-3884	55	10	appearance	appearance	NOUN
dpc-3884	55	11	of	of	ADP
dpc-3884	55	12	at	at	ADV
dpc-3884	55	13	least	least	ADV
dpc-3884	55	14	one	one	NUM
dpc-3884	55	15	diraes	dirae	NOUN
dpc-3884	55	16	due	due	ADJ
dpc-3884	55	17	to	to	ADP
dpc-3884	55	18	icis	icis	PROPN
dpc-3884	55	19	.	.	PUNCT
dpc-3884	56	1	exclusion	exclusion	NOUN
dpc-3884	56	2	criteria	criterion	NOUN
dpc-3884	56	3	were	be	AUX
dpc-3884	56	4	co	co	NOUN
dpc-3884	56	5	-	-	NOUN
dpc-3884	56	6	morbidities	morbidity	NOUN
dpc-3884	56	7	and	and	CCONJ
dpc-3884	56	8	co	co	NOUN
dpc-3884	56	9	-	-	NOUN
dpc-3884	56	10	medications	medication	NOUN
dpc-3884	56	11	that	that	PRON
dpc-3884	56	12	could	could	AUX
dpc-3884	56	13	result	result	VERB
dpc-3884	56	14	in	in	ADP
dpc-3884	56	15	development	development	NOUN
dpc-3884	56	16	of	of	ADP
dpc-3884	56	17	skin	skin	NOUN
dpc-3884	56	18	rashes	rash	NOUN
dpc-3884	56	19	similar	similar	ADJ
dpc-3884	56	20	to	to	ADP
dpc-3884	56	21	diraes	dirae	NOUN
dpc-3884	56	22	,	,	PUNCT
dpc-3884	56	23	as	as	ADV
dpc-3884	56	24	well	well	ADV
dpc-3884	56	25	as	as	ADP
dpc-3884	56	26	individuals	individual	NOUN
dpc-3884	56	27	who	who	PRON
dpc-3884	56	28	did	do	AUX
dpc-3884	56	29	not	not	PART
dpc-3884	56	30	have	have	VERB
dpc-3884	56	31	adequate	adequate	ADJ
dpc-3884	56	32	level	level	NOUN
dpc-3884	56	33	of	of	ADP
dpc-3884	56	34	greek	greek	ADJ
dpc-3884	56	35	language	language	NOUN
dpc-3884	56	36	,	,	PUNCT
dpc-3884	56	37	or	or	CCONJ
dpc-3884	56	38	were	be	AUX
dpc-3884	56	39	mentally	mentally	ADV
dpc-3884	56	40	and	and	CCONJ
dpc-3884	56	41	physically	physically	ADV
dpc-3884	56	42	unable	unable	ADJ
dpc-3884	56	43	to	to	PART
dpc-3884	56	44	complete	complete	VERB
dpc-3884	56	45	the	the	DET
dpc-3884	56	46	questionnaires	questionnaire	NOUN
dpc-3884	56	47	.	.	PUNCT
dpc-3884	57	1	the	the	DET
dpc-3884	57	2	patients	patient	NOUN
dpc-3884	57	3	first	first	ADV
dpc-3884	57	4	visit	visit	NOUN
dpc-3884	57	5	included	include	VERB
dpc-3884	57	6	the	the	DET
dpc-3884	57	7	clinical	clinical	ADJ
dpc-3884	57	8	assessment	assessment	NOUN
dpc-3884	57	9	of	of	ADP
dpc-3884	57	10	the	the	DET
dpc-3884	57	11	skin	skin	NOUN
dpc-3884	57	12	rash	rash	NOUN
dpc-3884	57	13	,	,	PUNCT
dpc-3884	57	14	the	the	DET
dpc-3884	57	15	evaluation	evaluation	NOUN
dpc-3884	57	16	of	of	ADP
dpc-3884	57	17	its	its	PRON
dpc-3884	57	18	severity	severity	NOUN
dpc-3884	57	19	based	base	VERB
dpc-3884	57	20	on	on	ADP
dpc-3884	57	21	the	the	DET
dpc-3884	57	22	ctcae	ctcae	PROPN
dpc-3884	57	23	v4.0	v4.0	NOUN
dpc-3884	57	24	criteria	criterion	NOUN
dpc-3884	57	25	,	,	PUNCT
dpc-3884	57	26	the	the	DET
dpc-3884	57	27	completion	completion	NOUN
dpc-3884	57	28	of	of	ADP
dpc-3884	57	29	the	the	DET
dpc-3884	57	30	dlqi	dlqi	NOUN
dpc-3884	57	31	,	,	PUNCT
dpc-3884	57	32	pnrs	pnrs	NOUN
dpc-3884	57	33	and	and	CCONJ
dpc-3884	57	34	eortc	eortc	VERB
dpc-3884	57	35	-	-	PUNCT
dpc-3884	57	36	qlq	qlq	ADJ
dpc-3884	57	37	-	-	PUNCT
dpc-3884	57	38	c30	c30	NOUN
dpc-3884	57	39	questionnaires	questionnaire	NOUN
dpc-3884	57	40	and	and	CCONJ
dpc-3884	57	41	the	the	DET
dpc-3884	57	42	administration	administration	NOUN
dpc-3884	57	43	of	of	ADP
dpc-3884	57	44	treatment	treatment	NOUN
dpc-3884	57	45	according	accord	VERB
dpc-3884	57	46	to	to	ADP
dpc-3884	57	47	standard	standard	ADJ
dpc-3884	57	48	clinical	clinical	ADJ
dpc-3884	57	49	practice	practice	NOUN
dpc-3884	57	50	[	[	X
dpc-3884	57	51	18,19	18,19	NUM
dpc-3884	57	52	]	]	PUNCT
dpc-3884	57	53	.	.	PUNCT
dpc-3884	58	1	iraes	iraes	PROPN
dpc-3884	58	2	,	,	PUNCT
dpc-3884	58	3	including	include	VERB
dpc-3884	58	4	diraes	dirae	NOUN
dpc-3884	58	5	,	,	PUNCT
dpc-3884	58	6	were	be	AUX
dpc-3884	58	7	recorded.during	recorded.dure	VERB
dpc-3884	58	8	follow	follow	VERB
dpc-3884	58	9	-	-	PUNCT
dpc-3884	58	10	up	up	ADP
dpc-3884	58	11	visits	visit	NOUN
dpc-3884	58	12	,	,	PUNCT
dpc-3884	58	13	scheduled	schedule	VERB
dpc-3884	58	14	at	at	ADP
dpc-3884	58	15	4	4	NUM
dpc-3884	58	16	and	and	CCONJ
dpc-3884	58	17	12	12	NUM
dpc-3884	58	18	weeks	week	NOUN
dpc-3884	58	19	from	from	ADP
dpc-3884	58	20	baseline	baseline	NOUN
dpc-3884	58	21	.	.	PUNCT
dpc-3884	59	1	during	during	ADP
dpc-3884	59	2	the	the	DET
dpc-3884	59	3	follow	follow	NOUN
dpc-3884	59	4	-	-	PUNCT
dpc-3884	59	5	up	up	ADP
dpc-3884	59	6	visits	visit	NOUN
dpc-3884	59	7	,	,	PUNCT
dpc-3884	59	8	the	the	DET
dpc-3884	59	9	severity	severity	NOUN
dpc-3884	59	10	of	of	ADP
dpc-3884	59	11	iraes	irae	NOUN
dpc-3884	59	12	based	base	VERB
dpc-3884	59	13	on	on	ADP
dpc-3884	59	14	ctcae	ctcae	NOUN
dpc-3884	59	15	was	be	AUX
dpc-3884	59	16	evaluated	evaluate	VERB
dpc-3884	59	17	and	and	CCONJ
dpc-3884	59	18	eortc	eortc	VERB
dpc-3884	59	19	-	-	PUNCT
dpc-3884	59	20	qlq	qlq	NOUN
dpc-3884	59	21	-	-	PUNCT
dpc-3884	59	22	c30	c30	NOUN
dpc-3884	59	23	,	,	PUNCT
dpc-3884	59	24	dlqi	dlqi	ADJ
dpc-3884	59	25	,	,	PUNCT
dpc-3884	59	26	and	and	CCONJ
dpc-3884	59	27	pnrs	pnrs	NOUN
dpc-3884	59	28	were	be	AUX
dpc-3884	59	29	collected	collect	VERB
dpc-3884	59	30	.	.	PUNCT
dpc-3884	60	1	additional	additional	ADJ
dpc-3884	60	2	recorded	record	VERB
dpc-3884	60	3	data	datum	NOUN
dpc-3884	60	4	included	include	VERB
dpc-3884	60	5	the	the	DET
dpc-3884	60	6	evolution	evolution	NOUN
dpc-3884	60	7	of	of	ADP
dpc-3884	60	8	the	the	DET
dpc-3884	60	9	underlying	underlying	ADJ
dpc-3884	60	10	neoplasm	neoplasm	NOUN
dpc-3884	60	11	and	and	CCONJ
dpc-3884	60	12	the	the	DET
dpc-3884	60	13	impact	impact	NOUN
dpc-3884	60	14	of	of	ADP
dpc-3884	60	15	the	the	DET
dpc-3884	60	16	dermatologic	dermatologic	ADJ
dpc-3884	60	17	adverse	adverse	ADJ
dpc-3884	60	18	event	event	NOUN
dpc-3884	60	19	on	on	ADP
dpc-3884	60	20	the	the	DET
dpc-3884	60	21	oncologic	oncologic	ADJ
dpc-3884	60	22	treatment	treatment	NOUN
dpc-3884	60	23	.	.	PUNCT
dpc-3884	61	1	topography	topography	NOUN
dpc-3884	61	2	of	of	ADP
dpc-3884	61	3	the	the	DET
dpc-3884	61	4	rash	rash	NOUN
dpc-3884	61	5	was	be	AUX
dpc-3884	61	6	documented	document	VERB
dpc-3884	61	7	with	with	ADP
dpc-3884	61	8	the	the	DET
dpc-3884	61	9	use	use	NOUN
dpc-3884	61	10	of	of	ADP
dpc-3884	61	11	digital	digital	ADJ
dpc-3884	61	12	imaging	imaging	NOUN
dpc-3884	61	13	at	at	ADP
dpc-3884	61	14	baseline	baseline	NOUN
dpc-3884	61	15	and	and	CCONJ
dpc-3884	61	16	follow	follow	VERB
dpc-3884	61	17	-	-	PUNCT
dpc-3884	61	18	up	up	ADP
dpc-3884	61	19	visits	visit	NOUN
dpc-3884	61	20	.	.	PUNCT
dpc-3884	62	1	statistics	statistic	NOUN
dpc-3884	62	2	a	a	DET
dpc-3884	62	3	descriptive	descriptive	ADJ
dpc-3884	62	4	analysis	analysis	NOUN
dpc-3884	62	5	with	with	ADP
dpc-3884	62	6	mean	mean	ADJ
dpc-3884	62	7	and	and	CCONJ
dpc-3884	62	8	standard	standard	ADJ
dpc-3884	62	9	deviation	deviation	NOUN
dpc-3884	62	10	for	for	ADP
dpc-3884	62	11	continuous	continuous	ADJ
dpc-3884	62	12	variables	variable	NOUN
dpc-3884	62	13	and	and	CCONJ
dpc-3884	62	14	frequencies	frequency	NOUN
dpc-3884	62	15	for	for	ADP
dpc-3884	62	16	categorical	categorical	ADJ
dpc-3884	62	17	was	be	AUX
dpc-3884	62	18	conducted	conduct	VERB
dpc-3884	62	19	.	.	PUNCT
dpc-3884	63	1	following	follow	VERB
dpc-3884	63	2	normality	normality	NOUN
dpc-3884	63	3	considerations	consideration	NOUN
dpc-3884	63	4	,	,	PUNCT
dpc-3884	63	5	mann	mann	PROPN
dpc-3884	63	6	–	–	PUNCT
dpc-3884	63	7	whitney	whitney	PROPN
dpc-3884	63	8	t	t	PROPN
dpc-3884	63	9	-	-	PUNCT
dpc-3884	63	10	test	test	NOUN
dpc-3884	63	11	(	(	PUNCT
dpc-3884	63	12	or	or	CCONJ
dpc-3884	63	13	anova	anova	PROPN
dpc-3884	63	14	kruskal	kruskal	PROPN
dpc-3884	63	15	–	–	PUNCT
dpc-3884	63	16	wallis	wallis	PROPN
dpc-3884	63	17	)	)	PUNCT
dpc-3884	63	18	and	and	CCONJ
dpc-3884	63	19	wilcoxon	wilcoxon	PROPN
dpc-3884	63	20	rank	rank	PROPN
dpc-3884	63	21	test	test	NOUN
dpc-3884	63	22	were	be	AUX
dpc-3884	63	23	used	use	VERB
dpc-3884	63	24	for	for	ADP
dpc-3884	63	25	comparisons	comparison	NOUN
dpc-3884	63	26	in	in	ADP
dpc-3884	63	27	unpaired	unpaired	ADJ
dpc-3884	63	28	and	and	CCONJ
dpc-3884	63	29	paired	paired	ADJ
dpc-3884	63	30	variables	variable	NOUN
dpc-3884	63	31	,	,	PUNCT
dpc-3884	63	32	respectively	respectively	ADV
dpc-3884	63	33	.	.	PUNCT
dpc-3884	64	1	in	in	ADP
dpc-3884	64	2	order	order	NOUN
dpc-3884	64	3	to	to	PART
dpc-3884	64	4	investigate	investigate	VERB
dpc-3884	64	5	possible	possible	ADJ
dpc-3884	64	6	correlation	correlation	NOUN
dpc-3884	64	7	among	among	ADP
dpc-3884	64	8	qols	qol	NOUN
dpc-3884	64	9	scores	score	NOUN
dpc-3884	64	10	,	,	PUNCT
dpc-3884	64	11	spearman	spearman	NOUN
dpc-3884	64	12	rho	rho	NOUN
dpc-3884	64	13	was	be	AUX
dpc-3884	64	14	preferred	prefer	VERB
dpc-3884	64	15	.	.	PUNCT
dpc-3884	65	1	also	also	ADV
dpc-3884	65	2	,	,	PUNCT
dpc-3884	65	3	for	for	ADP
dpc-3884	65	4	dlqi	dlqi	NOUN
dpc-3884	65	5	and	and	CCONJ
dpc-3884	65	6	pnrs	pnrs	VERB
dpc-3884	65	7	,	,	PUNCT
dpc-3884	65	8	a	a	DET
dpc-3884	65	9	change	change	NOUN
dpc-3884	65	10	in	in	ADP
dpc-3884	65	11	score	score	NOUN
dpc-3884	65	12	≥	≥	NOUN
dpc-3884	65	13	4	4	NUM
dpc-3884	65	14	was	be	AUX
dpc-3884	65	15	considered	consider	VERB
dpc-3884	65	16	as	as	ADP
dpc-3884	65	17	clinically	clinically	ADV
dpc-3884	65	18	significant	significant	ADJ
dpc-3884	65	19	,	,	PUNCT
dpc-3884	65	20	while	while	SCONJ
dpc-3884	65	21	for	for	SCONJ
dpc-3884	65	22	global	global	ADJ
dpc-3884	65	23	health	health	NOUN
dpc-3884	65	24	and	and	CCONJ
dpc-3884	65	25	summary	summary	NOUN
dpc-3884	65	26	score	score	NOUN
dpc-3884	65	27	the	the	DET
dpc-3884	65	28	change	change	NOUN
dpc-3884	65	29	was	be	AUX
dpc-3884	65	30	set	set	VERB
dpc-3884	65	31	≥10.20,21	≥10.20,21	ADJ
dpc-3884	65	32	moreover	moreover	ADV
dpc-3884	65	33	,	,	PUNCT
dpc-3884	65	34	linear	linear	ADJ
dpc-3884	65	35	mixed	mixed	ADJ
dpc-3884	65	36	models	model	NOUN
dpc-3884	65	37	were	be	AUX
dpc-3884	65	38	used	use	VERB
dpc-3884	65	39	to	to	PART
dpc-3884	65	40	evaluate	evaluate	VERB
dpc-3884	65	41	the	the	DET
dpc-3884	65	42	change	change	NOUN
dpc-3884	65	43	of	of	ADP
dpc-3884	65	44	qols	qol	NOUN
dpc-3884	65	45	after	after	ADP
dpc-3884	65	46	therapeutic	therapeutic	ADJ
dpc-3884	65	47	interventions	intervention	NOUN
dpc-3884	65	48	and	and	CCONJ
dpc-3884	65	49	to	to	PART
dpc-3884	65	50	compare	compare	VERB
dpc-3884	65	51	change	change	NOUN
dpc-3884	65	52	in	in	ADP
dpc-3884	65	53	score	score	NOUN
dpc-3884	65	54	between	between	ADP
dpc-3884	65	55	patients	patient	NOUN
dpc-3884	65	56	with	with	ADP
dpc-3884	65	57	and	and	CCONJ
dpc-3884	65	58	without	without	ADP
dpc-3884	65	59	pruritus	pruritus	PROPN
dpc-3884	65	60	.	.	PUNCT
dpc-3884	66	1	all	all	DET
dpc-3884	66	2	statistical	statistical	ADJ
dpc-3884	66	3	tests	test	NOUN
dpc-3884	66	4	were	be	AUX
dpc-3884	66	5	two	two	NUM
dpc-3884	66	6	-	-	PUNCT
dpc-3884	66	7	sided	sided	ADJ
dpc-3884	66	8	,	,	PUNCT
dpc-3884	66	9	p	p	X
dpc-3884	66	10	<	<	X
dpc-3884	66	11	0.05	0.05	NUM
dpc-3884	66	12	was	be	AUX
dpc-3884	66	13	considered	consider	VERB
dpc-3884	66	14	significant	significant	ADJ
dpc-3884	66	15	and	and	CCONJ
dpc-3884	66	16	the	the	DET
dpc-3884	66	17	analysis	analysis	NOUN
dpc-3884	66	18	was	be	AUX
dpc-3884	66	19	conducted	conduct	VERB
dpc-3884	66	20	with	with	ADP
dpc-3884	66	21	the	the	DET
dpc-3884	66	22	statistical	statistical	ADJ
dpc-3884	66	23	package	package	NOUN
dpc-3884	66	24	for	for	ADP
dpc-3884	66	25	social	social	ADJ
dpc-3884	66	26	sciences	science	NOUN
dpc-3884	66	27	statistical	statistical	ADJ
dpc-3884	66	28	software	software	NOUN
dpc-3884	66	29	(	(	PUNCT
dpc-3884	66	30	version	version	NOUN
dpc-3884	66	31	28.0	28.0	NUM
dpc-3884	66	32	,	,	PUNCT
dpc-3884	66	33	ibm	ibm	PROPN
dpc-3884	66	34	spss	spss	PROPN
dpc-3884	66	35	statistics	statistic	NOUN
dpc-3884	66	36	for	for	ADP
dpc-3884	66	37	windows	window	NOUN
dpc-3884	66	38	)	)	PUNCT
dpc-3884	66	39	.	.	PUNCT
dpc-3884	67	1	results	result	VERB
dpc-3884	67	2	demographic	demographic	ADJ
dpc-3884	67	3	and	and	CCONJ
dpc-3884	67	4	baseline	baseline	ADJ
dpc-3884	67	5	characteristics	characteristic	NOUN
dpc-3884	67	6	overall	overall	ADV
dpc-3884	67	7	,	,	PUNCT
dpc-3884	67	8	110	110	NUM
dpc-3884	67	9	patients	patient	NOUN
dpc-3884	67	10	with	with	ADP
dpc-3884	67	11	a	a	DET
dpc-3884	67	12	mean	mean	ADJ
dpc-3884	67	13	age	age	NOUN
dpc-3884	67	14	of	of	ADP
dpc-3884	67	15	67	67	NUM
dpc-3884	67	16	years	year	NOUN
dpc-3884	67	17	(	(	PUNCT
dpc-3884	67	18	range	range	NOUN
dpc-3884	67	19	37	37	NUM
dpc-3884	67	20	-	-	SYM
dpc-3884	67	21	86	86	NUM
dpc-3884	67	22	)	)	PUNCT
dpc-3884	67	23	who	who	PRON
dpc-3884	67	24	received	receive	VERB
dpc-3884	67	25	icis	icis	NOUN
dpc-3884	67	26	for	for	ADP
dpc-3884	67	27	various	various	ADJ
dpc-3884	67	28	oncologic	oncologic	NOUN
dpc-3884	67	29	indications	indication	NOUN
dpc-3884	67	30	were	be	AUX
dpc-3884	67	31	included	include	VERB
dpc-3884	67	32	in	in	ADP
dpc-3884	67	33	the	the	DET
dpc-3884	67	34	analysis	analysis	NOUN
dpc-3884	67	35	.	.	PUNCT
dpc-3884	68	1	the	the	DET
dpc-3884	68	2	most	most	ADV
dpc-3884	68	3	common	common	ADJ
dpc-3884	68	4	type	type	NOUN
dpc-3884	68	5	of	of	ADP
dpc-3884	68	6	primary	primary	ADJ
dpc-3884	68	7	cancer	cancer	NOUN
dpc-3884	68	8	was	be	AUX
dpc-3884	68	9	nsclc	nsclc	NOUN
dpc-3884	68	10	(	(	PUNCT
dpc-3884	68	11	53	53	NUM
dpc-3884	68	12	patients	patient	NOUN
dpc-3884	68	13	,	,	PUNCT
dpc-3884	68	14	48.2	48.2	NUM
dpc-3884	68	15	%	%	NOUN
dpc-3884	68	16	)	)	PUNCT
dpc-3884	68	17	followed	follow	VERB
dpc-3884	68	18	by	by	ADP
dpc-3884	68	19	melanoma	melanoma	NOUN
dpc-3884	68	20	(	(	PUNCT
dpc-3884	68	21	25	25	NUM
dpc-3884	68	22	patients	patient	NOUN
dpc-3884	68	23	,	,	PUNCT
dpc-3884	68	24	22.7	22.7	NUM
dpc-3884	68	25	%	%	NOUN
dpc-3884	68	26	)	)	PUNCT
dpc-3884	68	27	.	.	PUNCT
dpc-3884	69	1	most	most	ADJ
dpc-3884	69	2	of	of	ADP
dpc-3884	69	3	the	the	DET
dpc-3884	69	4	patients	patient	NOUN
dpc-3884	69	5	were	be	AUX
dpc-3884	69	6	treated	treat	VERB
dpc-3884	69	7	with	with	ADP
dpc-3884	69	8	anti	anti	ADJ
dpc-3884	69	9	-	-	ADJ
dpc-3884	69	10	pd1	pd1	VERB
dpc-3884	69	11	(	(	PUNCT
dpc-3884	69	12	93	93	NUM
dpc-3884	69	13	patients	patient	NOUN
dpc-3884	69	14	,	,	PUNCT
dpc-3884	69	15	84.5	84.5	NUM
dpc-3884	69	16	%	%	NOUN
dpc-3884	69	17	)	)	PUNCT
dpc-3884	69	18	.	.	PUNCT
dpc-3884	70	1	the	the	DET
dpc-3884	70	2	epidemiological	epidemiological	ADJ
dpc-3884	70	3	and	and	CCONJ
dpc-3884	70	4	clinical	clinical	ADJ
dpc-3884	70	5	characteristics	characteristic	NOUN
dpc-3884	70	6	of	of	ADP
dpc-3884	70	7	the	the	DET
dpc-3884	70	8	patients	patient	NOUN
dpc-3884	70	9	at	at	ADP
dpc-3884	70	10	baseline	baseline	NOUN
dpc-3884	70	11	can	can	AUX
dpc-3884	70	12	be	be	AUX
dpc-3884	70	13	found	find	VERB
dpc-3884	70	14	in	in	ADP
dpc-3884	70	15	the	the	DET
dpc-3884	70	16	supplement	supplement	NOUN
dpc-3884	70	17	table	table	NOUN
dpc-3884	70	18	.	.	PUNCT
dpc-3884	71	1	the	the	DET
dpc-3884	71	2	most	most	ADV
dpc-3884	71	3	prevalent	prevalent	ADJ
dpc-3884	71	4	dirae	dirae	NOUN
dpc-3884	71	5	was	be	AUX
dpc-3884	71	6	psoriasis	psoriasis	NOUN
dpc-3884	71	7	-	-	PUNCT
dpc-3884	71	8	like	like	ADJ
dpc-3884	71	9	rash	rash	NOUN
dpc-3884	71	10	(	(	PUNCT
dpc-3884	71	11	35	35	NUM
dpc-3884	71	12	out	out	ADP
dpc-3884	71	13	of	of	ADP
dpc-3884	71	14	110	110	NUM
dpc-3884	71	15	,	,	PUNCT
dpc-3884	71	16	31.8	31.8	NUM
dpc-3884	71	17	%	%	NOUN
dpc-3884	71	18	)	)	PUNCT
dpc-3884	71	19	,	,	PUNCT
dpc-3884	71	20	followed	follow	VERB
dpc-3884	71	21	by	by	ADP
dpc-3884	71	22	eczema	eczema	NOUN
dpc-3884	71	23	-	-	PUNCT
dpc-3884	71	24	like	like	ADJ
dpc-3884	71	25	rash	rash	NOUN
dpc-3884	71	26	(	(	PUNCT
dpc-3884	71	27	22	22	NUM
dpc-3884	71	28	patients	patient	NOUN
dpc-3884	71	29	,	,	PUNCT
dpc-3884	71	30	20	20	NUM
dpc-3884	71	31	%	%	NOUN
dpc-3884	71	32	)	)	PUNCT
dpc-3884	71	33	and	and	CCONJ
dpc-3884	71	34	pruritus	pruritus	PROPN
dpc-3884	71	35	(	(	PUNCT
dpc-3884	71	36	15	15	NUM
dpc-3884	71	37	patients	patient	NOUN
dpc-3884	71	38	,	,	PUNCT
dpc-3884	71	39	13.6	13.6	NUM
dpc-3884	71	40	%	%	NOUN
dpc-3884	71	41	)	)	PUNCT
dpc-3884	71	42	.	.	PUNCT
dpc-3884	72	1	fifteen	fifteen	NUM
dpc-3884	72	2	individuals	individual	NOUN
dpc-3884	72	3	experienced	experience	VERB
dpc-3884	72	4	two	two	NUM
dpc-3884	72	5	different	different	ADJ
dpc-3884	72	6	types	type	NOUN
dpc-3884	72	7	of	of	ADP
dpc-3884	72	8	dirae	dirae	NOUN
dpc-3884	72	9	.	.	PUNCT
dpc-3884	73	1	the	the	DET
dpc-3884	73	2	most	most	ADV
dpc-3884	73	3	common	common	ADJ
dpc-3884	73	4	dirae	dirae	NOUN
dpc-3884	73	5	in	in	ADP
dpc-3884	73	6	the	the	DET
dpc-3884	73	7	latter	latter	ADJ
dpc-3884	73	8	group	group	NOUN
dpc-3884	73	9	was	be	AUX
dpc-3884	73	10	vitiligo	vitiligo	ADJ
dpc-3884	73	11	(	(	PUNCT
dpc-3884	73	12	6	6	NUM
dpc-3884	73	13	out	out	ADV
dpc-3884	73	14	15	15	NUM
dpc-3884	73	15	patients	patient	NOUN
dpc-3884	73	16	,	,	PUNCT
dpc-3884	73	17	5.5	5.5	NUM
dpc-3884	73	18	%	%	NOUN
dpc-3884	73	19	)	)	PUNCT
dpc-3884	73	20	.	.	PUNCT
dpc-3884	74	1	responsiveness	responsiveness	NOUN
dpc-3884	74	2	analysis	analysis	NOUN
dpc-3884	74	3	at	at	ADP
dpc-3884	74	4	baseline	baseline	NOUN
dpc-3884	74	5	,	,	PUNCT
dpc-3884	74	6	mean	mean	INTJ
dpc-3884	74	7	(	(	PUNCT
dpc-3884	74	8	standard	standard	ADJ
dpc-3884	74	9	deviation	deviation	NOUN
dpc-3884	74	10	,	,	PUNCT
dpc-3884	74	11	sd	sd	NOUN
dpc-3884	74	12	)	)	PUNCT
dpc-3884	74	13	dlqi	dlqi	ADJ
dpc-3884	74	14	score	score	NOUN
dpc-3884	74	15	was	be	AUX
dpc-3884	74	16	15.54	15.54	NUM
dpc-3884	74	17	(	(	PUNCT
dpc-3884	74	18	5.44	5.44	NUM
dpc-3884	74	19	)	)	PUNCT
dpc-3884	74	20	,	,	PUNCT
dpc-3884	74	21	pnrs	pnrs	NOUN
dpc-3884	74	22	was	be	AUX
dpc-3884	74	23	7.25	7.25	NUM
dpc-3884	74	24	(	(	PUNCT
dpc-3884	74	25	2.95	2.95	NUM
dpc-3884	74	26	)	)	PUNCT
dpc-3884	74	27	,	,	PUNCT
dpc-3884	74	28	while	while	SCONJ
dpc-3884	74	29	functional	functional	ADJ
dpc-3884	74	30	,	,	PUNCT
dpc-3884	74	31	symptom	symptom	NOUN
dpc-3884	74	32	and	and	CCONJ
dpc-3884	74	33	summary	summary	NOUN
dpc-3884	74	34	scores	score	NOUN
dpc-3884	74	35	of	of	ADP
dpc-3884	74	36	eortc	eortc	VERB
dpc-3884	74	37	-	-	PUNCT
dpc-3884	74	38	c30	c30	NOUN
dpc-3884	74	39	were	be	AUX
dpc-3884	74	40	79.17	79.17	NUM
dpc-3884	74	41	(	(	PUNCT
dpc-3884	74	42	2.11	2.11	NUM
dpc-3884	74	43	)	)	PUNCT
dpc-3884	74	44	,	,	PUNCT
dpc-3884	74	45	17.66	17.66	NUM
dpc-3884	74	46	(	(	PUNCT
dpc-3884	74	47	3.60	3.60	NUM
dpc-3884	74	48	)	)	PUNCT
dpc-3884	74	49	and	and	CCONJ
dpc-3884	74	50	80.67	80.67	NUM
dpc-3884	74	51	(	(	PUNCT
dpc-3884	74	52	3.08	3.08	NUM
dpc-3884	74	53	)	)	PUNCT
dpc-3884	74	54	,	,	PUNCT
dpc-3884	74	55	respectively	respectively	ADV
dpc-3884	74	56	.	.	PUNCT
dpc-3884	75	1	after	after	ADP
dpc-3884	75	2	therapeutic	therapeutic	ADJ
dpc-3884	75	3	interventions	intervention	NOUN
dpc-3884	75	4	,	,	PUNCT
dpc-3884	75	5	there	there	PRON
dpc-3884	75	6	was	be	VERB
dpc-3884	75	7	a	a	DET
dpc-3884	75	8	statistically	statistically	ADV
dpc-3884	75	9	significant	significant	ADJ
dpc-3884	75	10	decrease	decrease	NOUN
dpc-3884	75	11	in	in	ADP
dpc-3884	75	12	dlqi	dlqi	ADJ
dpc-3884	75	13	scores	score	NOUN
dpc-3884	75	14	between	between	ADP
dpc-3884	75	15	the	the	DET
dpc-3884	75	16	first	first	ADJ
dpc-3884	75	17	intervention	intervention	NOUN
dpc-3884	75	18	compared	compare	VERB
dpc-3884	75	19	to	to	PART
dpc-3884	75	20	baseline	baseline	VERB
dpc-3884	75	21	,	,	PUNCT
dpc-3884	75	22	and	and	CCONJ
dpc-3884	75	23	between	between	ADP
dpc-3884	75	24	the	the	DET
dpc-3884	75	25	second	second	ADJ
dpc-3884	75	26	intervention	intervention	NOUN
dpc-3884	75	27	compared	compare	VERB
dpc-3884	75	28	to	to	ADP
dpc-3884	75	29	th	th	PRON
dpc-3884	75	30	efirst	efirst	PROPN
dpc-3884	75	31	[	[	X
dpc-3884	75	32	mean	mean	ADJ
dpc-3884	75	33	(	(	PUNCT
dpc-3884	75	34	sd	sd	NOUN
dpc-3884	75	35	)	)	PUNCT
dpc-3884	75	36	decrease	decrease	NOUN
dpc-3884	75	37	4.38	4.38	NUM
dpc-3884	75	38	(	(	PUNCT
dpc-3884	75	39	2.91	2.91	NUM
dpc-3884	75	40	)	)	PUNCT
dpc-3884	75	41	,	,	PUNCT
dpc-3884	75	42	p	p	X
dpc-3884	75	43	<	<	X
dpc-3884	75	44	0.001	0.001	NUM
dpc-3884	75	45	and	and	CCONJ
dpc-3884	75	46	5.16	5.16	NUM
dpc-3884	75	47	(	(	PUNCT
dpc-3884	75	48	3.99	3.99	NUM
dpc-3884	75	49	)	)	PUNCT
dpc-3884	75	50	,	,	PUNCT
dpc-3884	75	51	p	p	X
dpc-3884	75	52	<	<	X
dpc-3884	75	53	0.001	0.001	NUM
dpc-3884	75	54	,	,	PUNCT
dpc-3884	75	55	respectively	respectively	ADV
dpc-3884	75	56	]	]	PUNCT
dpc-3884	75	57	.	.	PUNCT
dpc-3884	76	1	the	the	DET
dpc-3884	76	2	same	same	ADJ
dpc-3884	76	3	statistically	statistically	ADV
dpc-3884	76	4	significant	significant	ADJ
dpc-3884	76	5	difference	difference	NOUN
dpc-3884	76	6	was	be	AUX
dpc-3884	76	7	seen	see	VERB
dpc-3884	76	8	for	for	ADP
dpc-3884	76	9	pnrs	pnrs	NOUN
dpc-3884	76	10	scores	score	NOUN
dpc-3884	76	11	after	after	ADP
dpc-3884	76	12	each	each	DET
dpc-3884	76	13	intervention	intervention	NOUN
dpc-3884	76	14	(	(	PUNCT
dpc-3884	76	15	table	table	NOUN
dpc-3884	76	16	i	i	PROPN
dpc-3884	76	17	)	)	PUNCT
dpc-3884	76	18	.	.	PUNCT
dpc-3884	77	1	regarding	regard	VERB
dpc-3884	77	2	summary	summary	NOUN
dpc-3884	77	3	score	score	NOUN
dpc-3884	77	4	of	of	ADP
dpc-3884	77	5	eortc	eortc	NOUN
dpc-3884	77	6	-	-	PUNCT
dpc-3884	77	7	c30	c30	NOUN
dpc-3884	77	8	,	,	PUNCT
dpc-3884	77	9	a	a	DET
dpc-3884	77	10	significant	significant	ADJ
dpc-3884	77	11	increase	increase	NOUN
dpc-3884	77	12	in	in	ADP
dpc-3884	77	13	mean	mean	NOUN
dpc-3884	77	14	scores	score	NOUN
dpc-3884	77	15	was	be	AUX
dpc-3884	77	16	detected	detect	VERB
dpc-3884	77	17	after	after	ADP
dpc-3884	77	18	the	the	DET
dpc-3884	77	19	first	first	ADJ
dpc-3884	77	20	(	(	PUNCT
dpc-3884	77	21	mean	mean	INTJ
dpc-3884	77	22	increase	increase	NOUN
dpc-3884	77	23	1.34	1.34	NUM
dpc-3884	77	24	(	(	PUNCT
dpc-3884	77	25	2.64	2.64	NUM
dpc-3884	77	26	)	)	PUNCT
dpc-3884	77	27	,	,	PUNCT
dpc-3884	77	28	p	p	X
dpc-3884	77	29	<	<	X
dpc-3884	77	30	0.001	0.001	NUM
dpc-3884	77	31	)	)	PUNCT
dpc-3884	77	32	and	and	CCONJ
dpc-3884	77	33	the	the	DET
dpc-3884	77	34	second	second	ADJ
dpc-3884	77	35	intervention	intervention	NOUN
dpc-3884	77	36	(	(	PUNCT
dpc-3884	77	37	mean	mean	INTJ
dpc-3884	77	38	increase	increase	NOUN
dpc-3884	77	39	0.96	0.96	NUM
dpc-3884	77	40	(	(	PUNCT
dpc-3884	77	41	2.26	2.26	NUM
dpc-3884	77	42	)	)	PUNCT
dpc-3884	77	43	,	,	PUNCT
dpc-3884	77	44	p	p	X
dpc-3884	77	45	<	<	X
dpc-3884	77	46	0.001	0.001	NUM
dpc-3884	77	47	)	)	PUNCT
dpc-3884	77	48	,	,	PUNCT
dpc-3884	77	49	but	but	CCONJ
dpc-3884	77	50	the	the	DET
dpc-3884	77	51	same	same	ADJ
dpc-3884	77	52	significant	significant	ADJ
dpc-3884	77	53	association	association	NOUN
dpc-3884	77	54	was	be	AUX
dpc-3884	77	55	not	not	PART
dpc-3884	77	56	detected	detect	VERB
dpc-3884	77	57	for	for	ADP
dpc-3884	77	58	functional	functional	ADJ
dpc-3884	77	59	table	table	NOUN
dpc-3884	77	60	1	1	NUM
dpc-3884	77	61	.	.	PUNCT
dpc-3884	78	1	mean	mean	NOUN
dpc-3884	78	2	of	of	ADP
dpc-3884	78	3	main	main	ADJ
dpc-3884	78	4	qols	qol	NOUN
dpc-3884	78	5	scores	score	NOUN
dpc-3884	78	6	and	and	CCONJ
dpc-3884	78	7	their	their	PRON
dpc-3884	78	8	change	change	NOUN
dpc-3884	78	9	after	after	ADP
dpc-3884	78	10	each	each	DET
dpc-3884	78	11	intervention	intervention	NOUN
dpc-3884	78	12	.	.	PUNCT
dpc-3884	79	1	baseline	baseline	PROPN
dpc-3884	79	2	1st	1st	ADJ
dpc-3884	79	3	intervention	intervention	NOUN
dpc-3884	79	4	p	p	PROPN
dpc-3884	79	5	2nd	2nd	ADJ
dpc-3884	79	6	intervention	intervention	NOUN
dpc-3884	80	1	p	p	PROPN
dpc-3884	80	2	dlqi	dlqi	VERB
dpc-3884	80	3	15.54	15.54	NUM
dpc-3884	80	4	(	(	PUNCT
dpc-3884	80	5	5.44	5.44	NUM
dpc-3884	80	6	)	)	PUNCT
dpc-3884	80	7	11.15	11.15	NUM
dpc-3884	80	8	(	(	PUNCT
dpc-3884	80	9	6.07	6.07	NUM
dpc-3884	80	10	)	)	PUNCT
dpc-3884	80	11	p<0.001	p<0.001	NOUN
dpc-3884	80	12	5.99	5.99	NUM
dpc-3884	80	13	(	(	PUNCT
dpc-3884	80	14	4.70	4.70	NUM
dpc-3884	80	15	)	)	PUNCT
dpc-3884	80	16	p<0.001	p<0.001	PROPN
dpc-3884	80	17	global	global	ADJ
dpc-3884	80	18	health	health	NOUN
dpc-3884	80	19	-	-	PUNCT
dpc-3884	80	20	qol	qol	NOUN
dpc-3884	80	21	59.16	59.16	NUM
dpc-3884	80	22	(	(	PUNCT
dpc-3884	80	23	13.4	13.4	NUM
dpc-3884	80	24	)	)	PUNCT
dpc-3884	80	25	65.90	65.90	NUM
dpc-3884	80	26	(	(	PUNCT
dpc-3884	80	27	10.1	10.1	NUM
dpc-3884	80	28	)	)	PUNCT
dpc-3884	80	29	p<0.001	p<0.001	X
dpc-3884	80	30	66.4	66.4	NUM
dpc-3884	80	31	(	(	PUNCT
dpc-3884	80	32	9.71	9.71	NUM
dpc-3884	80	33	)	)	PUNCT
dpc-3884	80	34	p=0.47	p=0.47	NOUN
dpc-3884	80	35	pnrs	pnrs	NOUN
dpc-3884	80	36	7.25	7.25	NUM
dpc-3884	80	37	(	(	PUNCT
dpc-3884	80	38	2.95	2.95	NUM
dpc-3884	80	39	)	)	PUNCT
dpc-3884	80	40	5.25	5.25	NUM
dpc-3884	80	41	(	(	PUNCT
dpc-3884	80	42	3.11	3.11	NUM
dpc-3884	80	43	)	)	PUNCT
dpc-3884	80	44	p<0.001	p<0.001	NOUN
dpc-3884	80	45	3.47	3.47	NUM
dpc-3884	80	46	(	(	PUNCT
dpc-3884	80	47	2.79	2.79	NUM
dpc-3884	80	48	)	)	PUNCT
dpc-3884	80	49	p<0.001	p<0.001	ADJ
dpc-3884	80	50	functional	functional	ADJ
dpc-3884	80	51	score	score	NOUN
dpc-3884	80	52	79.17	79.17	NUM
dpc-3884	80	53	(	(	PUNCT
dpc-3884	80	54	2.11	2.11	NUM
dpc-3884	80	55	)	)	PUNCT
dpc-3884	80	56	79.04	79.04	NUM
dpc-3884	80	57	(	(	PUNCT
dpc-3884	80	58	1.85	1.85	NUM
dpc-3884	80	59	)	)	PUNCT
dpc-3884	80	60	p=0.46	p=0.46	NOUN
dpc-3884	80	61	79.07	79.07	NUM
dpc-3884	80	62	(	(	PUNCT
dpc-3884	80	63	1.95	1.95	NUM
dpc-3884	80	64	)	)	PUNCT
dpc-3884	80	65	p=0.98	p=0.98	NOUN
dpc-3884	80	66	symptom	symptom	NOUN
dpc-3884	80	67	score	score	NOUN
dpc-3884	80	68	17.66	17.66	NUM
dpc-3884	80	69	(	(	PUNCT
dpc-3884	80	70	3.60	3.60	NUM
dpc-3884	80	71	)	)	PUNCT
dpc-3884	80	72	16.1	16.1	NUM
dpc-3884	80	73	(	(	PUNCT
dpc-3884	80	74	3.56	3.56	NUM
dpc-3884	80	75	)	)	PUNCT
dpc-3884	80	76	p<0.001	p<0.001	NOUN
dpc-3884	80	77	14.6	14.6	NUM
dpc-3884	80	78	(	(	PUNCT
dpc-3884	80	79	3.99	3.99	NUM
dpc-3884	80	80	)	)	PUNCT
dpc-3884	80	81	p<0.001	p<0.001	PROPN
dpc-3884	80	82	eortc	eortc	VERB
dpc-3884	80	83	-	-	PUNCT
dpc-3884	80	84	qlq	qlq	NOUN
dpc-3884	80	85	-	-	PUNCT
dpc-3884	80	86	c30	c30	NOUN
dpc-3884	80	87	summary	summary	NOUN
dpc-3884	80	88	score	score	NOUN
dpc-3884	80	89	80.67	80.67	NUM
dpc-3884	80	90	(	(	PUNCT
dpc-3884	80	91	3.08	3.08	NUM
dpc-3884	80	92	82.01	82.01	NUM
dpc-3884	80	93	(	(	PUNCT
dpc-3884	80	94	2.33	2.33	NUM
dpc-3884	80	95	)	)	PUNCT
dpc-3884	80	96	p<0.001	p<0.001	X
dpc-3884	81	1	83.0	83.0	NUM
dpc-3884	81	2	(	(	PUNCT
dpc-3884	81	3	2.59	2.59	NUM
dpc-3884	81	4	)	)	PUNCT
dpc-3884	81	5	p<0.001	p<0.001	NOUN
dpc-3884	81	6	dlqi	dlqi	VERB
dpc-3884	81	7	=	=	PUNCT
dpc-3884	81	8	dermatology	dermatology	NOUN
dpc-3884	81	9	quality	quality	NOUN
dpc-3884	81	10	of	of	ADP
dpc-3884	81	11	life	life	NOUN
dpc-3884	81	12	index	index	NOUN
dpc-3884	81	13	;	;	PUNCT
dpc-3884	81	14	pnrs	pnrs	NOUN
dpc-3884	81	15	=	=	SYM
dpc-3884	81	16	numerical	numerical	ADJ
dpc-3884	81	17	rating	rating	NOUN
dpc-3884	81	18	scale	scale	NOUN
dpc-3884	81	19	for	for	ADP
dpc-3884	81	20	pruritus	pruritus	NOUN
dpc-3884	81	21	;	;	PUNCT
dpc-3884	81	22	qol	qol	NOUN
dpc-3884	81	23	=	=	SYM
dpc-3884	81	24	quality	quality	NOUN
dpc-3884	81	25	-	-	PUNCT
dpc-3884	81	26	of	of	ADP
dpc-3884	81	27	-	-	PUNCT
dpc-3884	81	28	life	life	NOUN
dpc-3884	81	29	.	.	PUNCT
dpc-3884	82	1	4	4	NUM
dpc-3884	82	2	original	original	ADJ
dpc-3884	82	3	article	article	NOUN
dpc-3884	82	4	|	|	ADV
dpc-3884	82	5	dermatol	dermatol	ADJ
dpc-3884	82	6	pract	pract	NOUN
dpc-3884	82	7	concept	concept	NOUN
dpc-3884	82	8	.	.	PUNCT
dpc-3884	83	1	2024;14(3):e2024118	2024;14(3):e2024118	NUM
dpc-3884	83	2	further	far	ADV
dpc-3884	83	3	increased	increase	VERB
dpc-3884	83	4	after	after	ADP
dpc-3884	83	5	the	the	DET
dpc-3884	83	6	second	second	ADJ
dpc-3884	83	7	intervention	intervention	NOUN
dpc-3884	83	8	,	,	PUNCT
dpc-3884	83	9	as	as	SCONJ
dpc-3884	83	10	compared	compare	VERB
dpc-3884	83	11	to	to	ADP
dpc-3884	83	12	first	first	ADJ
dpc-3884	83	13	.	.	PUNCT
dpc-3884	84	1	on	on	ADP
dpc-3884	84	2	the	the	DET
dpc-3884	84	3	other	other	ADJ
dpc-3884	84	4	hand	hand	NOUN
dpc-3884	84	5	,	,	PUNCT
dpc-3884	84	6	considering	consider	VERB
dpc-3884	84	7	the	the	DET
dpc-3884	84	8	global	global	ADJ
dpc-3884	84	9	qol	qol	PROPN
dpc-3884	84	10	score	score	PROPN
dpc-3884	84	11	,	,	PUNCT
dpc-3884	84	12	a	a	DET
dpc-3884	84	13	significant	significant	ADJ
dpc-3884	84	14	change	change	NOUN
dpc-3884	84	15	was	be	AUX
dpc-3884	84	16	detected	detect	VERB
dpc-3884	84	17	in	in	ADP
dpc-3884	84	18	19	19	NUM
dpc-3884	84	19	patients	patient	NOUN
dpc-3884	84	20	(	(	PUNCT
dpc-3884	84	21	17.3	17.3	NUM
dpc-3884	84	22	%	%	NOUN
dpc-3884	84	23	)	)	PUNCT
dpc-3884	84	24	after	after	ADP
dpc-3884	84	25	the	the	DET
dpc-3884	84	26	first	first	ADJ
dpc-3884	84	27	and	and	CCONJ
dpc-3884	84	28	in	in	ADP
dpc-3884	84	29	4	4	NUM
dpc-3884	84	30	(	(	PUNCT
dpc-3884	84	31	3.6	3.6	NUM
dpc-3884	84	32	%	%	NOUN
dpc-3884	84	33	)	)	PUNCT
dpc-3884	84	34	patients	patient	NOUN
dpc-3884	84	35	after	after	ADP
dpc-3884	84	36	second	second	ADJ
dpc-3884	84	37	intervention	intervention	NOUN
dpc-3884	84	38	.	.	PUNCT
dpc-3884	85	1	based	base	VERB
dpc-3884	85	2	on	on	ADP
dpc-3884	85	3	summary	summary	NOUN
dpc-3884	85	4	score	score	NOUN
dpc-3884	85	5	,	,	PUNCT
dpc-3884	85	6	that	that	DET
dpc-3884	85	7	change	change	NOUN
dpc-3884	85	8	was	be	AUX
dpc-3884	85	9	found	find	VERB
dpc-3884	85	10	in	in	ADP
dpc-3884	85	11	2	2	NUM
dpc-3884	85	12	(	(	PUNCT
dpc-3884	85	13	1.8	1.8	NUM
dpc-3884	85	14	%	%	NOUN
dpc-3884	85	15	)	)	PUNCT
dpc-3884	85	16	patients	patient	NOUN
dpc-3884	85	17	after	after	ADP
dpc-3884	85	18	second	second	ADJ
dpc-3884	85	19	intervention	intervention	NOUN
dpc-3884	85	20	as	as	SCONJ
dpc-3884	85	21	compared	compare	VERB
dpc-3884	85	22	to	to	PART
dpc-3884	85	23	baseline	baseline	VERB
dpc-3884	85	24	(	(	PUNCT
dpc-3884	85	25	figure	figure	NOUN
dpc-3884	85	26	2	2	NUM
dpc-3884	85	27	)	)	PUNCT
dpc-3884	85	28	.	.	PUNCT
dpc-3884	86	1	symptoms	symptom	NOUN
dpc-3884	86	2	(	(	PUNCT
dpc-3884	86	3	table	table	NOUN
dpc-3884	86	4	1	1	NUM
dpc-3884	86	5	)	)	PUNCT
dpc-3884	86	6	.	.	PUNCT
dpc-3884	87	1	also	also	ADV
dpc-3884	87	2	,	,	PUNCT
dpc-3884	87	3	global	global	ADJ
dpc-3884	87	4	health	health	NOUN
dpc-3884	87	5	status	status	PROPN
dpc-3884	87	6	/	/	SYM
dpc-3884	87	7	qols	qol	NOUN
dpc-3884	87	8	significantly	significantly	ADV
dpc-3884	87	9	change	change	VERB
dpc-3884	87	10	only	only	ADV
dpc-3884	87	11	after	after	ADP
dpc-3884	87	12	first	first	ADJ
dpc-3884	87	13	intervention	intervention	NOUN
dpc-3884	87	14	(	(	PUNCT
dpc-3884	87	15	figure	figure	NOUN
dpc-3884	87	16	1	1	NUM
dpc-3884	87	17	)	)	PUNCT
dpc-3884	87	18	.	.	PUNCT
dpc-3884	88	1	as	as	SCONJ
dpc-3884	88	2	regards	regard	NOUN
dpc-3884	88	3	to	to	ADP
dpc-3884	88	4	a	a	DET
dpc-3884	88	5	change	change	NOUN
dpc-3884	88	6	in	in	ADP
dpc-3884	88	7	dlqi	dlqi	ADJ
dpc-3884	88	8	score	score	NOUN
dpc-3884	88	9	≥4	≥4	PROPN
dpc-3884	88	10	and	and	CCONJ
dpc-3884	88	11	pnrs	pnrs	VERB
dpc-3884	88	12	score	score	NOUN
dpc-3884	88	13	≥4	≥4	PROPN
dpc-3884	88	14	(	(	PUNCT
dpc-3884	88	15	thresholds	threshold	NOUN
dpc-3884	88	16	that	that	PRON
dpc-3884	88	17	are	be	AUX
dpc-3884	88	18	widely	widely	ADV
dpc-3884	88	19	considered	consider	VERB
dpc-3884	88	20	as	as	ADP
dpc-3884	88	21	clinically	clinically	ADV
dpc-3884	88	22	meaningful	meaningful	ADJ
dpc-3884	88	23	changes	change	NOUN
dpc-3884	88	24	)	)	PUNCT
dpc-3884	88	25	58	58	NUM
dpc-3884	88	26	(	(	PUNCT
dpc-3884	88	27	52.7	52.7	NUM
dpc-3884	88	28	%	%	NOUN
dpc-3884	88	29	)	)	PUNCT
dpc-3884	88	30	and	and	CCONJ
dpc-3884	88	31	31	31	NUM
dpc-3884	88	32	(	(	PUNCT
dpc-3884	88	33	28.2	28.2	NUM
dpc-3884	88	34	%	%	NOUN
dpc-3884	88	35	)	)	PUNCT
dpc-3884	88	36	individuals	individual	NOUN
dpc-3884	88	37	achieved	achieve	VERB
dpc-3884	88	38	this	this	DET
dpc-3884	88	39	level	level	NOUN
dpc-3884	88	40	of	of	ADP
dpc-3884	88	41	response	response	NOUN
dpc-3884	88	42	in	in	ADP
dpc-3884	88	43	dlqi	dlqi	NOUN
dpc-3884	88	44	and	and	CCONJ
dpc-3884	88	45	pnrs	pnrs	VERB
dpc-3884	88	46	,	,	PUNCT
dpc-3884	88	47	accordingly	accordingly	ADV
dpc-3884	88	48	after	after	ADP
dpc-3884	88	49	the	the	DET
dpc-3884	88	50	first	first	ADJ
dpc-3884	88	51	intervention	intervention	NOUN
dpc-3884	88	52	,	,	PUNCT
dpc-3884	88	53	respectively	respectively	ADV
dpc-3884	88	54	.	.	PUNCT
dpc-3884	89	1	these	these	DET
dpc-3884	89	2	rates	rate	NOUN
dpc-3884	89	3	figure	figure	VERB
dpc-3884	89	4	1	1	NUM
dpc-3884	89	5	.	.	PUNCT
dpc-3884	90	1	boxplots	boxplot	NOUN
dpc-3884	90	2	demonstrating	demonstrate	VERB
dpc-3884	90	3	qol	qol	PROPN
dpc-3884	90	4	scores	score	NOUN
dpc-3884	90	5	at	at	ADP
dpc-3884	90	6	baseline	baseline	NOUN
dpc-3884	90	7	and	and	CCONJ
dpc-3884	90	8	after	after	ADP
dpc-3884	90	9	first	first	ADJ
dpc-3884	90	10	and	and	CCONJ
dpc-3884	90	11	second	second	ADJ
dpc-3884	90	12	intervention	intervention	NOUN
dpc-3884	90	13	.	.	PUNCT
dpc-3884	91	1	figure	figure	NOUN
dpc-3884	91	2	2	2	NUM
dpc-3884	91	3	.	.	PUNCT
dpc-3884	92	1	barplots	barplot	NOUN
dpc-3884	92	2	showing	show	VERB
dpc-3884	92	3	significant	significant	ADJ
dpc-3884	92	4	and	and	CCONJ
dpc-3884	92	5	non	non	ADJ
dpc-3884	92	6	-	-	ADJ
dpc-3884	92	7	significant	significant	ADJ
dpc-3884	92	8	changes	change	NOUN
dpc-3884	92	9	in	in	ADP
dpc-3884	92	10	quality	quality	NOUN
dpc-3884	92	11	of	of	ADP
dpc-3884	92	12	life	life	NOUN
dpc-3884	92	13	scores	score	NOUN
dpc-3884	92	14	after	after	ADP
dpc-3884	92	15	each	each	DET
dpc-3884	92	16	intervention	intervention	NOUN
dpc-3884	92	17	.	.	PUNCT
dpc-3884	93	1	original	original	ADJ
dpc-3884	93	2	article	article	NOUN
dpc-3884	93	3	|	|	ADV
dpc-3884	93	4	dermatol	dermatol	ADJ
dpc-3884	93	5	pract	pract	NOUN
dpc-3884	93	6	concept	concept	NOUN
dpc-3884	93	7	.	.	PUNCT
dpc-3884	94	1	2024;14(3):e2024118	2024;14(3):e2024118	NUM
dpc-3884	94	2	5	5	NUM
dpc-3884	94	3	qols	qol	NOUN
dpc-3884	94	4	scales	scale	VERB
dpc-3884	94	5	and	and	CCONJ
dpc-3884	94	6	baseline	baseline	PROPN
dpc-3884	94	7	characteristics	characteristic	NOUN
dpc-3884	94	8	qols	qol	NOUN
dpc-3884	94	9	scores	score	NOUN
dpc-3884	94	10	did	do	AUX
dpc-3884	94	11	not	not	PART
dpc-3884	94	12	significantly	significantly	ADV
dpc-3884	94	13	differ	differ	VERB
dpc-3884	94	14	in	in	ADP
dpc-3884	94	15	terms	term	NOUN
dpc-3884	94	16	of	of	ADP
dpc-3884	94	17	gender	gender	NOUN
dpc-3884	94	18	,	,	PUNCT
dpc-3884	94	19	number	number	NOUN
dpc-3884	94	20	of	of	ADP
dpc-3884	94	21	doses	dose	NOUN
dpc-3884	94	22	and	and	CCONJ
dpc-3884	94	23	personal	personal	ADJ
dpc-3884	94	24	history	history	NOUN
dpc-3884	94	25	of	of	ADP
dpc-3884	94	26	skin	skin	NOUN
dpc-3884	94	27	disease	disease	NOUN
dpc-3884	94	28	.	.	PUNCT
dpc-3884	95	1	the	the	DET
dpc-3884	95	2	mean	mean	ADJ
dpc-3884	95	3	(	(	PUNCT
dpc-3884	95	4	sd	sd	NOUN
dpc-3884	95	5	)	)	PUNCT
dpc-3884	95	6	bsa	bsa	NOUN
dpc-3884	95	7	of	of	ADP
dpc-3884	95	8	the	the	DET
dpc-3884	95	9	patients	patient	NOUN
dpc-3884	95	10	was	be	AUX
dpc-3884	95	11	0.41	0.41	NUM
dpc-3884	95	12	(	(	PUNCT
dpc-3884	95	13	0.18	0.18	NUM
dpc-3884	95	14	)	)	PUNCT
dpc-3884	95	15	and	and	CCONJ
dpc-3884	95	16	was	be	AUX
dpc-3884	95	17	not	not	PART
dpc-3884	95	18	significantly	significantly	ADV
dpc-3884	95	19	correlated	correlate	VERB
dpc-3884	95	20	with	with	ADP
dpc-3884	95	21	either	either	CCONJ
dpc-3884	95	22	qol	qol	PROPN
dpc-3884	95	23	scores	score	NOUN
dpc-3884	95	24	at	at	ADP
dpc-3884	95	25	baseline	baseline	NOUN
dpc-3884	95	26	.	.	PUNCT
dpc-3884	96	1	moreover	moreover	ADV
dpc-3884	96	2	,	,	PUNCT
dpc-3884	96	3	individuals	individual	NOUN
dpc-3884	96	4	experiencing	experience	VERB
dpc-3884	96	5	dirae	dirae	NOUN
dpc-3884	96	6	of	of	ADP
dpc-3884	96	7	higher	high	ADJ
dpc-3884	96	8	grades	grade	NOUN
dpc-3884	96	9	at	at	ADP
dpc-3884	96	10	baseline	baseline	PROPN
dpc-3884	96	11	had	have	VERB
dpc-3884	96	12	more	more	ADV
dpc-3884	96	13	impaired	impaired	ADJ
dpc-3884	96	14	dlqi	dlqi	NOUN
dpc-3884	96	15	,	,	PUNCT
dpc-3884	96	16	pnrs	pnrs	NOUN
dpc-3884	96	17	and	and	CCONJ
dpc-3884	96	18	summary	summary	NOUN
dpc-3884	96	19	score	score	NOUN
dpc-3884	96	20	as	as	SCONJ
dpc-3884	96	21	compared	compare	VERB
dpc-3884	96	22	to	to	ADP
dpc-3884	96	23	those	those	PRON
dpc-3884	96	24	with	with	ADP
dpc-3884	96	25	lower	low	ADJ
dpc-3884	96	26	grades	grade	NOUN
dpc-3884	96	27	.	.	PUNCT
dpc-3884	97	1	analytically	analytically	ADV
dpc-3884	97	2	,	,	PUNCT
dpc-3884	97	3	patients	patient	NOUN
dpc-3884	97	4	with	with	ADP
dpc-3884	97	5	grade	grade	NOUN
dpc-3884	97	6	4	4	NUM
dpc-3884	97	7	toxicities	toxicity	NOUN
dpc-3884	97	8	had	have	AUX
dpc-3884	97	9	mean	mean	VERB
dpc-3884	97	10	dlqi	dlqi	VERB
dpc-3884	97	11	,	,	PUNCT
dpc-3884	97	12	pnrs	pnrs	NOUN
dpc-3884	97	13	and	and	CCONJ
dpc-3884	97	14	summary	summary	VERB
dpc-3884	97	15	score	score	NOUN
dpc-3884	97	16	20	20	NUM
dpc-3884	97	17	,	,	PUNCT
dpc-3884	97	18	10	10	NUM
dpc-3884	97	19	,	,	PUNCT
dpc-3884	97	20	81.2	81.2	NUM
dpc-3884	97	21	respectively	respectively	ADV
dpc-3884	97	22	,	,	PUNCT
dpc-3884	97	23	while	while	SCONJ
dpc-3884	97	24	for	for	ADP
dpc-3884	97	25	grade	grade	NOUN
dpc-3884	97	26	1	1	NUM
dpc-3884	97	27	toxicities	toxicity	NOUN
dpc-3884	97	28	the	the	DET
dpc-3884	97	29	corresponding	corresponding	ADJ
dpc-3884	97	30	scores	score	NOUN
dpc-3884	97	31	were	be	AUX
dpc-3884	97	32	13	13	NUM
dpc-3884	97	33	,	,	PUNCT
dpc-3884	97	34	4.57	4.57	NUM
dpc-3884	97	35	and	and	CCONJ
dpc-3884	97	36	79.8	79.8	NUM
dpc-3884	97	37	.	.	PUNCT
dpc-3884	98	1	there	there	PRON
dpc-3884	98	2	was	be	VERB
dpc-3884	98	3	a	a	DET
dpc-3884	98	4	significant	significant	ADJ
dpc-3884	98	5	correlation	correlation	NOUN
dpc-3884	98	6	between	between	ADP
dpc-3884	98	7	age	age	NOUN
dpc-3884	98	8	and	and	CCONJ
dpc-3884	98	9	pnrs	pnrs	NOUN
dpc-3884	98	10	correlation	correlation	NOUN
dpc-3884	98	11	analysis	analysis	NOUN
dpc-3884	98	12	at	at	ADP
dpc-3884	98	13	baseline	baseline	NOUN
dpc-3884	98	14	,	,	PUNCT
dpc-3884	98	15	dlqi	dlqi	VERB
dpc-3884	98	16	and	and	CCONJ
dpc-3884	98	17	pnrs	pnrs	NOUN
dpc-3884	98	18	were	be	AUX
dpc-3884	98	19	moderately	moderately	ADV
dpc-3884	98	20	correlated	correlate	VERB
dpc-3884	98	21	(	(	PUNCT
dpc-3884	98	22	rho	rho	NOUN
dpc-3884	98	23	0.44	0.44	NUM
dpc-3884	98	24	,	,	PUNCT
dpc-3884	98	25	p	p	X
dpc-3884	98	26	<	<	X
dpc-3884	98	27	0.001	0.001	NUM
dpc-3884	98	28	)	)	PUNCT
dpc-3884	98	29	,	,	PUNCT
dpc-3884	98	30	while	while	SCONJ
dpc-3884	98	31	dlqi	dlqi	PROPN
dpc-3884	98	32	showed	show	VERB
dpc-3884	98	33	weak	weak	ADJ
dpc-3884	98	34	correlation	correlation	NOUN
dpc-3884	98	35	with	with	ADP
dpc-3884	98	36	summary	summary	NOUN
dpc-3884	98	37	score	score	NOUN
dpc-3884	98	38	of	of	ADP
dpc-3884	98	39	eortc	eortc	ADJ
dpc-3884	98	40	-	-	PUNCT
dpc-3884	98	41	c30	c30	NOUN
dpc-3884	98	42	(	(	PUNCT
dpc-3884	98	43	rho	rho	NOUN
dpc-3884	98	44	0.19	0.19	NUM
dpc-3884	98	45	,	,	PUNCT
dpc-3884	98	46	p	p	NOUN
dpc-3884	98	47	=	=	NOUN
dpc-3884	98	48	0.04	0.04	NUM
dpc-3884	98	49	)	)	PUNCT
dpc-3884	98	50	,	,	PUNCT
dpc-3884	98	51	functional	functional	ADJ
dpc-3884	98	52	(	(	PUNCT
dpc-3884	98	53	rho	rho	ADJ
dpc-3884	98	54	-0.14	-0.14	NOUN
dpc-3884	98	55	,	,	PUNCT
dpc-3884	98	56	p	p	NOUN
dpc-3884	98	57	=	=	NOUN
dpc-3884	98	58	0.14	0.14	NUM
dpc-3884	98	59	)	)	PUNCT
dpc-3884	98	60	and	and	CCONJ
dpc-3884	98	61	symptom	symptom	NOUN
dpc-3884	98	62	scores	score	NOUN
dpc-3884	98	63	(	(	PUNCT
dpc-3884	98	64	rho	rho	ADJ
dpc-3884	98	65	-0.17	-0.17	NOUN
dpc-3884	98	66	,	,	PUNCT
dpc-3884	98	67	p	p	NOUN
dpc-3884	98	68	=	=	NOUN
dpc-3884	98	69	0.06	0.06	NUM
dpc-3884	98	70	)	)	PUNCT
dpc-3884	98	71	,	,	PUNCT
dpc-3884	98	72	and	and	CCONJ
dpc-3884	98	73	no	no	DET
dpc-3884	98	74	correlation	correlation	NOUN
dpc-3884	98	75	with	with	ADP
dpc-3884	98	76	global	global	ADJ
dpc-3884	98	77	health	health	NOUN
dpc-3884	98	78	status	status	NOUN
dpc-3884	98	79	/	/	SYM
dpc-3884	98	80	qols	qol	NOUN
dpc-3884	98	81	(	(	PUNCT
dpc-3884	98	82	rho	rho	NOUN
dpc-3884	98	83	0.01	0.01	NUM
dpc-3884	98	84	,	,	PUNCT
dpc-3884	98	85	p	p	X
dpc-3884	98	86	=	=	NOUN
dpc-3884	98	87	0.90	0.90	NUM
dpc-3884	98	88	)	)	PUNCT
dpc-3884	98	89	(	(	PUNCT
dpc-3884	98	90	figure	figure	NOUN
dpc-3884	98	91	3	3	NUM
dpc-3884	98	92	)	)	PUNCT
dpc-3884	98	93	.	.	PUNCT
dpc-3884	99	1	after	after	SCONJ
dpc-3884	99	2	the	the	DET
dpc-3884	99	3	first	first	ADJ
dpc-3884	99	4	and	and	CCONJ
dpc-3884	99	5	the	the	DET
dpc-3884	99	6	second	second	ADJ
dpc-3884	99	7	intervention	intervention	NOUN
dpc-3884	99	8	,	,	PUNCT
dpc-3884	99	9	a	a	DET
dpc-3884	99	10	weak	weak	ADJ
dpc-3884	99	11	correlation	correlation	NOUN
dpc-3884	99	12	between	between	ADP
dpc-3884	99	13	dlqi	dlqi	NOUN
dpc-3884	99	14	and	and	CCONJ
dpc-3884	99	15	pnrs	pnrs	NOUN
dpc-3884	99	16	remained	remain	VERB
dpc-3884	99	17	(	(	PUNCT
dpc-3884	99	18	rho	rho	NOUN
dpc-3884	99	19	0.20	0.20	NUM
dpc-3884	99	20	,	,	PUNCT
dpc-3884	99	21	p	p	NOUN
dpc-3884	99	22	=	=	NOUN
dpc-3884	99	23	0.02	0.02	NUM
dpc-3884	99	24	and	and	CCONJ
dpc-3884	99	25	rho	rho	ADJ
dpc-3884	99	26	0.23	0.23	NUM
dpc-3884	99	27	,	,	PUNCT
dpc-3884	99	28	p	p	X
dpc-3884	99	29	=	=	NOUN
dpc-3884	99	30	0.01	0.01	NUM
dpc-3884	99	31	,	,	PUNCT
dpc-3884	99	32	respectively	respectively	ADV
dpc-3884	99	33	)	)	PUNCT
dpc-3884	99	34	,	,	PUNCT
dpc-3884	99	35	whereas	whereas	SCONJ
dpc-3884	99	36	summary	summary	NOUN
dpc-3884	99	37	score	score	NOUN
dpc-3884	99	38	,	,	PUNCT
dpc-3884	99	39	functional	functional	ADJ
dpc-3884	99	40	or	or	CCONJ
dpc-3884	99	41	symptoms	symptom	NOUN
dpc-3884	99	42	scores	score	NOUN
dpc-3884	99	43	were	be	AUX
dpc-3884	99	44	not	not	PART
dpc-3884	99	45	correlated	correlate	VERB
dpc-3884	99	46	with	with	ADP
dpc-3884	99	47	either	either	CCONJ
dpc-3884	99	48	dlqi	dlqi	ADJ
dpc-3884	99	49	or	or	CCONJ
dpc-3884	99	50	pnrs	pnrs	NOUN
dpc-3884	99	51	(	(	PUNCT
dpc-3884	99	52	table	table	NOUN
dpc-3884	99	53	2	2	NUM
dpc-3884	99	54	)	)	PUNCT
dpc-3884	99	55	.	.	PUNCT
dpc-3884	100	1	figure	figure	VERB
dpc-3884	100	2	3	3	NUM
dpc-3884	100	3	.	.	PUNCT
dpc-3884	101	1	scatterplots	scatterplot	NOUN
dpc-3884	101	2	showing	show	VERB
dpc-3884	101	3	the	the	DET
dpc-3884	101	4	correlation	correlation	NOUN
dpc-3884	101	5	between	between	ADP
dpc-3884	101	6	dermatology	dermatology	NOUN
dpc-3884	101	7	life	life	NOUN
dpc-3884	101	8	quality	quality	NOUN
dpc-3884	101	9	index	index	NOUN
dpc-3884	101	10	and	and	CCONJ
dpc-3884	101	11	numerical	numerical	ADJ
dpc-3884	101	12	rating	rating	NOUN
dpc-3884	101	13	scale	scale	NOUN
dpc-3884	101	14	for	for	ADP
dpc-3884	101	15	pruritus	pruritus	PROPN
dpc-3884	101	16	,	,	PUNCT
dpc-3884	101	17	global	global	ADJ
dpc-3884	101	18	health	health	NOUN
dpc-3884	101	19	status	status	NOUN
dpc-3884	101	20	and	and	CCONJ
dpc-3884	101	21	summary	summary	VERB
dpc-3884	101	22	score	score	NOUN
dpc-3884	101	23	a	a	NOUN
dpc-3884	101	24	)	)	PUNCT
dpc-3884	101	25	at	at	ADP
dpc-3884	101	26	baseline	baseline	NOUN
dpc-3884	101	27	,	,	PUNCT
dpc-3884	101	28	b	b	NOUN
dpc-3884	101	29	)	)	PUNCT
dpc-3884	101	30	after	after	ADP
dpc-3884	101	31	1st	1st	ADJ
dpc-3884	101	32	intervention	intervention	NOUN
dpc-3884	101	33	and	and	CCONJ
dpc-3884	101	34	c	c	NOUN
dpc-3884	101	35	)	)	PUNCT
dpc-3884	101	36	after	after	ADP
dpc-3884	101	37	2nd	2nd	PROPN
dpc-3884	101	38	intervention	intervention	PROPN
dpc-3884	101	39	.	.	PUNCT
dpc-3884	102	1	table	table	NOUN
dpc-3884	102	2	2	2	NUM
dpc-3884	102	3	.	.	PUNCT
dpc-3884	102	4	correlation	correlation	NOUN
dpc-3884	102	5	analysis	analysis	NOUN
dpc-3884	102	6	between	between	ADP
dpc-3884	102	7	dlqi	dlqi	NOUN
dpc-3884	102	8	and	and	CCONJ
dpc-3884	102	9	other	other	ADJ
dpc-3884	102	10	qol	qol	PROPN
dpc-3884	102	11	scores	score	NOUN
dpc-3884	102	12	.	.	PUNCT
dpc-3884	103	1	baseline	baseline	PROPN
dpc-3884	103	2	1st	1st	ADJ
dpc-3884	103	3	intervention	intervention	NOUN
dpc-3884	103	4	2nd	2nd	PROPN
dpc-3884	103	5	intervention	intervention	NOUN
dpc-3884	103	6	rho	rho	ADJ
dpc-3884	104	1	p	p	PROPN
dpc-3884	104	2	rho	rho	ADJ
dpc-3884	104	3	p	p	PROPN
dpc-3884	104	4	rho	rho	PROPN
dpc-3884	104	5	v	v	ADP
dpc-3884	104	6	dlqi	dlqi	ADJ
dpc-3884	104	7	global	global	ADJ
dpc-3884	104	8	health	health	PROPN
dpc-3884	104	9	0.012	0.012	NUM
dpc-3884	104	10	0.90	0.90	NUM
dpc-3884	104	11	-0.056	-0.056	NUM
dpc-3884	104	12	0.56	0.56	NUM
dpc-3884	104	13	-0.129	-0.129	NUM
dpc-3884	104	14	0.17	0.17	NUM
dpc-3884	104	15	pnrs	pnrs	VERB
dpc-3884	104	16	0.441	0.441	NUM
dpc-3884	104	17	<	<	X
dpc-3884	104	18	0.001	0.001	NUM
dpc-3884	104	19	0.227	0.227	NUM
dpc-3884	104	20	0.02	0.02	NUM
dpc-3884	104	21	0.260	0.260	NUM
dpc-3884	104	22	0.01	0.01	NUM
dpc-3884	104	23	eortc	eortc	VERB
dpc-3884	104	24	-	-	PUNCT
dpc-3884	104	25	qlq	qlq	ADJ
dpc-3884	104	26	-	-	PUNCT
dpc-3884	104	27	c30	c30	NOUN
dpc-3884	104	28	summary	summary	NOUN
dpc-3884	104	29	score	score	NOUN
dpc-3884	104	30	0.197	0.197	NUM
dpc-3884	104	31	0.04	0.04	NUM
dpc-3884	104	32	0.064	0.064	NUM
dpc-3884	104	33	0.50	0.50	NUM
dpc-3884	104	34	0.066	0.066	NUM
dpc-3884	104	35	0.49	0.49	NUM
dpc-3884	104	36	functional	functional	ADJ
dpc-3884	104	37	scale	scale	NOUN
dpc-3884	104	38	-0.140	-0.140	PROPN
dpc-3884	104	39	0.14	0.14	NUM
dpc-3884	104	40	0.056	0.056	NUM
dpc-3884	104	41	0.56	0.56	NUM
dpc-3884	104	42	-0.061	-0.061	NOUN
dpc-3884	104	43	0.52	0.52	NUM
dpc-3884	104	44	symptom	symptom	NOUN
dpc-3884	104	45	scale	scale	NOUN
dpc-3884	104	46	-0.177	-0.177	PROPN
dpc-3884	104	47	0.06	0.06	NUM
dpc-3884	104	48	-0.047	-0.047	NUM
dpc-3884	104	49	0.62	0.62	NUM
dpc-3884	104	50	-0.074	-0.074	NOUN
dpc-3884	104	51	0.44	0.44	NUM
dpc-3884	104	52	dlqi	dlqi	ADJ
dpc-3884	104	53	=	=	PUNCT
dpc-3884	104	54	dermatology	dermatology	NOUN
dpc-3884	104	55	quality	quality	NOUN
dpc-3884	104	56	of	of	ADP
dpc-3884	104	57	life	life	NOUN
dpc-3884	104	58	index	index	NOUN
dpc-3884	104	59	;	;	PUNCT
dpc-3884	104	60	pnrs	pnrs	NOUN
dpc-3884	104	61	=	=	SYM
dpc-3884	104	62	numerical	numerical	ADJ
dpc-3884	104	63	rating	rating	NOUN
dpc-3884	104	64	scale	scale	NOUN
dpc-3884	104	65	for	for	ADP
dpc-3884	104	66	pruritus	pruritus	NOUN
dpc-3884	104	67	;	;	PUNCT
dpc-3884	104	68	qol	qol	NOUN
dpc-3884	104	69	=	=	SYM
dpc-3884	104	70	quality	quality	NOUN
dpc-3884	104	71	-	-	PUNCT
dpc-3884	104	72	of	of	ADP
dpc-3884	104	73	-	-	PUNCT
dpc-3884	104	74	life	life	NOUN
dpc-3884	104	75	.	.	PUNCT
dpc-3884	105	1	6	6	NUM
dpc-3884	105	2	original	original	ADJ
dpc-3884	105	3	article	article	NOUN
dpc-3884	105	4	|	|	ADV
dpc-3884	105	5	dermatol	dermatol	ADJ
dpc-3884	105	6	pract	pract	NOUN
dpc-3884	105	7	concept	concept	NOUN
dpc-3884	105	8	.	.	PUNCT
dpc-3884	106	1	2024;14(3):e2024118	2024;14(3):e2024118	NUM
dpc-3884	106	2	to	to	ADP
dpc-3884	106	3	individuals	individual	NOUN
dpc-3884	106	4	managed	manage	VERB
dpc-3884	106	5	by	by	ADP
dpc-3884	106	6	non	non	NOUN
dpc-3884	106	7	-	-	NOUN
dpc-3884	106	8	dermatologists	dermatologist	NOUN
dpc-3884	106	9	[	[	X
dpc-3884	106	10	22	22	NUM
dpc-3884	106	11	]	]	PUNCT
dpc-3884	106	12	.	.	PUNCT
dpc-3884	107	1	the	the	DET
dpc-3884	107	2	aforementioned	aforementioned	ADJ
dpc-3884	107	3	observations	observation	NOUN
dpc-3884	107	4	highlight	highlight	VERB
dpc-3884	107	5	the	the	DET
dpc-3884	107	6	crucial	crucial	ADJ
dpc-3884	107	7	role	role	NOUN
dpc-3884	107	8	of	of	ADP
dpc-3884	107	9	the	the	DET
dpc-3884	107	10	dermatologist	dermatologist	NOUN
dpc-3884	107	11	in	in	ADP
dpc-3884	107	12	early	early	ADJ
dpc-3884	107	13	diagnosis	diagnosis	NOUN
dpc-3884	107	14	and	and	CCONJ
dpc-3884	107	15	successful	successful	ADJ
dpc-3884	107	16	treatment	treatment	NOUN
dpc-3884	107	17	of	of	ADP
dpc-3884	107	18	diraes	dirae	NOUN
dpc-3884	107	19	,	,	PUNCT
dpc-3884	107	20	towards	towards	ADP
dpc-3884	107	21	improvement	improvement	NOUN
dpc-3884	107	22	of	of	ADP
dpc-3884	107	23	patients	patient	NOUN
dpc-3884	107	24	status	status	VERB
dpc-3884	107	25	and	and	CCONJ
dpc-3884	107	26	unimpaired	unimpaire	VERB
dpc-3884	107	27	oncologic	oncologic	NOUN
dpc-3884	107	28	therapy	therapy	NOUN
dpc-3884	107	29	[	[	X
dpc-3884	107	30	22	22	NUM
dpc-3884	107	31	]	]	PUNCT
dpc-3884	107	32	.	.	PUNCT
dpc-3884	108	1	in	in	ADP
dpc-3884	108	2	addition	addition	NOUN
dpc-3884	108	3	,	,	PUNCT
dpc-3884	108	4	the	the	DET
dpc-3884	108	5	use	use	NOUN
dpc-3884	108	6	of	of	ADP
dpc-3884	108	7	the	the	DET
dpc-3884	108	8	aforementioned	aforementioned	ADJ
dpc-3884	108	9	scores	score	NOUN
dpc-3884	108	10	was	be	AUX
dpc-3884	108	11	useful	useful	ADJ
dpc-3884	108	12	in	in	ADP
dpc-3884	108	13	detecting	detect	VERB
dpc-3884	108	14	clinically	clinically	ADV
dpc-3884	108	15	significant	significant	ADJ
dpc-3884	108	16	changes	change	NOUN
dpc-3884	108	17	in	in	ADP
dpc-3884	108	18	qol	qol	NOUN
dpc-3884	108	19	after	after	ADP
dpc-3884	108	20	appropriate	appropriate	ADJ
dpc-3884	108	21	treatment	treatment	NOUN
dpc-3884	108	22	,	,	PUNCT
dpc-3884	108	23	in	in	ADP
dpc-3884	108	24	contrast	contrast	NOUN
dpc-3884	108	25	to	to	ADP
dpc-3884	108	26	the	the	DET
dpc-3884	108	27	eortcc30	eortcc30	NOUN
dpc-3884	108	28	and	and	CCONJ
dpc-3884	108	29	the	the	DET
dpc-3884	108	30	global	global	ADJ
dpc-3884	108	31	health	health	NOUN
dpc-3884	108	32	status	status	NOUN
dpc-3884	108	33	that	that	PRON
dpc-3884	108	34	appeared	appear	VERB
dpc-3884	108	35	insufficient	insufficient	ADJ
dpc-3884	108	36	to	to	PART
dpc-3884	108	37	capture	capture	VERB
dpc-3884	108	38	changes	change	NOUN
dpc-3884	108	39	related	relate	VERB
dpc-3884	108	40	to	to	ADP
dpc-3884	108	41	skin	skin	NOUN
dpc-3884	108	42	qol	qol	PROPN
dpc-3884	108	43	.	.	PUNCT
dpc-3884	109	1	data	datum	NOUN
dpc-3884	109	2	regarding	regard	VERB
dpc-3884	109	3	qol	qol	NOUN
dpc-3884	109	4	of	of	ADP
dpc-3884	109	5	the	the	DET
dpc-3884	109	6	oncologic	oncologic	ADJ
dpc-3884	109	7	patients	patient	NOUN
dpc-3884	109	8	treated	treat	VERB
dpc-3884	109	9	with	with	ADP
dpc-3884	109	10	icis	icis	NOUN
dpc-3884	109	11	mostly	mostly	ADV
dpc-3884	109	12	emerge	emerge	VERB
dpc-3884	109	13	from	from	ADP
dpc-3884	109	14	phase	phase	NOUN
dpc-3884	109	15	iii	iii	NUM
dpc-3884	109	16	trials	trial	NOUN
dpc-3884	109	17	testing	testing	NOUN
dpc-3884	109	18	efficacy	efficacy	NOUN
dpc-3884	109	19	and	and	CCONJ
dpc-3884	109	20	safety	safety	NOUN
dpc-3884	109	21	of	of	ADP
dpc-3884	109	22	certain	certain	ADJ
dpc-3884	109	23	immunotherapies	immunotherapy	NOUN
dpc-3884	109	24	[	[	X
dpc-3884	109	25	13,18,23	13,18,23	NUM
dpc-3884	109	26	-	-	SYM
dpc-3884	109	27	25	25	NUM
dpc-3884	109	28	]	]	PUNCT
dpc-3884	109	29	.	.	PUNCT
dpc-3884	110	1	a	a	DET
dpc-3884	110	2	meta	meta	ADJ
dpc-3884	110	3	-	-	PUNCT
dpc-3884	110	4	analysis	analysis	NOUN
dpc-3884	110	5	assessed	assess	VERB
dpc-3884	110	6	the	the	DET
dpc-3884	110	7	difference	difference	NOUN
dpc-3884	110	8	in	in	ADP
dpc-3884	110	9	qol	qol	NOUN
dpc-3884	110	10	between	between	ADP
dpc-3884	110	11	patients	patient	NOUN
dpc-3884	110	12	under	under	ADP
dpc-3884	110	13	chemotherapy	chemotherapy	NOUN
dpc-3884	110	14	versus	versus	ADP
dpc-3884	110	15	icis	icis	PROPN
dpc-3884	110	16	and	and	CCONJ
dpc-3884	110	17	found	find	VERB
dpc-3884	110	18	that	that	SCONJ
dpc-3884	110	19	icis	icis	PROPN
dpc-3884	110	20	are	be	AUX
dpc-3884	110	21	associated	associate	VERB
dpc-3884	110	22	with	with	ADP
dpc-3884	110	23	a	a	DET
dpc-3884	110	24	better	well	ADJ
dpc-3884	110	25	qol	qol	NOUN
dpc-3884	110	26	and	and	CCONJ
dpc-3884	110	27	a	a	DET
dpc-3884	110	28	longer	long	ADJ
dpc-3884	110	29	time	time	NOUN
dpc-3884	110	30	to	to	ADP
dpc-3884	110	31	clinical	clinical	ADJ
dpc-3884	110	32	deterioration	deterioration	NOUN
dpc-3884	110	33	as	as	ADP
dpc-3884	110	34	compared	compare	VERB
dpc-3884	110	35	to	to	ADP
dpc-3884	110	36	chemotherapeutics	chemotherapeutic	NOUN
dpc-3884	110	37	[	[	X
dpc-3884	110	38	25	25	NUM
dpc-3884	110	39	]	]	PUNCT
dpc-3884	110	40	.	.	PUNCT
dpc-3884	111	1	qol	qol	PROPN
dpc-3884	111	2	in	in	ADP
dpc-3884	111	3	the	the	DET
dpc-3884	111	4	majority	majority	NOUN
dpc-3884	111	5	of	of	ADP
dpc-3884	111	6	cancer	cancer	NOUN
dpc-3884	111	7	-	-	PUNCT
dpc-3884	111	8	drugs	drug	NOUN
dpc-3884	111	9	trials	trial	NOUN
dpc-3884	111	10	is	be	AUX
dpc-3884	111	11	assessed	assess	VERB
dpc-3884	111	12	by	by	ADP
dpc-3884	111	13	oncologyderived	oncologyderive	VERB
dpc-3884	111	14	,	,	PUNCT
dpc-3884	111	15	generic	generic	ADJ
dpc-3884	111	16	questionnaires	questionnaire	NOUN
dpc-3884	111	17	,	,	PUNCT
dpc-3884	111	18	such	such	ADJ
dpc-3884	111	19	as	as	ADP
dpc-3884	111	20	the	the	DET
dpc-3884	111	21	eortc	eortc	VERB
dpc-3884	111	22	-	-	PUNCT
dpc-3884	111	23	qlq	qlq	NOUN
dpc-3884	111	24	-	-	PUNCT
dpc-3884	111	25	c30	c30	NOUN
dpc-3884	111	26	.	.	PUNCT
dpc-3884	112	1	however	however	ADV
dpc-3884	112	2	,	,	PUNCT
dpc-3884	112	3	icis	icis	NOUN
dpc-3884	112	4	-	-	PUNCT
dpc-3884	112	5	derived	derive	VERB
dpc-3884	112	6	toxicities	toxicity	NOUN
dpc-3884	112	7	differ	differ	VERB
dpc-3884	112	8	from	from	ADP
dpc-3884	112	9	those	those	PRON
dpc-3884	112	10	traditionally	traditionally	ADV
dpc-3884	112	11	reported	report	VERB
dpc-3884	112	12	with	with	ADP
dpc-3884	112	13	conventional	conventional	ADJ
dpc-3884	112	14	oncologic	oncologic	ADJ
dpc-3884	112	15	drugs	drug	NOUN
dpc-3884	112	16	,	,	PUNCT
dpc-3884	112	17	rendering	render	VERB
dpc-3884	112	18	the	the	DET
dpc-3884	112	19	measurement	measurement	NOUN
dpc-3884	112	20	of	of	ADP
dpc-3884	112	21	qol	qol	PROPN
dpc-3884	112	22	in	in	ADP
dpc-3884	112	23	the	the	DET
dpc-3884	112	24	context	context	NOUN
dpc-3884	112	25	of	of	ADP
dpc-3884	112	26	ici	ici	PROPN
dpc-3884	112	27	treatment	treatment	NOUN
dpc-3884	112	28	particularly	particularly	ADV
dpc-3884	112	29	challenging	challenging	ADJ
dpc-3884	112	30	.	.	PUNCT
dpc-3884	113	1	in	in	ADP
dpc-3884	113	2	particular	particular	ADJ
dpc-3884	113	3	,	,	PUNCT
dpc-3884	113	4	the	the	DET
dpc-3884	113	5	impact	impact	NOUN
dpc-3884	113	6	of	of	ADP
dpc-3884	113	7	cutaneous	cutaneous	ADJ
dpc-3884	113	8	rash	rash	NOUN
dpc-3884	113	9	and	and	CCONJ
dpc-3884	113	10	pruritus	pruritus	NOUN
dpc-3884	113	11	that	that	PRON
dpc-3884	113	12	are	be	AUX
dpc-3884	113	13	the	the	DET
dpc-3884	113	14	most	most	ADV
dpc-3884	113	15	common	common	ADJ
dpc-3884	113	16	iraes	irae	NOUN
dpc-3884	113	17	,	,	PUNCT
dpc-3884	113	18	is	be	AUX
dpc-3884	113	19	poorly	poorly	ADV
dpc-3884	113	20	represented	represent	VERB
dpc-3884	113	21	in	in	ADP
dpc-3884	113	22	generic	generic	ADJ
dpc-3884	113	23	indexes	index	NOUN
dpc-3884	113	24	,	,	PUNCT
dpc-3884	113	25	like	like	ADP
dpc-3884	113	26	sf-36	sf-36	NOUN
dpc-3884	113	27	questionnaire	questionnaire	NOUN
dpc-3884	113	28	or	or	CCONJ
dpc-3884	113	29	eortc-qlq-c30.taking	eortc-qlq-c30.take	VERB
dpc-3884	113	30	into	into	ADP
dpc-3884	113	31	account	account	NOUN
dpc-3884	113	32	the	the	DET
dpc-3884	113	33	aforementioned	aforementioned	ADJ
dpc-3884	113	34	limitations	limitation	NOUN
dpc-3884	113	35	and	and	CCONJ
dpc-3884	113	36	considering	consider	VERB
dpc-3884	113	37	that	that	SCONJ
dpc-3884	113	38	real	real	ADJ
dpc-3884	113	39	-	-	PUNCT
dpc-3884	113	40	life	life	NOUN
dpc-3884	113	41	data	datum	NOUN
dpc-3884	113	42	about	about	ADP
dpc-3884	113	43	dermatology	dermatology	NOUN
dpc-3884	113	44	qol	qol	NOUN
dpc-3884	113	45	of	of	ADP
dpc-3884	113	46	patients	patient	NOUN
dpc-3884	113	47	experiencing	experience	VERB
dpc-3884	113	48	diraesare	diraesare	ADJ
dpc-3884	113	49	scarce	scarce	NOUN
dpc-3884	113	50	in	in	ADP
dpc-3884	113	51	the	the	DET
dpc-3884	113	52	literature	literature	NOUN
dpc-3884	113	53	,	,	PUNCT
dpc-3884	113	54	we	we	PRON
dpc-3884	113	55	decided	decide	VERB
dpc-3884	113	56	to	to	PART
dpc-3884	113	57	use	use	VERB
dpc-3884	113	58	both	both	PRON
dpc-3884	113	59	,	,	PUNCT
dpc-3884	113	60	dermatology	dermatology	NOUN
dpc-3884	113	61	-	-	PUNCT
dpc-3884	113	62	derived	derive	VERB
dpc-3884	113	63	(	(	PUNCT
dpc-3884	113	64	dlqi	dlqi	ADJ
dpc-3884	113	65	,	,	PUNCT
dpc-3884	113	66	pnrs	pnrs	NOUN
dpc-3884	113	67	)	)	PUNCT
dpc-3884	113	68	and	and	CCONJ
dpc-3884	113	69	oncology	oncology	NOUN
dpc-3884	113	70	-	-	PUNCT
dpc-3884	113	71	derived	derive	VERB
dpc-3884	113	72	(	(	PUNCT
dpc-3884	113	73	eortc	eortc	VERB
dpc-3884	113	74	-	-	PUNCT
dpc-3884	113	75	qlq	qlq	NOUN
dpc-3884	113	76	-	-	PUNCT
dpc-3884	113	77	c30	c30	NOUN
dpc-3884	113	78	)	)	PUNCT
dpc-3884	113	79	pros	pro	NOUN
dpc-3884	113	80	and	and	CCONJ
dpc-3884	113	81	investigate	investigate	VERB
dpc-3884	113	82	the	the	DET
dpc-3884	113	83	correlation	correlation	NOUN
dpc-3884	113	84	between	between	ADP
dpc-3884	113	85	them	they	PRON
dpc-3884	114	1	[	[	X
dpc-3884	114	2	13	13	NUM
dpc-3884	114	3	]	]	PUNCT
dpc-3884	114	4	.	.	PUNCT
dpc-3884	115	1	our	our	PRON
dpc-3884	115	2	findings	finding	NOUN
dpc-3884	115	3	,	,	PUNCT
dpc-3884	115	4	based	base	VERB
dpc-3884	115	5	on	on	ADP
dpc-3884	115	6	dlqi	dlqi	NOUN
dpc-3884	115	7	and	and	CCONJ
dpc-3884	115	8	pnrs	pnrs	NOUN
dpc-3884	115	9	scores	score	NOUN
dpc-3884	115	10	,	,	PUNCT
dpc-3884	115	11	clearly	clearly	ADV
dpc-3884	115	12	indicate	indicate	VERB
dpc-3884	115	13	an	an	DET
dpc-3884	115	14	impairment	impairment	NOUN
dpc-3884	115	15	of	of	ADP
dpc-3884	115	16	patients	patient	NOUN
dpc-3884	115	17	qol	qol	INTJ
dpc-3884	115	18	related	relate	VERB
dpc-3884	115	19	to	to	ADP
dpc-3884	115	20	the	the	DET
dpc-3884	115	21	development	development	NOUN
dpc-3884	115	22	of	of	ADP
dpc-3884	115	23	cutaneous	cutaneous	ADJ
dpc-3884	115	24	adverse	adverse	ADJ
dpc-3884	115	25	events	event	NOUN
dpc-3884	115	26	.	.	PUNCT
dpc-3884	116	1	however	however	ADV
dpc-3884	116	2	,	,	PUNCT
dpc-3884	116	3	this	this	DET
dpc-3884	116	4	observation	observation	NOUN
dpc-3884	116	5	is	be	AUX
dpc-3884	116	6	not	not	PART
dpc-3884	116	7	clearly	clearly	ADV
dpc-3884	116	8	reflected	reflect	VERB
dpc-3884	116	9	in	in	ADP
dpc-3884	116	10	the	the	DET
dpc-3884	116	11	eortc	eortc	VERB
dpc-3884	116	12	-	-	PUNCT
dpc-3884	116	13	qlq	qlq	NOUN
dpc-3884	116	14	-	-	PUNCT
dpc-3884	116	15	c30	c30	NOUN
dpc-3884	116	16	.	.	PUNCT
dpc-3884	117	1	our	our	PRON
dpc-3884	117	2	findings	finding	NOUN
dpc-3884	117	3	are	be	AUX
dpc-3884	117	4	in	in	ADP
dpc-3884	117	5	line	line	NOUN
dpc-3884	117	6	with	with	ADP
dpc-3884	117	7	the	the	DET
dpc-3884	117	8	conclusions	conclusion	NOUN
dpc-3884	117	9	of	of	ADP
dpc-3884	117	10	a	a	DET
dpc-3884	117	11	systematic	systematic	ADJ
dpc-3884	117	12	review	review	NOUN
dpc-3884	117	13	by	by	ADP
dpc-3884	117	14	frances	france	NOUN
dpc-3884	117	15	et	et	PROPN
dpc-3884	117	16	al	al	PROPN
dpc-3884	117	17	suggesting	suggest	VERB
dpc-3884	117	18	that	that	SCONJ
dpc-3884	117	19	data	datum	NOUN
dpc-3884	117	20	in	in	ADP
dpc-3884	117	21	existing	exist	VERB
dpc-3884	117	22	literature	literature	NOUN
dpc-3884	117	23	regarding	regard	VERB
dpc-3884	117	24	the	the	DET
dpc-3884	117	25	impact	impact	NOUN
dpc-3884	117	26	of	of	ADP
dpc-3884	117	27	icis	icis	NOUN
dpc-3884	117	28	on	on	ADP
dpc-3884	117	29	health	health	NOUN
dpc-3884	117	30	-	-	PUNCT
dpc-3884	117	31	related	relate	VERB
dpc-3884	117	32	qol	qol	NOUN
dpc-3884	117	33	do	do	AUX
dpc-3884	117	34	not	not	PART
dpc-3884	117	35	adequately	adequately	ADV
dpc-3884	117	36	capture	capture	VERB
dpc-3884	117	37	the	the	DET
dpc-3884	117	38	impact	impact	NOUN
dpc-3884	117	39	of	of	ADP
dpc-3884	117	40	cutaneous	cutaneous	ADJ
dpc-3884	117	41	adverse	adverse	ADJ
dpc-3884	117	42	reactions	reaction	NOUN
dpc-3884	117	43	.	.	PUNCT
dpc-3884	118	1	the	the	DET
dpc-3884	118	2	latter	latter	ADJ
dpc-3884	118	3	indicates	indicate	VERB
dpc-3884	118	4	that	that	SCONJ
dpc-3884	118	5	conventional	conventional	ADJ
dpc-3884	118	6	oncologic	oncologic	ADJ
dpc-3884	118	7	qol	qol	NOUN
dpc-3884	118	8	assessment	assessment	NOUN
dpc-3884	118	9	tools	tool	NOUN
dpc-3884	118	10	like	like	ADP
dpc-3884	118	11	eortc	eortc	VERB
dpc-3884	118	12	-	-	PUNCT
dpc-3884	118	13	qlq-30	qlq-30	NOUN
dpc-3884	118	14	,	,	PUNCT
dpc-3884	118	15	once	once	ADV
dpc-3884	118	16	developed	develop	VERB
dpc-3884	118	17	for	for	ADP
dpc-3884	118	18	capturing	capture	VERB
dpc-3884	118	19	the	the	DET
dpc-3884	118	20	impact	impact	NOUN
dpc-3884	118	21	mostly	mostly	ADV
dpc-3884	118	22	of	of	ADP
dpc-3884	118	23	chemotherapy	chemotherapy	NOUN
dpc-3884	118	24	,	,	PUNCT
dpc-3884	118	25	may	may	AUX
dpc-3884	118	26	be	be	AUX
dpc-3884	118	27	insufficient	insufficient	ADJ
dpc-3884	118	28	to	to	PART
dpc-3884	118	29	capture	capture	VERB
dpc-3884	118	30	the	the	DET
dpc-3884	118	31	impact	impact	NOUN
dpc-3884	118	32	of	of	ADP
dpc-3884	118	33	newer	new	ADJ
dpc-3884	118	34	oncologic	oncologic	ADJ
dpc-3884	118	35	treatments	treatment	NOUN
dpc-3884	118	36	.	.	PUNCT
dpc-3884	119	1	therefore	therefore	ADV
dpc-3884	119	2	,	,	PUNCT
dpc-3884	119	3	dermatology	dermatology	NOUN
dpc-3884	119	4	derived	derive	VERB
dpc-3884	119	5	questionnaires	questionnaire	NOUN
dpc-3884	119	6	,	,	PUNCT
dpc-3884	119	7	like	like	ADP
dpc-3884	119	8	dlqi	dlqi	NOUN
dpc-3884	119	9	,	,	PUNCT
dpc-3884	119	10	pnrs	pnrs	NOUN
dpc-3884	119	11	,	,	PUNCT
dpc-3884	119	12	skindex7	skindex7	NOUN
dpc-3884	119	13	and	and	CCONJ
dpc-3884	119	14	itchyqol	itchyqol	NOUN
dpc-3884	119	15	should	should	AUX
dpc-3884	119	16	be	be	AUX
dpc-3884	119	17	integrated	integrate	VERB
dpc-3884	119	18	in	in	ADP
dpc-3884	119	19	clinical	clinical	ADJ
dpc-3884	119	20	practice	practice	NOUN
dpc-3884	119	21	to	to	PART
dpc-3884	119	22	better	well	ADV
dpc-3884	119	23	cover	cover	VERB
dpc-3884	119	24	this	this	DET
dpc-3884	119	25	aspect	aspect	NOUN
dpc-3884	119	26	of	of	ADP
dpc-3884	119	27	qol	qol	PROPN
dpc-3884	119	28	.	.	PUNCT
dpc-3884	120	1	towards	towards	ADP
dpc-3884	120	2	overcoming	overcome	VERB
dpc-3884	120	3	the	the	DET
dpc-3884	120	4	aforementioned	aforementioned	ADJ
dpc-3884	120	5	limitations	limitation	NOUN
dpc-3884	120	6	,	,	PUNCT
dpc-3884	120	7	adapted	adapt	VERB
dpc-3884	120	8	measurement	measurement	NOUN
dpc-3884	120	9	scales	scale	NOUN
dpc-3884	120	10	are	be	AUX
dpc-3884	120	11	being	be	AUX
dpc-3884	120	12	developed	develop	VERB
dpc-3884	120	13	to	to	PART
dpc-3884	120	14	improve	improve	VERB
dpc-3884	120	15	the	the	DET
dpc-3884	120	16	assessment	assessment	NOUN
dpc-3884	120	17	of	of	ADP
dpc-3884	120	18	the	the	DET
dpc-3884	120	19	impact	impact	NOUN
dpc-3884	120	20	of	of	ADP
dpc-3884	120	21	these	these	DET
dpc-3884	120	22	life	life	NOUN
dpc-3884	120	23	-	-	PUNCT
dpc-3884	120	24	changing	change	VERB
dpc-3884	120	25	treatments	treatment	NOUN
dpc-3884	120	26	on	on	ADP
dpc-3884	120	27	patients	patient	NOUN
dpc-3884	120	28	qol	qol	VERB
dpc-3884	121	1	[	[	X
dpc-3884	121	2	13,23,24,27,28	13,23,24,27,28	NUM
dpc-3884	121	3	]	]	X
dpc-3884	121	4	.	.	PUNCT
dpc-3884	122	1	a	a	DET
dpc-3884	122	2	significant	significant	ADJ
dpc-3884	122	3	observation	observation	NOUN
dpc-3884	122	4	was	be	AUX
dpc-3884	122	5	that	that	SCONJ
dpc-3884	122	6	pruritus	pruritus	PROPN
dpc-3884	122	7	appears	appear	VERB
dpc-3884	122	8	to	to	PART
dpc-3884	122	9	be	be	AUX
dpc-3884	122	10	a	a	DET
dpc-3884	122	11	decisive	decisive	ADJ
dpc-3884	122	12	factor	factor	NOUN
dpc-3884	122	13	in	in	ADP
dpc-3884	122	14	most	most	ADJ
dpc-3884	122	15	patients	patient	NOUN
dpc-3884	122	16	perceived	perceive	VERB
dpc-3884	122	17	qol	qol	PROPN
dpc-3884	122	18	.	.	PUNCT
dpc-3884	123	1	mean	mean	VERB
dpc-3884	123	2	pnrs	pnrs	NOUN
dpc-3884	123	3	in	in	ADP
dpc-3884	123	4	our	our	PRON
dpc-3884	123	5	sample	sample	NOUN
dpc-3884	123	6	was	be	AUX
dpc-3884	123	7	particularly	particularly	ADV
dpc-3884	123	8	high	high	ADJ
dpc-3884	123	9	at	at	ADP
dpc-3884	123	10	baseline	baseline	NOUN
dpc-3884	123	11	and	and	CCONJ
dpc-3884	123	12	score	score	VERB
dpc-3884	123	13	at	at	ADP
dpc-3884	123	14	baseline	baseline	NOUN
dpc-3884	123	15	,	,	PUNCT
dpc-3884	123	16	with	with	ADP
dpc-3884	123	17	an	an	DET
dpc-3884	123	18	increase	increase	NOUN
dpc-3884	123	19	of	of	ADP
dpc-3884	123	20	0.04	0.04	NUM
dpc-3884	123	21	in	in	ADP
dpc-3884	123	22	pnrs	pnrs	NOUN
dpc-3884	123	23	for	for	ADP
dpc-3884	123	24	every	every	DET
dpc-3884	123	25	added	add	VERB
dpc-3884	123	26	year	year	NOUN
dpc-3884	123	27	of	of	ADP
dpc-3884	123	28	age	age	NOUN
dpc-3884	123	29	(	(	PUNCT
dpc-3884	123	30	b	b	NOUN
dpc-3884	123	31	=	=	SYM
dpc-3884	123	32	0.04	0.04	NUM
dpc-3884	123	33	,	,	PUNCT
dpc-3884	123	34	95	95	NUM
dpc-3884	123	35	%	%	NOUN
dpc-3884	123	36	confidence	confidence	NOUN
dpc-3884	123	37	interval	interval	NOUN
dpc-3884	123	38	[	[	X
dpc-3884	123	39	ci	ci	X
dpc-3884	123	40	]	]	X
dpc-3884	123	41	0.005	0.005	NUM
dpc-3884	123	42	–	–	PUNCT
dpc-3884	123	43	0.08	0.08	NUM
dpc-3884	123	44	)	)	PUNCT
dpc-3884	123	45	.	.	PUNCT
dpc-3884	124	1	regarding	regard	VERB
dpc-3884	124	2	type	type	NOUN
dpc-3884	124	3	of	of	ADP
dpc-3884	124	4	primary	primary	ADJ
dpc-3884	124	5	cancer	cancer	NOUN
dpc-3884	124	6	,	,	PUNCT
dpc-3884	124	7	there	there	PRON
dpc-3884	124	8	was	be	VERB
dpc-3884	124	9	a	a	DET
dpc-3884	124	10	statistically	statistically	ADV
dpc-3884	124	11	significant	significant	ADJ
dpc-3884	124	12	difference	difference	NOUN
dpc-3884	124	13	in	in	ADP
dpc-3884	124	14	pnrs	pnrs	NOUN
dpc-3884	124	15	and	and	CCONJ
dpc-3884	124	16	global	global	ADJ
dpc-3884	124	17	health	health	NOUN
dpc-3884	124	18	qols	qol	NOUN
dpc-3884	124	19	,	,	PUNCT
dpc-3884	124	20	and	and	CCONJ
dpc-3884	124	21	from	from	ADP
dpc-3884	124	22	pairwise	pairwise	NOUN
dpc-3884	124	23	comparisons	comparison	NOUN
dpc-3884	124	24	,	,	PUNCT
dpc-3884	124	25	patients	patient	NOUN
dpc-3884	124	26	with	with	ADP
dpc-3884	124	27	melanoma	melanoma	PROPN
dpc-3884	124	28	had	have	VERB
dpc-3884	124	29	a	a	DET
dpc-3884	124	30	significantly	significantly	ADV
dpc-3884	124	31	lower	low	ADJ
dpc-3884	124	32	mean	mean	ADJ
dpc-3884	124	33	pnrs	pnrs	NOUN
dpc-3884	124	34	score	score	NOUN
dpc-3884	124	35	at	at	ADP
dpc-3884	124	36	baseline	baseline	NOUN
dpc-3884	124	37	,	,	PUNCT
dpc-3884	124	38	compared	compare	VERB
dpc-3884	124	39	to	to	ADP
dpc-3884	124	40	patients	patient	NOUN
dpc-3884	124	41	with	with	ADP
dpc-3884	124	42	head	head	NOUN
dpc-3884	124	43	and	and	CCONJ
dpc-3884	124	44	neck	neck	NOUN
dpc-3884	124	45	scc	scc	NOUN
dpc-3884	124	46	(	(	PUNCT
dpc-3884	124	47	mean	mean	INTJ
dpc-3884	124	48	difference	difference	NOUN
dpc-3884	124	49	2.82	2.82	NUM
dpc-3884	124	50	,	,	PUNCT
dpc-3884	124	51	p	p	X
dpc-3884	124	52	=	=	NOUN
dpc-3884	124	53	0.03	0.03	NUM
dpc-3884	124	54	)	)	PUNCT
dpc-3884	124	55	and	and	CCONJ
dpc-3884	124	56	a	a	DET
dpc-3884	124	57	higher	high	ADJ
dpc-3884	124	58	mean	mean	ADJ
dpc-3884	124	59	global	global	ADJ
dpc-3884	124	60	health	health	NOUN
dpc-3884	124	61	qols	qol	NOUN
dpc-3884	124	62	,	,	PUNCT
dpc-3884	124	63	respectively	respectively	ADV
dpc-3884	124	64	.	.	PUNCT
dpc-3884	125	1	in	in	ADP
dpc-3884	125	2	relation	relation	NOUN
dpc-3884	125	3	to	to	ADP
dpc-3884	125	4	type	type	NOUN
dpc-3884	125	5	of	of	ADP
dpc-3884	125	6	ici	ici	PROPN
dpc-3884	125	7	treatment	treatment	NOUN
dpc-3884	125	8	,	,	PUNCT
dpc-3884	125	9	patients	patient	NOUN
dpc-3884	125	10	treated	treat	VERB
dpc-3884	125	11	with	with	ADP
dpc-3884	125	12	combination	combination	NOUN
dpc-3884	125	13	therapy	therapy	NOUN
dpc-3884	125	14	had	have	VERB
dpc-3884	125	15	higher	high	ADJ
dpc-3884	125	16	dlqi	dlqi	ADJ
dpc-3884	125	17	score	score	NOUN
dpc-3884	125	18	at	at	ADP
dpc-3884	125	19	baseline	baseline	PROPN
dpc-3884	125	20	(	(	PUNCT
dpc-3884	125	21	mean	mean	INTJ
dpc-3884	125	22	dlqi	dlqi	VERB
dpc-3884	125	23	22.0	22.0	NUM
dpc-3884	125	24	)	)	PUNCT
dpc-3884	125	25	compared	compare	VERB
dpc-3884	125	26	to	to	ADP
dpc-3884	125	27	patients	patient	NOUN
dpc-3884	125	28	treated	treat	VERB
dpc-3884	125	29	with	with	ADP
dpc-3884	125	30	anti	anti	ADJ
dpc-3884	125	31	-	-	ADJ
dpc-3884	125	32	pd1	pd1	VERB
dpc-3884	125	33	(	(	PUNCT
dpc-3884	125	34	mean	mean	NOUN
dpc-3884	125	35	15.1	15.1	NUM
dpc-3884	126	1	[	[	X
dpc-3884	126	2	5.57	5.57	NUM
dpc-3884	126	3	]	]	PUNCT
dpc-3884	126	4	,	,	PUNCT
dpc-3884	126	5	p	p	NOUN
dpc-3884	126	6	=	=	NOUN
dpc-3884	126	7	0.001	0.001	NUM
dpc-3884	126	8	)	)	PUNCT
dpc-3884	126	9	and	and	CCONJ
dpc-3884	126	10	patients	patient	NOUN
dpc-3884	126	11	treated	treat	VERB
dpc-3884	126	12	with	with	ADP
dpc-3884	126	13	anti	anti	ADJ
dpc-3884	126	14	-	-	ADJ
dpc-3884	126	15	pdl1	pdl1	ADJ
dpc-3884	126	16	)	)	PUNCT
dpc-3884	126	17	(	(	PUNCT
dpc-3884	126	18	mean	mean	VERB
dpc-3884	126	19	15.9	15.9	NUM
dpc-3884	127	1	[	[	X
dpc-3884	127	2	3.18	3.18	NUM
dpc-3884	127	3	]	]	PUNCT
dpc-3884	127	4	,	,	PUNCT
dpc-3884	127	5	p	p	X
dpc-3884	127	6	=	=	NOUN
dpc-3884	127	7	0.002	0.002	NUM
dpc-3884	127	8	)	)	PUNCT
dpc-3884	127	9	.	.	PUNCT
dpc-3884	128	1	analysis	analysis	NOUN
dpc-3884	128	2	for	for	ADP
dpc-3884	128	3	patients	patient	NOUN
dpc-3884	128	4	with	with	ADP
dpc-3884	128	5	pruritus	pruritus	PROPN
dpc-3884	128	6	patients	patient	NOUN
dpc-3884	128	7	with	with	ADP
dpc-3884	128	8	pruritus	pruritus	PROPN
dpc-3884	128	9	had	have	VERB
dpc-3884	128	10	a	a	DET
dpc-3884	128	11	higher	high	ADJ
dpc-3884	128	12	mean	mean	NOUN
dpc-3884	128	13	baseline	baseline	NOUN
dpc-3884	128	14	dlqi	dlqi	ADJ
dpc-3884	128	15	(	(	PUNCT
dpc-3884	128	16	mean	mean	PROPN
dpc-3884	128	17	20.27	20.27	NUM
dpc-3884	129	1	[	[	X
dpc-3884	129	2	3.06	3.06	NUM
dpc-3884	129	3	]	]	PUNCT
dpc-3884	129	4	)	)	PUNCT
dpc-3884	129	5	and	and	CCONJ
dpc-3884	129	6	pnrs	pnrs	NOUN
dpc-3884	129	7	score	score	NOUN
dpc-3884	129	8	(	(	PUNCT
dpc-3884	129	9	mean	mean	NOUN
dpc-3884	130	1	8.93	8.93	NUM
dpc-3884	131	1	[	[	X
dpc-3884	131	2	1.16	1.16	NUM
dpc-3884	131	3	]	]	PUNCT
dpc-3884	131	4	)	)	PUNCT
dpc-3884	131	5	compared	compare	VERB
dpc-3884	131	6	to	to	ADP
dpc-3884	131	7	all	all	DET
dpc-3884	131	8	other	other	ADJ
dpc-3884	131	9	individuals	individual	NOUN
dpc-3884	131	10	(	(	PUNCT
dpc-3884	131	11	mann	mann	PROPN
dpc-3884	131	12	-	-	PUNCT
dpc-3884	131	13	whitney	whitney	PROPN
dpc-3884	131	14	t	t	PROPN
dpc-3884	131	15	-	-	PUNCT
dpc-3884	131	16	test	test	NOUN
dpc-3884	131	17	,	,	PUNCT
dpc-3884	131	18	p	p	X
dpc-3884	131	19	<	<	X
dpc-3884	131	20	0.001	0.001	NUM
dpc-3884	131	21	and	and	CCONJ
dpc-3884	131	22	p	p	X
dpc-3884	131	23	<	<	X
dpc-3884	131	24	0.034	0.034	NUM
dpc-3884	131	25	,	,	PUNCT
dpc-3884	131	26	respectively	respectively	ADV
dpc-3884	131	27	)	)	PUNCT
dpc-3884	131	28	.	.	PUNCT
dpc-3884	132	1	all	all	DET
dpc-3884	132	2	other	other	ADJ
dpc-3884	132	3	scores	score	NOUN
dpc-3884	132	4	,	,	PUNCT
dpc-3884	132	5	including	include	VERB
dpc-3884	132	6	summary	summary	NOUN
dpc-3884	132	7	eortc	eortc	NOUN
dpc-3884	132	8	-	-	PUNCT
dpc-3884	132	9	c30	c30	NOUN
dpc-3884	132	10	,	,	PUNCT
dpc-3884	132	11	functional	functional	ADJ
dpc-3884	132	12	and	and	CCONJ
dpc-3884	132	13	symptom	symptom	NOUN
dpc-3884	132	14	scales	scale	NOUN
dpc-3884	132	15	and	and	CCONJ
dpc-3884	132	16	global	global	ADJ
dpc-3884	132	17	health	health	NOUN
dpc-3884	132	18	,	,	PUNCT
dpc-3884	132	19	did	do	AUX
dpc-3884	132	20	not	not	PART
dpc-3884	132	21	significantly	significantly	ADV
dpc-3884	132	22	differ	differ	VERB
dpc-3884	132	23	in	in	ADP
dpc-3884	132	24	patients	patient	NOUN
dpc-3884	132	25	with	with	ADP
dpc-3884	132	26	pruritus	pruritus	PROPN
dpc-3884	132	27	,	,	PUNCT
dpc-3884	132	28	as	as	SCONJ
dpc-3884	132	29	compared	compare	VERB
dpc-3884	132	30	to	to	ADP
dpc-3884	132	31	all	all	DET
dpc-3884	132	32	other	other	ADJ
dpc-3884	132	33	participants	participant	NOUN
dpc-3884	132	34	.	.	PUNCT
dpc-3884	133	1	from	from	ADP
dpc-3884	133	2	mixed	mixed	ADJ
dpc-3884	133	3	models	model	NOUN
dpc-3884	133	4	,	,	PUNCT
dpc-3884	133	5	after	after	ADP
dpc-3884	133	6	each	each	DET
dpc-3884	133	7	intervention	intervention	NOUN
dpc-3884	133	8	,	,	PUNCT
dpc-3884	133	9	patients	patient	NOUN
dpc-3884	133	10	with	with	ADP
dpc-3884	133	11	pruritus	pruritus	PROPN
dpc-3884	133	12	had	have	VERB
dpc-3884	133	13	higher	high	ADJ
dpc-3884	133	14	dlqi	dlqi	ADJ
dpc-3884	133	15	score	score	NOUN
dpc-3884	133	16	compared	compare	VERB
dpc-3884	133	17	to	to	ADP
dpc-3884	133	18	all	all	DET
dpc-3884	133	19	other	other	ADJ
dpc-3884	133	20	patients	patient	NOUN
dpc-3884	133	21	(	(	PUNCT
dpc-3884	133	22	4.67	4.67	NUM
dpc-3884	133	23	,	,	PUNCT
dpc-3884	133	24	95%ci	95%ci	NUM
dpc-3884	133	25	2.07	2.07	NUM
dpc-3884	133	26	–	–	PUNCT
dpc-3884	133	27	7.28	7.28	NUM
dpc-3884	133	28	,	,	PUNCT
dpc-3884	133	29	p	p	X
dpc-3884	133	30	<	<	X
dpc-3884	133	31	0.001	0.001	NUM
dpc-3884	133	32	)	)	PUNCT
dpc-3884	133	33	.	.	PUNCT
dpc-3884	134	1	dlqi	dlqi	PROPN
dpc-3884	134	2	was	be	AUX
dpc-3884	134	3	significantly	significantly	ADV
dpc-3884	134	4	impaired	impair	VERB
dpc-3884	134	5	at	at	ADP
dpc-3884	134	6	baseline	baseline	NOUN
dpc-3884	134	7	,	,	PUNCT
dpc-3884	134	8	but	but	CCONJ
dpc-3884	134	9	rapidly	rapidly	ADV
dpc-3884	134	10	improved	improve	VERB
dpc-3884	134	11	after	after	ADP
dpc-3884	134	12	adequate	adequate	ADJ
dpc-3884	134	13	therapeutic	therapeutic	ADJ
dpc-3884	134	14	intervention	intervention	NOUN
dpc-3884	134	15	,	,	PUNCT
dpc-3884	134	16	as	as	SCONJ
dpc-3884	134	17	shown	show	VERB
dpc-3884	134	18	in	in	ADP
dpc-3884	134	19	follow	follow	NOUN
dpc-3884	134	20	-	-	PUNCT
dpc-3884	134	21	up	up	ADP
dpc-3884	134	22	visits	visit	NOUN
dpc-3884	134	23	.	.	PUNCT
dpc-3884	135	1	in	in	ADP
dpc-3884	135	2	a	a	DET
dpc-3884	135	3	similar	similar	ADJ
dpc-3884	135	4	manner	manner	NOUN
dpc-3884	135	5	,	,	PUNCT
dpc-3884	135	6	pnrs	pnrs	NOUN
dpc-3884	135	7	significantly	significantly	ADV
dpc-3884	135	8	improved	improve	VERB
dpc-3884	135	9	from	from	ADP
dpc-3884	135	10	baseline	baseline	NOUN
dpc-3884	135	11	.	.	PUNCT
dpc-3884	136	1	pnrs	pnrs	VERB
dpc-3884	136	2	moderately	moderately	ADV
dpc-3884	136	3	correlated	correlate	VERB
dpc-3884	136	4	with	with	ADP
dpc-3884	136	5	dlqi	dlqi	NOUN
dpc-3884	136	6	.	.	PUNCT
dpc-3884	137	1	individuals	individual	NOUN
dpc-3884	137	2	experiencing	experience	VERB
dpc-3884	137	3	pruritus	pruritus	PROPN
dpc-3884	137	4	reported	report	VERB
dpc-3884	137	5	worse	bad	ADJ
dpc-3884	137	6	quality	quality	NOUN
dpc-3884	137	7	of	of	ADP
dpc-3884	137	8	life	life	NOUN
dpc-3884	137	9	(	(	PUNCT
dpc-3884	137	10	higher	high	ADJ
dpc-3884	137	11	mean	mean	NOUN
dpc-3884	137	12	dlqi	dlqi	ADJ
dpc-3884	137	13	and	and	CCONJ
dpc-3884	137	14	mean	mean	VERB
dpc-3884	137	15	pnrs	pnrs	NOUN
dpc-3884	137	16	compared	compare	VERB
dpc-3884	137	17	to	to	ADP
dpc-3884	137	18	all	all	DET
dpc-3884	137	19	other	other	ADJ
dpc-3884	137	20	patients	patient	NOUN
dpc-3884	137	21	at	at	ADP
dpc-3884	137	22	baseline	baseline	NOUN
dpc-3884	137	23	)	)	PUNCT
dpc-3884	137	24	,	,	PUNCT
dpc-3884	137	25	highlighting	highlight	VERB
dpc-3884	137	26	that	that	SCONJ
dpc-3884	137	27	pruritus	pruritus	PROPN
dpc-3884	137	28	is	be	AUX
dpc-3884	137	29	a	a	DET
dpc-3884	137	30	key	key	ADJ
dpc-3884	137	31	symptom	symptom	NOUN
dpc-3884	137	32	in	in	ADP
dpc-3884	137	33	qol	qol	PROPN
dpc-3884	137	34	.	.	PUNCT
dpc-3884	138	1	conclusions	conclusion	NOUN
dpc-3884	138	2	skin	skin	NOUN
dpc-3884	138	3	toxicities	toxicity	NOUN
dpc-3884	138	4	occur	occur	VERB
dpc-3884	138	5	in	in	ADP
dpc-3884	138	6	up	up	ADP
dpc-3884	138	7	to	to	PART
dpc-3884	138	8	50	50	NUM
dpc-3884	138	9	%	%	NOUN
dpc-3884	138	10	of	of	ADP
dpc-3884	138	11	patients	patient	NOUN
dpc-3884	138	12	treated	treat	VERB
dpc-3884	138	13	with	with	ADP
dpc-3884	138	14	icis	icis	PROPN
dpc-3884	138	15	.	.	PUNCT
dpc-3884	139	1	however	however	ADV
dpc-3884	139	2	,	,	PUNCT
dpc-3884	139	3	publications	publication	NOUN
dpc-3884	139	4	reporting	report	VERB
dpc-3884	139	5	skin	skin	NOUN
dpc-3884	139	6	-	-	PUNCT
dpc-3884	139	7	related	relate	VERB
dpc-3884	139	8	qol	qol	NOUN
dpc-3884	139	9	in	in	ADP
dpc-3884	139	10	this	this	DET
dpc-3884	139	11	group	group	NOUN
dpc-3884	139	12	are	be	AUX
dpc-3884	139	13	lacking	lack	VERB
dpc-3884	139	14	.	.	PUNCT
dpc-3884	140	1	in	in	ADP
dpc-3884	140	2	this	this	DET
dpc-3884	140	3	study	study	NOUN
dpc-3884	140	4	we	we	PRON
dpc-3884	140	5	evaluatedthe	evaluatedthe	DET
dpc-3884	140	6	impact	impact	NOUN
dpc-3884	140	7	of	of	ADP
dpc-3884	140	8	diraes	diraes	NOUN
dpc-3884	140	9	on	on	ADP
dpc-3884	140	10	patients	patient	NOUN
dpc-3884	140	11	qol	qol	PROPN
dpc-3884	140	12	,	,	PUNCT
dpc-3884	140	13	based	base	VERB
dpc-3884	140	14	on	on	ADP
dpc-3884	140	15	dlqi	dlqi	NOUN
dpc-3884	140	16	and	and	CCONJ
dpc-3884	140	17	pnrs	pnrs	VERB
dpc-3884	140	18	in	in	ADP
dpc-3884	140	19	conjunction	conjunction	NOUN
dpc-3884	140	20	with	with	ADP
dpc-3884	140	21	eortc	eortc	VERB
dpc-3884	140	22	-	-	PUNCT
dpc-3884	140	23	qlq	qlq	NOUN
dpc-3884	140	24	-	-	PUNCT
dpc-3884	140	25	c30	c30	NOUN
dpc-3884	140	26	,	,	PUNCT
dpc-3884	140	27	as	as	ADV
dpc-3884	140	28	well	well	ADV
dpc-3884	140	29	as	as	ADP
dpc-3884	140	30	the	the	DET
dpc-3884	140	31	role	role	NOUN
dpc-3884	140	32	of	of	ADP
dpc-3884	140	33	dermatologic	dermatologic	ADJ
dpc-3884	140	34	intervention	intervention	NOUN
dpc-3884	140	35	towards	towards	ADP
dpc-3884	140	36	improvement	improvement	NOUN
dpc-3884	140	37	of	of	ADP
dpc-3884	140	38	qol	qol	NOUN
dpc-3884	140	39	.	.	PUNCT
dpc-3884	141	1	our	our	PRON
dpc-3884	141	2	main	main	ADJ
dpc-3884	141	3	finding	finding	NOUN
dpc-3884	141	4	was	be	AUX
dpc-3884	141	5	that	that	SCONJ
dpc-3884	141	6	diraes	dirae	NOUN
dpc-3884	141	7	significantly	significantly	ADV
dpc-3884	141	8	impair	impair	VERB
dpc-3884	141	9	patients	patient	NOUN
dpc-3884	141	10	qol	qol	VERB
dpc-3884	141	11	,	,	PUNCT
dpc-3884	141	12	with	with	ADP
dpc-3884	141	13	moderate	moderate	ADJ
dpc-3884	141	14	and	and	CCONJ
dpc-3884	141	15	severe	severe	ADJ
dpc-3884	141	16	diraes	dirae	NOUN
dpc-3884	141	17	resulting	result	VERB
dpc-3884	141	18	in	in	ADP
dpc-3884	141	19	greater	great	ADJ
dpc-3884	141	20	impact	impact	NOUN
dpc-3884	141	21	compared	compare	VERB
dpc-3884	141	22	to	to	ADP
dpc-3884	141	23	mild	mild	ADJ
dpc-3884	141	24	skin	skin	NOUN
dpc-3884	141	25	toxicities	toxicity	NOUN
dpc-3884	141	26	.	.	PUNCT
dpc-3884	142	1	furthermore	furthermore	ADV
dpc-3884	142	2	,	,	PUNCT
dpc-3884	142	3	we	we	PRON
dpc-3884	142	4	showed	show	VERB
dpc-3884	142	5	that	that	SCONJ
dpc-3884	142	6	adequate	adequate	ADJ
dpc-3884	142	7	dermatologic	dermatologic	ADJ
dpc-3884	142	8	intervention	intervention	NOUN
dpc-3884	142	9	improved	improve	VERB
dpc-3884	142	10	dlqi	dlqi	NOUN
dpc-3884	142	11	and	and	CCONJ
dpc-3884	142	12	pnrs	pnrs	VERB
dpc-3884	142	13	.	.	PUNCT
dpc-3884	143	1	in	in	ADP
dpc-3884	143	2	a	a	DET
dpc-3884	143	3	retrospective	retrospective	ADJ
dpc-3884	143	4	cohort	cohort	NOUN
dpc-3884	143	5	study	study	NOUN
dpc-3884	143	6	,	,	PUNCT
dpc-3884	143	7	chen	chen	PROPN
dpc-3884	143	8	et	et	PROPN
dpc-3884	143	9	al	al	PROPN
dpc-3884	143	10	pointed	point	VERB
dpc-3884	143	11	out	out	ADP
dpc-3884	143	12	that	that	SCONJ
dpc-3884	143	13	patients	patient	NOUN
dpc-3884	143	14	with	with	ADP
dpc-3884	143	15	diraes	dirae	NOUN
dpc-3884	143	16	when	when	SCONJ
dpc-3884	143	17	managed	manage	VERB
dpc-3884	143	18	by	by	ADP
dpc-3884	143	19	dermatologists	dermatologist	NOUN
dpc-3884	143	20	were	be	AUX
dpc-3884	143	21	less	less	ADV
dpc-3884	143	22	likely	likely	ADJ
dpc-3884	143	23	to	to	PART
dpc-3884	143	24	receive	receive	VERB
dpc-3884	143	25	systemic	systemic	ADJ
dpc-3884	143	26	immunosuppression	immunosuppression	NOUN
dpc-3884	143	27	and	and	CCONJ
dpc-3884	143	28	less	less	ADV
dpc-3884	143	29	likely	likely	ADJ
dpc-3884	143	30	to	to	PART
dpc-3884	143	31	require	require	VERB
dpc-3884	143	32	ici	ici	NOUN
dpc-3884	143	33	discontinuation	discontinuation	NOUN
dpc-3884	143	34	due	due	ADP
dpc-3884	143	35	to	to	ADP
dpc-3884	143	36	skin	skin	NOUN
dpc-3884	143	37	toxicity	toxicity	NOUN
dpc-3884	143	38	,	,	PUNCT
dpc-3884	143	39	as	as	SCONJ
dpc-3884	143	40	compared	compare	VERB
dpc-3884	143	41	original	original	ADJ
dpc-3884	143	42	article	article	NOUN
dpc-3884	143	43	|	|	ADV
dpc-3884	143	44	dermatol	dermatol	ADJ
dpc-3884	143	45	pract	pract	NOUN
dpc-3884	143	46	concept	concept	NOUN
dpc-3884	143	47	.	.	PUNCT
dpc-3884	144	1	2024;14(3):e2024118	2024;14(3):e2024118	NUM
dpc-3884	144	2	7	7	NUM
dpc-3884	144	3	melanoma	melanoma	NOUN
dpc-3884	144	4	:	:	PUNCT
dpc-3884	144	5	characteristics	characteristic	NOUN
dpc-3884	144	6	of	of	ADP
dpc-3884	144	7	immune	immune	NOUN
dpc-3884	144	8	-	-	PUNCT
dpc-3884	144	9	related	relate	VERB
dpc-3884	144	10	adverse	adverse	ADJ
dpc-3884	144	11	events	event	NOUN
dpc-3884	144	12	and	and	CCONJ
dpc-3884	144	13	association	association	NOUN
dpc-3884	144	14	with	with	ADP
dpc-3884	144	15	outcomes	outcome	NOUN
dpc-3884	144	16	nivolumab	nivolumab	ADV
dpc-3884	144	17	in	in	ADP
dpc-3884	144	18	metastatic	metastatic	ADJ
dpc-3884	144	19	melanoma	melanoma	NOUN
dpc-3884	144	20	:	:	PUNCT
dpc-3884	144	21	irae	irae	NOUN
dpc-3884	144	22	relation	relation	NOUN
dpc-3884	144	23	to	to	ADP
dpc-3884	144	24	survival	survival	NOUN
dpc-3884	144	25	.	.	PUNCT
dpc-3884	145	1	clin	clin	PROPN
dpc-3884	145	2	cancer	cancer	NOUN
dpc-3884	145	3	res	re	VERB
dpc-3884	145	4	2016	2016	NUM
dpc-3884	145	5	;	;	PUNCT
dpc-3884	145	6	22	22	NUM
dpc-3884	145	7	:	:	PUNCT
dpc-3884	145	8	886–94	886–94	NOUN
dpc-3884	145	9	.	.	PUNCT
dpc-3884	146	1	11	11	NUM
dpc-3884	146	2	.	.	X
dpc-3884	146	3	nagao	nagao	ADV
dpc-3884	146	4	a	a	X
dpc-3884	146	5	,	,	PUNCT
dpc-3884	146	6	takei	takei	PROPN
dpc-3884	146	7	y	y	PROPN
dpc-3884	146	8	,	,	PUNCT
dpc-3884	146	9	ogawa	ogawa	PROPN
dpc-3884	146	10	y	y	PROPN
dpc-3884	146	11	,	,	PUNCT
dpc-3884	146	12	shimada	shimada	PROPN
dpc-3884	146	13	m	m	PROPN
dpc-3884	146	14	,	,	PUNCT
dpc-3884	146	15	tanigawa	tanigawa	PROPN
dpc-3884	146	16	k	k	PROPN
dpc-3884	146	17	,	,	PUNCT
dpc-3884	146	18	suzuki	suzuki	PROPN
dpc-3884	146	19	s.	s.	PROPN
dpc-3884	146	20	examination	examination	PROPN
dpc-3884	146	21	of	of	ADP
dpc-3884	146	22	the	the	DET
dpc-3884	146	23	quality	quality	NOUN
dpc-3884	146	24	of	of	ADP
dpc-3884	146	25	life	life	NOUN
dpc-3884	146	26	in	in	ADP
dpc-3884	146	27	the	the	DET
dpc-3884	146	28	cancer	cancer	NOUN
dpc-3884	146	29	patients	patient	NOUN
dpc-3884	146	30	under	under	ADP
dpc-3884	146	31	immunotherapy	immunotherapy	NOUN
dpc-3884	146	32	.	.	PUNCT
dpc-3884	147	1	gan	gin	VERB
dpc-3884	147	2	to	to	ADP
dpc-3884	147	3	kagaku	kagaku	PROPN
dpc-3884	147	4	ryoho	ryoho	PROPN
dpc-3884	147	5	2012	2012	NUM
dpc-3884	147	6	;	;	PUNCT
dpc-3884	147	7	39	39	NUM
dpc-3884	147	8	:	:	PUNCT
dpc-3884	147	9	1785–7	1785–7	NUM
dpc-3884	147	10	.	.	NOUN
dpc-3884	147	11	12	12	NUM
dpc-3884	147	12	.	.	PUNCT
dpc-3884	148	1	lins	lin	NOUN
dpc-3884	148	2	l	l	PROPN
dpc-3884	148	3	,	,	PUNCT
dpc-3884	148	4	carvalho	carvalho	PROPN
dpc-3884	148	5	fm	fm	PROPN
dpc-3884	148	6	.	.	PROPN
dpc-3884	148	7	sf-36	sf-36	NOUN
dpc-3884	148	8	total	total	ADJ
dpc-3884	148	9	score	score	NOUN
dpc-3884	148	10	as	as	ADP
dpc-3884	148	11	a	a	DET
dpc-3884	148	12	single	single	ADJ
dpc-3884	148	13	measure	measure	NOUN
dpc-3884	148	14	of	of	ADP
dpc-3884	148	15	health	health	NOUN
dpc-3884	148	16	-	-	PUNCT
dpc-3884	148	17	related	relate	VERB
dpc-3884	148	18	quality	quality	NOUN
dpc-3884	148	19	of	of	ADP
dpc-3884	148	20	life	life	NOUN
dpc-3884	148	21	:	:	PUNCT
dpc-3884	148	22	scoping	scope	VERB
dpc-3884	148	23	review	review	NOUN
dpc-3884	148	24	.	.	PUNCT
dpc-3884	149	1	sage	sage	VERB
dpc-3884	149	2	open	open	ADJ
dpc-3884	149	3	med	med	ADJ
dpc-3884	150	1	[	[	X
dpc-3884	150	2	internet	internet	NOUN
dpc-3884	150	3	]	]	PUNCT
dpc-3884	150	4	.	.	PUNCT
dpc-3884	151	1	2016	2016	NUM
dpc-3884	151	2	oct	oct	NOUN
dpc-3884	151	3	4	4	NUM
dpc-3884	152	1	[	[	NOUN
dpc-3884	152	2	cited	cite	VERB
dpc-3884	152	3	2020	2020	NUM
dpc-3884	152	4	oct	oct	PROPN
dpc-3884	152	5	15];4	15];4	NUM
dpc-3884	152	6	.	.	PUNCT
dpc-3884	153	1	available	available	ADJ
dpc-3884	153	2	from	from	ADP
dpc-3884	153	3	:	:	PUNCT
dpc-3884	153	4	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5052926/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5052926/	PROPN
dpc-3884	153	5	13	13	NUM
dpc-3884	153	6	.	.	PUNCT
dpc-3884	153	7	13	13	NUM
dpc-3884	153	8	o’reilly	o’reilly	ADV
dpc-3884	153	9	a	a	PRON
dpc-3884	153	10	,	,	PUNCT
dpc-3884	153	11	hughes	hughes	PROPN
dpc-3884	153	12	p	p	PROPN
dpc-3884	153	13	,	,	PUNCT
dpc-3884	153	14	mann	mann	PROPN
dpc-3884	153	15	j	j	PROPN
dpc-3884	153	16	et	et	PROPN
dpc-3884	153	17	al	al	PROPN
dpc-3884	153	18	.	.	PUNCT
dpc-3884	154	1	an	an	DET
dpc-3884	154	2	immunotherapy	immunotherapy	NOUN
dpc-3884	154	3	survivor	survivor	NOUN
dpc-3884	154	4	population	population	NOUN
dpc-3884	154	5	:	:	PUNCT
dpc-3884	154	6	health	health	NOUN
dpc-3884	154	7	-	-	PUNCT
dpc-3884	154	8	related	relate	VERB
dpc-3884	154	9	quality	quality	NOUN
dpc-3884	154	10	of	of	ADP
dpc-3884	154	11	life	life	NOUN
dpc-3884	154	12	and	and	CCONJ
dpc-3884	154	13	toxicity	toxicity	NOUN
dpc-3884	154	14	in	in	ADP
dpc-3884	154	15	patients	patient	NOUN
dpc-3884	154	16	with	with	ADP
dpc-3884	154	17	metastatic	metastatic	ADJ
dpc-3884	154	18	melanoma	melanoma	NOUN
dpc-3884	154	19	treated	treat	VERB
dpc-3884	154	20	with	with	ADP
dpc-3884	154	21	immune	immune	ADJ
dpc-3884	154	22	checkpoint	checkpoint	NOUN
dpc-3884	154	23	inhibitors	inhibitor	NOUN
dpc-3884	154	24	.	.	PUNCT
dpc-3884	155	1	support	support	NOUN
dpc-3884	155	2	care	care	NOUN
dpc-3884	155	3	cancer	cancer	NOUN
dpc-3884	155	4	2020	2020	NUM
dpc-3884	155	5	;	;	PUNCT
dpc-3884	155	6	28	28	NUM
dpc-3884	155	7	:	:	PUNCT
dpc-3884	155	8	561–70	561–70	NUM
dpc-3884	155	9	.	.	PUNCT
dpc-3884	156	1	14	14	NUM
dpc-3884	156	2	.	.	PUNCT
dpc-3884	157	1	finlay	finlay	VERB
dpc-3884	157	2	ay	ay	PROPN
dpc-3884	157	3	,	,	PUNCT
dpc-3884	157	4	khan	khan	PROPN
dpc-3884	157	5	g.	g.	PROPN
dpc-3884	157	6	dermatology	dermatology	PROPN
dpc-3884	157	7	life	life	PROPN
dpc-3884	157	8	quality	quality	NOUN
dpc-3884	157	9	index	index	NOUN
dpc-3884	157	10	(	(	PUNCT
dpc-3884	157	11	dlqi)—a	dlqi)—a	ADJ
dpc-3884	157	12	simple	simple	ADJ
dpc-3884	157	13	practical	practical	ADJ
dpc-3884	157	14	measure	measure	NOUN
dpc-3884	157	15	for	for	ADP
dpc-3884	157	16	routine	routine	ADJ
dpc-3884	157	17	clinical	clinical	ADJ
dpc-3884	157	18	use	use	NOUN
dpc-3884	157	19	.	.	PUNCT
dpc-3884	158	1	clin	clin	PROPN
dpc-3884	158	2	exp	exp	NOUN
dpc-3884	158	3	dermatol	dermatol	NOUN
dpc-3884	158	4	1994	1994	NUM
dpc-3884	158	5	;	;	PUNCT
dpc-3884	158	6	19	19	NUM
dpc-3884	158	7	:	:	SYM
dpc-3884	158	8	210–6	210–6	NUM
dpc-3884	158	9	.	.	NOUN
dpc-3884	158	10	15	15	NUM
dpc-3884	158	11	.	.	PUNCT
dpc-3884	159	1	cella	cella	PROPN
dpc-3884	159	2	d	d	PROPN
dpc-3884	159	3	,	,	PUNCT
dpc-3884	159	4	grünwald	grünwald	NOUN
dpc-3884	159	5	v	v	NOUN
dpc-3884	159	6	,	,	PUNCT
dpc-3884	159	7	nathan	nathan	PROPN
dpc-3884	159	8	p	p	PROPN
dpc-3884	159	9	et	et	PROPN
dpc-3884	159	10	al	al	PROPN
dpc-3884	159	11	.	.	PUNCT
dpc-3884	159	12	quality	quality	NOUN
dpc-3884	159	13	of	of	ADP
dpc-3884	159	14	life	life	NOUN
dpc-3884	159	15	in	in	ADP
dpc-3884	159	16	patients	patient	NOUN
dpc-3884	159	17	with	with	ADP
dpc-3884	159	18	advanced	advanced	ADJ
dpc-3884	159	19	renal	renal	ADJ
dpc-3884	159	20	cell	cell	NOUN
dpc-3884	159	21	carcinoma	carcinoma	NOUN
dpc-3884	159	22	given	give	VERB
dpc-3884	159	23	nivolumab	nivolumab	NOUN
dpc-3884	159	24	versus	versus	ADP
dpc-3884	159	25	everolimus	everolimus	NOUN
dpc-3884	159	26	in	in	ADP
dpc-3884	159	27	checkmate	checkmate	NOUN
dpc-3884	159	28	025	025	NUM
dpc-3884	159	29	:	:	PUNCT
dpc-3884	159	30	a	a	DET
dpc-3884	159	31	randomised	randomised	ADJ
dpc-3884	159	32	,	,	PUNCT
dpc-3884	159	33	open	open	ADJ
dpc-3884	159	34	-	-	PUNCT
dpc-3884	159	35	label	label	NOUN
dpc-3884	159	36	,	,	PUNCT
dpc-3884	159	37	phase	phase	NOUN
dpc-3884	159	38	3	3	NUM
dpc-3884	159	39	trial	trial	NOUN
dpc-3884	159	40	.	.	PUNCT
dpc-3884	160	1	lancet	lancet	PROPN
dpc-3884	160	2	onco	onco	PROPN
dpc-3884	160	3	.	.	PUNCT
dpc-3884	161	1	2016	2016	NUM
dpc-3884	161	2	;	;	PUNCT
dpc-3884	161	3	17	17	NUM
dpc-3884	161	4	:	:	SYM
dpc-3884	161	5	994–1003	994–1003	NUM
dpc-3884	161	6	.	.	NOUN
dpc-3884	162	1	16	16	NUM
dpc-3884	162	2	.	.	PUNCT
dpc-3884	162	3	aaronson	aaronson	PROPN
dpc-3884	162	4	nk	nk	PROPN
dpc-3884	162	5	,	,	PUNCT
dpc-3884	162	6	ahmedzai	ahmedzai	NOUN
dpc-3884	162	7	s	s	PROPN
dpc-3884	162	8	,	,	PUNCT
dpc-3884	162	9	bergman	bergman	PROPN
dpc-3884	162	10	b	b	PROPN
dpc-3884	162	11	et	et	PROPN
dpc-3884	162	12	al	al	PROPN
dpc-3884	162	13	.	.	PUNCT
dpc-3884	163	1	the	the	DET
dpc-3884	163	2	european	european	PROPN
dpc-3884	163	3	organization	organization	PROPN
dpc-3884	163	4	for	for	ADP
dpc-3884	163	5	research	research	NOUN
dpc-3884	163	6	and	and	CCONJ
dpc-3884	163	7	treatment	treatment	NOUN
dpc-3884	163	8	of	of	ADP
dpc-3884	163	9	cancer	cancer	NOUN
dpc-3884	163	10	qlq	qlq	PROPN
dpc-3884	163	11	-	-	PUNCT
dpc-3884	163	12	c30	c30	NOUN
dpc-3884	163	13	:	:	PUNCT
dpc-3884	163	14	a	a	DET
dpc-3884	163	15	quality	quality	NOUN
dpc-3884	163	16	-	-	PUNCT
dpc-3884	163	17	of	of	ADP
dpc-3884	163	18	-	-	PUNCT
dpc-3884	163	19	life	life	NOUN
dpc-3884	163	20	instrument	instrument	NOUN
dpc-3884	163	21	for	for	ADP
dpc-3884	163	22	use	use	NOUN
dpc-3884	163	23	in	in	ADP
dpc-3884	163	24	international	international	ADJ
dpc-3884	163	25	clinical	clinical	ADJ
dpc-3884	163	26	trials	trial	NOUN
dpc-3884	163	27	in	in	ADP
dpc-3884	163	28	oncology	oncology	NOUN
dpc-3884	163	29	.	.	PUNCT
dpc-3884	164	1	j	j	PROPN
dpc-3884	164	2	natl	natl	PROPN
dpc-3884	164	3	cancer	cancer	PROPN
dpc-3884	164	4	inst	inst	PROPN
dpc-3884	164	5	.	.	PROPN
dpc-3884	164	6	1993	1993	NUM
dpc-3884	164	7	;	;	PUNCT
dpc-3884	164	8	85	85	NUM
dpc-3884	164	9	:	:	PUNCT
dpc-3884	164	10	365–76	365–76	NUM
dpc-3884	164	11	.	.	X
dpc-3884	165	1	17	17	NUM
dpc-3884	165	2	.	.	X
dpc-3884	165	3	de	de	X
dpc-3884	165	4	luca	luca	PROPN
dpc-3884	165	5	r	r	PROPN
dpc-3884	165	6	,	,	PUNCT
dpc-3884	165	7	coco	coco	PROPN
dpc-3884	165	8	gl	gl	PROPN
dpc-3884	165	9	,	,	PUNCT
dpc-3884	165	10	addeo	addeo	PROPN
dpc-3884	165	11	r	r	NOUN
dpc-3884	165	12	et	et	PROPN
dpc-3884	165	13	al	al	PROPN
dpc-3884	165	14	.	.	PUNCT
dpc-3884	165	15	quality	quality	NOUN
dpc-3884	165	16	of	of	ADP
dpc-3884	165	17	life	life	NOUN
dpc-3884	165	18	in	in	ADP
dpc-3884	165	19	patients	patient	NOUN
dpc-3884	165	20	with	with	ADP
dpc-3884	165	21	severe	severe	ADJ
dpc-3884	165	22	skin	skin	NOUN
dpc-3884	165	23	reactions	reaction	NOUN
dpc-3884	165	24	in	in	ADP
dpc-3884	165	25	course	course	NOUN
dpc-3884	165	26	of	of	ADP
dpc-3884	165	27	first	first	ADJ
dpc-3884	165	28	-	-	PUNCT
dpc-3884	165	29	generation	generation	NOUN
dpc-3884	165	30	epidermal	epidermal	ADJ
dpc-3884	165	31	growth	growth	NOUN
dpc-3884	165	32	factor	factor	NOUN
dpc-3884	165	33	receptor	receptor	NOUN
dpc-3884	165	34	inhibitors	inhibitor	NOUN
dpc-3884	165	35	monoclonal	monoclonal	NOUN
dpc-3884	165	36	antibodies	antibody	NOUN
dpc-3884	165	37	(	(	PUNCT
dpc-3884	165	38	our	our	PRON
dpc-3884	165	39	experience	experience	NOUN
dpc-3884	165	40	with	with	ADP
dpc-3884	165	41	cetuximab	cetuximab	NOUN
dpc-3884	165	42	)	)	PUNCT
dpc-3884	165	43	.	.	PUNCT
dpc-3884	166	1	world	world	PROPN
dpc-3884	166	2	j	j	PROPN
dpc-3884	166	3	oncol	oncol	ADJ
dpc-3884	166	4	2021	2021	NUM
dpc-3884	166	5	;	;	PUNCT
dpc-3884	166	6	12	12	NUM
dpc-3884	166	7	:	:	SYM
dpc-3884	166	8	104	104	NUM
dpc-3884	166	9	.	.	X
dpc-3884	167	1	18	18	NUM
dpc-3884	167	2	.	.	PUNCT
dpc-3884	168	1	barbu	barbu	PROPN
dpc-3884	168	2	ma	ma	PROPN
dpc-3884	168	3	,	,	PUNCT
dpc-3884	168	4	niţipir	niţipir	PROPN
dpc-3884	168	5	c	c	PROPN
dpc-3884	168	6	,	,	PUNCT
dpc-3884	168	7	voiosu	voiosu	PROPN
dpc-3884	168	8	t	t	PROPN
dpc-3884	168	9	,	,	PUNCT
dpc-3884	168	10	giurcăneanu	giurcăneanu	PROPN
dpc-3884	168	11	c.	c.	PROPN
dpc-3884	168	12	impact	impact	NOUN
dpc-3884	168	13	of	of	ADP
dpc-3884	168	14	dermatologic	dermatologic	ADJ
dpc-3884	168	15	adverse	adverse	ADJ
dpc-3884	168	16	reactions	reaction	NOUN
dpc-3884	168	17	on	on	ADP
dpc-3884	168	18	qol	qol	NOUN
dpc-3884	168	19	in	in	ADP
dpc-3884	168	20	oncologic	oncologic	ADJ
dpc-3884	168	21	patients	patient	NOUN
dpc-3884	168	22	:	:	PUNCT
dpc-3884	168	23	results	result	VERB
dpc-3884	168	24	from	from	ADP
dpc-3884	168	25	a	a	DET
dpc-3884	168	26	single	single	ADJ
dpc-3884	168	27	-	-	PUNCT
dpc-3884	168	28	center	center	NOUN
dpc-3884	168	29	prospective	prospective	ADJ
dpc-3884	168	30	study	study	NOUN
dpc-3884	168	31	.	.	PUNCT
dpc-3884	169	1	rom	rom	PROPN
dpc-3884	170	1	j	j	PROPN
dpc-3884	170	2	intern	intern	NOUN
dpc-3884	170	3	med	me	VERB
dpc-3884	170	4	2018	2018	NUM
dpc-3884	170	5	;	;	PUNCT
dpc-3884	171	1	56	56	NUM
dpc-3884	171	2	:	:	PUNCT
dpc-3884	171	3	96–101	96–101	NUM
dpc-3884	171	4	.	.	PUNCT
dpc-3884	171	5	19	19	NUM
dpc-3884	171	6	.	.	PUNCT
dpc-3884	172	1	mazieres	mazieres	PROPN
dpc-3884	172	2	j	j	PROPN
dpc-3884	172	3	,	,	PUNCT
dpc-3884	172	4	kowalski	kowalski	PROPN
dpc-3884	172	5	d	d	PROPN
dpc-3884	172	6	,	,	PUNCT
dpc-3884	172	7	luft	luft	PROPN
dpc-3884	172	8	a	a	PROPN
dpc-3884	172	9	et	et	PROPN
dpc-3884	172	10	al	al	PROPN
dpc-3884	172	11	.	.	PUNCT
dpc-3884	173	1	health	health	NOUN
dpc-3884	173	2	-	-	PUNCT
dpc-3884	173	3	related	relate	VERB
dpc-3884	173	4	quality	quality	NOUN
dpc-3884	173	5	of	of	ADP
dpc-3884	173	6	life	life	NOUN
dpc-3884	173	7	with	with	ADP
dpc-3884	173	8	carboplatin	carboplatin	NOUN
dpc-3884	173	9	-	-	PUNCT
dpc-3884	173	10	paclitaxel	paclitaxel	PROPN
dpc-3884	173	11	or	or	CCONJ
dpc-3884	173	12	nab	nab	NOUN
dpc-3884	173	13	-	-	PUNCT
dpc-3884	173	14	paclitaxel	paclitaxel	NOUN
dpc-3884	173	15	with	with	ADP
dpc-3884	173	16	or	or	CCONJ
dpc-3884	173	17	without	without	ADP
dpc-3884	173	18	pembrolizumab	pembrolizumab	NOUN
dpc-3884	173	19	in	in	ADP
dpc-3884	173	20	patients	patient	NOUN
dpc-3884	173	21	with	with	ADP
dpc-3884	173	22	metastatic	metastatic	ADJ
dpc-3884	173	23	squamous	squamous	ADJ
dpc-3884	173	24	non	non	ADJ
dpc-3884	173	25	-	-	ADJ
dpc-3884	173	26	smallcell	smallcell	ADJ
dpc-3884	173	27	lung	lung	NOUN
dpc-3884	173	28	cancer	cancer	NOUN
dpc-3884	173	29	.	.	PUNCT
dpc-3884	174	1	j	j	PROPN
dpc-3884	174	2	clin	clin	PROPN
dpc-3884	174	3	oncol	oncol	PROPN
dpc-3884	174	4	2020	2020	NUM
dpc-3884	174	5	;	;	PUNCT
dpc-3884	174	6	38	38	NUM
dpc-3884	174	7	:	:	PUNCT
dpc-3884	174	8	271–280	271–280	NUM
dpc-3884	174	9	.	.	X
dpc-3884	175	1	ooki	ooki	PROPN
dpc-3884	175	2	,	,	PUNCT
dpc-3884	175	3	a	a	PRON
dpc-3884	175	4	,	,	PUNCT
dpc-3884	175	5	morita	morita	PROPN
dpc-3884	175	6	s	s	PROPN
dpc-3884	175	7	,	,	PUNCT
dpc-3884	175	8	tsuji	tsuji	PROPN
dpc-3884	175	9	a	a	PROPN
dpc-3884	175	10	,	,	PUNCT
dpc-3884	175	11	et	et	PROPN
dpc-3884	175	12	al	al	PROPN
dpc-3884	175	13	.	.	PROPN
dpc-3884	176	1	disagreement	disagreement	NOUN
dpc-3884	176	2	between	between	ADP
dpc-3884	176	3	patientand	patientand	NOUN
dpc-3884	176	4	physician	physician	NOUN
dpc-3884	176	5	-	-	PUNCT
dpc-3884	176	6	reported	report	VERB
dpc-3884	176	7	outcomes	outcome	NOUN
dpc-3884	176	8	on	on	ADP
dpc-3884	176	9	symptomatic	symptomatic	ADJ
dpc-3884	176	10	adverse	adverse	ADJ
dpc-3884	176	11	events	event	NOUN
dpc-3884	176	12	as	as	ADP
dpc-3884	176	13	poor	poor	ADJ
dpc-3884	176	14	prognosis	prognosis	NOUN
dpc-3884	176	15	in	in	ADP
dpc-3884	176	16	patients	patient	NOUN
dpc-3884	176	17	treated	treat	VERB
dpc-3884	176	18	with	with	ADP
dpc-3884	176	19	first	first	ADJ
dpc-3884	176	20	-	-	PUNCT
dpc-3884	176	21	line	line	NOUN
dpc-3884	176	22	cetuximab	cetuximab	NOUN
dpc-3884	176	23	plus	plus	CCONJ
dpc-3884	176	24	chemotherapy	chemotherapy	NOUN
dpc-3884	176	25	for	for	ADP
dpc-3884	176	26	unresectable	unresectable	ADJ
dpc-3884	176	27	metastatic	metastatic	ADJ
dpc-3884	176	28	colorectal	colorectal	ADJ
dpc-3884	176	29	cancer	cancer	NOUN
dpc-3884	176	30	:	:	PUNCT
dpc-3884	176	31	results	result	NOUN
dpc-3884	176	32	of	of	ADP
dpc-3884	176	33	phase	phase	NOUN
dpc-3884	176	34	ii	ii	PROPN
dpc-3884	176	35	quack	quack	NOUN
dpc-3884	176	36	trial	trial	NOUN
dpc-3884	176	37	.	.	PUNCT
dpc-3884	177	1	cancer	cancer	NOUN
dpc-3884	177	2	med	med	PROPN
dpc-3884	177	3	2000	2000	NUM
dpc-3884	177	4	;	;	PUNCT
dpc-3884	177	5	9	9	NUM
dpc-3884	177	6	:	:	SYM
dpc-3884	177	7	9419–9430	9419–9430	NUM
dpc-3884	177	8	.	.	NOUN
dpc-3884	177	9	20	20	NUM
dpc-3884	177	10	.	.	PUNCT
dpc-3884	178	1	basra	basra	PROPN
dpc-3884	178	2	mk	mk	PROPN
dpc-3884	178	3	,	,	PUNCT
dpc-3884	178	4	salek	salek	VERB
dpc-3884	178	5	ms	ms	PROPN
dpc-3884	178	6	,	,	PUNCT
dpc-3884	178	7	camilleri	camilleri	PROPN
dpc-3884	178	8	l	l	PROPN
dpc-3884	178	9	,	,	PUNCT
dpc-3884	178	10	sturkey	sturkey	ADJ
dpc-3884	178	11	r	r	NOUN
dpc-3884	178	12	,	,	PUNCT
dpc-3884	178	13	finlay	finlay	VERB
dpc-3884	178	14	ay	ay	NOUN
dpc-3884	178	15	.	.	PUNCT
dpc-3884	179	1	determining	determine	VERB
dpc-3884	179	2	the	the	DET
dpc-3884	179	3	minimal	minimal	ADJ
dpc-3884	179	4	clinically	clinically	ADV
dpc-3884	179	5	important	important	ADJ
dpc-3884	179	6	difference	difference	NOUN
dpc-3884	179	7	and	and	CCONJ
dpc-3884	179	8	responsiveness	responsiveness	NOUN
dpc-3884	179	9	of	of	ADP
dpc-3884	179	10	the	the	DET
dpc-3884	179	11	dermatology	dermatology	NOUN
dpc-3884	179	12	life	life	NOUN
dpc-3884	179	13	quality	quality	NOUN
dpc-3884	179	14	index	index	NOUN
dpc-3884	179	15	(	(	PUNCT
dpc-3884	179	16	dlqi	dlqi	VERB
dpc-3884	179	17	):	):	PUNCT
dpc-3884	179	18	further	further	ADJ
dpc-3884	179	19	data	datum	NOUN
dpc-3884	179	20	.	.	PUNCT
dpc-3884	180	1	dermatology	dermatology	NOUN
dpc-3884	180	2	2015	2015	NUM
dpc-3884	180	3	;	;	PUNCT
dpc-3884	180	4	230	230	NUM
dpc-3884	180	5	:	:	PUNCT
dpc-3884	180	6	27–33	27–33	NUM
dpc-3884	180	7	.	.	NOUN
dpc-3884	180	8	21	21	NUM
dpc-3884	180	9	.	.	PUNCT
dpc-3884	181	1	chen	chen	PROPN
dpc-3884	181	2	st	st	PROPN
dpc-3884	181	3	,	,	PUNCT
dpc-3884	181	4	molina	molina	PROPN
dpc-3884	181	5	ge	ge	PROPN
dpc-3884	181	6	,	,	PUNCT
dpc-3884	181	7	lo	lo	PROPN
dpc-3884	181	8	ja	ja	INTJ
dpc-3884	181	9	et	et	PROPN
dpc-3884	181	10	al	al	PROPN
dpc-3884	181	11	.	.	PROPN
dpc-3884	181	12	dermatology	dermatology	NOUN
dpc-3884	181	13	consultation	consultation	NOUN
dpc-3884	181	14	reduces	reduce	VERB
dpc-3884	181	15	interruption	interruption	NOUN
dpc-3884	181	16	of	of	ADP
dpc-3884	181	17	oncologic	oncologic	ADJ
dpc-3884	181	18	management	management	NOUN
dpc-3884	181	19	among	among	ADP
dpc-3884	181	20	hospitalized	hospitalize	VERB
dpc-3884	181	21	patients	patient	NOUN
dpc-3884	181	22	with	with	ADP
dpc-3884	181	23	immune	immune	NOUN
dpc-3884	181	24	-	-	PUNCT
dpc-3884	181	25	related	relate	VERB
dpc-3884	181	26	adverse	adverse	ADJ
dpc-3884	181	27	events	event	NOUN
dpc-3884	181	28	:	:	PUNCT
dpc-3884	181	29	a	a	DET
dpc-3884	181	30	retrospective	retrospective	ADJ
dpc-3884	181	31	cohort	cohort	NOUN
dpc-3884	181	32	study	study	NOUN
dpc-3884	181	33	.	.	PUNCT
dpc-3884	182	1	j	j	PROPN
dpc-3884	182	2	am	be	AUX
dpc-3884	182	3	acad	acad	ADJ
dpc-3884	182	4	dermatol	dermatol	NOUN
dpc-3884	182	5	2020	2020	NUM
dpc-3884	182	6	;	;	PUNCT
dpc-3884	182	7	82	82	NUM
dpc-3884	182	8	:	:	SYM
dpc-3884	182	9	994–6	994–6	PROPN
dpc-3884	182	10	.	.	PROPN
dpc-3884	183	1	22	22	NUM
dpc-3884	183	2	.	.	PUNCT
dpc-3884	183	3	walocko	walocko	PROPN
dpc-3884	183	4	fm	fm	PROPN
dpc-3884	183	5	,	,	PUNCT
dpc-3884	183	6	ly	ly	PROPN
dpc-3884	183	7	bc	bc	PROPN
dpc-3884	183	8	,	,	PUNCT
dpc-3884	183	9	white	white	PROPN
dpc-3884	183	10	ms	ms	PROPN
dpc-3884	183	11	,	,	PUNCT
dpc-3884	183	12	chen	chen	PROPN
dpc-3884	183	13	sc	sc	PROPN
dpc-3884	183	14	,	,	PUNCT
dpc-3884	183	15	yeung	yeung	PROPN
dpc-3884	183	16	h.	h.	PROPN
dpc-3884	183	17	health	health	PROPN
dpc-3884	183	18	related	relate	VERB
dpc-3884	183	19	quality	quality	NOUN
dpc-3884	183	20	of	of	ADP
dpc-3884	183	21	life	life	NOUN
dpc-3884	183	22	measures	measure	NOUN
dpc-3884	183	23	and	and	CCONJ
dpc-3884	183	24	immune	immune	ADJ
dpc-3884	183	25	checkpoint	checkpoint	NOUN
dpc-3884	183	26	inhibitors	inhibitor	NOUN
dpc-3884	183	27	:	:	PUNCT
dpc-3884	183	28	a	a	DET
dpc-3884	183	29	systematic	systematic	ADJ
dpc-3884	183	30	review	review	NOUN
dpc-3884	183	31	.	.	PUNCT
dpc-3884	184	1	j	j	PROPN
dpc-3884	184	2	am	be	AUX
dpc-3884	184	3	acad	acad	ADJ
dpc-3884	184	4	dermatol	dermatol	NOUN
dpc-3884	184	5	2020	2020	NUM
dpc-3884	184	6	;	;	PUNCT
dpc-3884	184	7	82	82	NUM
dpc-3884	184	8	:	:	SYM
dpc-3884	184	9	1004–6	1004–6	NUM
dpc-3884	184	10	.	.	NOUN
dpc-3884	184	11	23	23	NUM
dpc-3884	184	12	.	.	PUNCT
dpc-3884	185	1	barrios	barrios	PROPN
dpc-3884	185	2	dm	dm	NUM
dpc-3884	185	3	,	,	PUNCT
dpc-3884	185	4	phillips	phillips	PROPN
dpc-3884	185	5	gs	gs	PROPN
dpc-3884	185	6	,	,	PUNCT
dpc-3884	185	7	freites	freite	VERB
dpc-3884	185	8	-	-	PUNCT
dpc-3884	185	9	martinez	martinez	PROPN
dpc-3884	186	1	a	a	PRON
dpc-3884	186	2	et	et	PROPN
dpc-3884	186	3	al	al	PROPN
dpc-3884	186	4	.	.	PROPN
dpc-3884	186	5	outpatient	outpatient	NOUN
dpc-3884	186	6	dermatology	dermatology	NOUN
dpc-3884	186	7	consultations	consultation	NOUN
dpc-3884	186	8	for	for	ADP
dpc-3884	186	9	oncology	oncology	NOUN
dpc-3884	186	10	patients	patient	NOUN
dpc-3884	186	11	with	with	ADP
dpc-3884	186	12	acute	acute	ADJ
dpc-3884	186	13	dermatologic	dermatologic	ADJ
dpc-3884	186	14	adverse	adverse	ADJ
dpc-3884	186	15	events	event	NOUN
dpc-3884	186	16	impact	impact	NOUN
dpc-3884	186	17	anticancer	anticancer	NOUN
dpc-3884	186	18	therapy	therapy	NOUN
dpc-3884	186	19	interruption	interruption	NOUN
dpc-3884	186	20	:	:	PUNCT
dpc-3884	186	21	a	a	DET
dpc-3884	186	22	retrospective	retrospective	ADJ
dpc-3884	186	23	study	study	NOUN
dpc-3884	186	24	.	.	PUNCT
dpc-3884	187	1	j	j	PROPN
dpc-3884	187	2	euracad	euracad	ADJ
dpc-3884	187	3	dermatol	dermatol	NOUN
dpc-3884	187	4	venereol	venereol	NOUN
dpc-3884	187	5	2020	2020	NUM
dpc-3884	187	6	;	;	PUNCT
dpc-3884	187	7	34	34	NUM
dpc-3884	187	8	:	:	SYM
dpc-3884	187	9	1340–1347	1340–1347	NUM
dpc-3884	187	10	.	.	PUNCT
dpc-3884	187	11	correlated	correlate	VERB
dpc-3884	187	12	with	with	ADP
dpc-3884	187	13	dlqi	dlqi	NOUN
dpc-3884	187	14	,	,	PUNCT
dpc-3884	187	15	indicating	indicate	VERB
dpc-3884	187	16	that	that	SCONJ
dpc-3884	187	17	pruritus	pruritus	PROPN
dpc-3884	187	18	plays	play	VERB
dpc-3884	187	19	a	a	DET
dpc-3884	187	20	key	key	ADJ
dpc-3884	187	21	role	role	NOUN
dpc-3884	187	22	in	in	ADP
dpc-3884	187	23	qol	qol	NOUN
dpc-3884	187	24	.	.	PUNCT
dpc-3884	188	1	given	give	VERB
dpc-3884	188	2	that	that	SCONJ
dpc-3884	188	3	currently	currently	ADV
dpc-3884	188	4	available	available	ADJ
dpc-3884	188	5	treatments	treatment	NOUN
dpc-3884	188	6	can	can	AUX
dpc-3884	188	7	only	only	ADV
dpc-3884	188	8	moderately	moderately	ADV
dpc-3884	188	9	control	control	VERB
dpc-3884	188	10	severe	severe	ADJ
dpc-3884	188	11	ici	ici	NOUN
dpc-3884	188	12	-	-	PUNCT
dpc-3884	188	13	derived	derive	VERB
dpc-3884	188	14	pruritus	pruritus	NOUN
dpc-3884	188	15	,	,	PUNCT
dpc-3884	188	16	the	the	DET
dpc-3884	188	17	development	development	NOUN
dpc-3884	188	18	of	of	ADP
dpc-3884	188	19	new	new	ADJ
dpc-3884	188	20	therapeutic	therapeutic	ADJ
dpc-3884	188	21	interventions	intervention	NOUN
dpc-3884	188	22	,	,	PUNCT
dpc-3884	188	23	or	or	CCONJ
dpc-3884	188	24	combined	combined	ADJ
dpc-3884	188	25	treatment	treatment	NOUN
dpc-3884	188	26	strategies	strategy	NOUN
dpc-3884	188	27	for	for	ADP
dpc-3884	188	28	pruritus	pruritus	PROPN
dpc-3884	188	29	,	,	PUNCT
dpc-3884	188	30	are	be	AUX
dpc-3884	188	31	highly	highly	ADV
dpc-3884	188	32	needed	need	VERB
dpc-3884	188	33	.	.	PUNCT
dpc-3884	189	1	interestingly	interestingly	ADV
dpc-3884	189	2	,	,	PUNCT
dpc-3884	189	3	a	a	DET
dpc-3884	189	4	recent	recent	ADJ
dpc-3884	189	5	study	study	NOUN
dpc-3884	189	6	showed	show	VERB
dpc-3884	189	7	that	that	SCONJ
dpc-3884	189	8	regular	regular	ADJ
dpc-3884	189	9	recording	recording	NOUN
dpc-3884	189	10	of	of	ADP
dpc-3884	189	11	pros	pro	NOUN
dpc-3884	189	12	demonstrated	demonstrate	VERB
dpc-3884	189	13	a	a	DET
dpc-3884	189	14	5	5	NUM
dpc-3884	189	15	-	-	PUNCT
dpc-3884	189	16	month	month	NOUN
dpc-3884	189	17	overall	overall	ADJ
dpc-3884	189	18	survival	survival	NOUN
dpc-3884	189	19	benefit	benefit	NOUN
dpc-3884	189	20	for	for	ADP
dpc-3884	189	21	patients	patient	NOUN
dpc-3884	189	22	with	with	ADP
dpc-3884	189	23	metastatic	metastatic	ADJ
dpc-3884	189	24	solid	solid	ADJ
dpc-3884	189	25	tumors	tumor	NOUN
dpc-3884	189	26	,	,	PUNCT
dpc-3884	189	27	as	as	SCONJ
dpc-3884	189	28	compared	compare	VERB
dpc-3884	189	29	to	to	ADP
dpc-3884	189	30	patients	patient	NOUN
dpc-3884	189	31	receiving	receive	VERB
dpc-3884	189	32	standard	standard	ADJ
dpc-3884	189	33	care	care	NOUN
dpc-3884	190	1	[	[	X
dpc-3884	190	2	29,20	29,20	NUM
dpc-3884	190	3	]	]	PUNCT
dpc-3884	190	4	.	.	PUNCT
dpc-3884	191	1	the	the	DET
dpc-3884	191	2	latter	latter	ADJ
dpc-3884	191	3	highlights	highlight	NOUN
dpc-3884	191	4	the	the	DET
dpc-3884	191	5	benefits	benefit	NOUN
dpc-3884	191	6	of	of	ADP
dpc-3884	191	7	incorporating	incorporate	VERB
dpc-3884	191	8	tools	tool	NOUN
dpc-3884	191	9	that	that	PRON
dpc-3884	191	10	adequately	adequately	ADV
dpc-3884	191	11	capture	capture	VERB
dpc-3884	191	12	patients	patient	NOUN
dpc-3884	191	13	health	health	NOUN
dpc-3884	191	14	status	status	NOUN
dpc-3884	191	15	in	in	ADP
dpc-3884	191	16	our	our	PRON
dpc-3884	191	17	daily	daily	ADJ
dpc-3884	191	18	practice	practice	NOUN
dpc-3884	191	19	and	and	CCONJ
dpc-3884	191	20	the	the	DET
dpc-3884	191	21	need	need	NOUN
dpc-3884	191	22	of	of	ADP
dpc-3884	191	23	a	a	DET
dpc-3884	191	24	more	more	ADV
dpc-3884	191	25	patient	patient	ADJ
dpc-3884	191	26	-	-	PUNCT
dpc-3884	191	27	centric	centric	ADJ
dpc-3884	191	28	medicine	medicine	NOUN
dpc-3884	191	29	.	.	PUNCT
dpc-3884	192	1	although	although	SCONJ
dpc-3884	192	2	correlating	correlate	VERB
dpc-3884	192	3	overall	overall	ADJ
dpc-3884	192	4	survival	survival	NOUN
dpc-3884	192	5	with	with	ADP
dpc-3884	192	6	qol	qol	NOUN
dpc-3884	192	7	monitoring	monitoring	NOUN
dpc-3884	192	8	was	be	AUX
dpc-3884	192	9	not	not	PART
dpc-3884	192	10	in	in	ADP
dpc-3884	192	11	the	the	DET
dpc-3884	192	12	aims	aim	NOUN
dpc-3884	192	13	of	of	ADP
dpc-3884	192	14	the	the	DET
dpc-3884	192	15	current	current	ADJ
dpc-3884	192	16	study	study	NOUN
dpc-3884	192	17	,	,	PUNCT
dpc-3884	192	18	we	we	PRON
dpc-3884	192	19	strongly	strongly	ADV
dpc-3884	192	20	believe	believe	VERB
dpc-3884	192	21	that	that	SCONJ
dpc-3884	192	22	outlining	outline	VERB
dpc-3884	192	23	the	the	DET
dpc-3884	192	24	patients	patient	NOUN
dpc-3884	192	25	profile	profile	VERB
dpc-3884	192	26	with	with	ADP
dpc-3884	192	27	the	the	DET
dpc-3884	192	28	use	use	NOUN
dpc-3884	192	29	of	of	ADP
dpc-3884	192	30	pros	pro	NOUN
dpc-3884	192	31	improves	improve	VERB
dpc-3884	192	32	treatment	treatment	NOUN
dpc-3884	192	33	decision	decision	NOUN
dpc-3884	192	34	making	making	NOUN
dpc-3884	192	35	.	.	PUNCT
dpc-3884	193	1	in	in	ADP
dpc-3884	193	2	conclusion	conclusion	NOUN
dpc-3884	193	3	,	,	PUNCT
dpc-3884	193	4	our	our	PRON
dpc-3884	193	5	study	study	NOUN
dpc-3884	193	6	confirmed	confirm	VERB
dpc-3884	193	7	the	the	DET
dpc-3884	193	8	significant	significant	ADJ
dpc-3884	193	9	impact	impact	NOUN
dpc-3884	193	10	of	of	ADP
dpc-3884	193	11	diraes	diraes	NOUN
dpc-3884	193	12	on	on	ADP
dpc-3884	193	13	patients	patient	NOUN
dpc-3884	193	14	qol	qol	ADV
dpc-3884	193	15	and	and	CCONJ
dpc-3884	193	16	the	the	DET
dpc-3884	193	17	important	important	ADJ
dpc-3884	193	18	role	role	NOUN
dpc-3884	193	19	of	of	ADP
dpc-3884	193	20	the	the	DET
dpc-3884	193	21	dermatologist	dermatologist	NOUN
dpc-3884	193	22	in	in	ADP
dpc-3884	193	23	managing	manage	VERB
dpc-3884	193	24	ici	ici	NOUN
dpc-3884	193	25	-	-	PUNCT
dpc-3884	193	26	derived	derive	VERB
dpc-3884	193	27	skin	skin	NOUN
dpc-3884	193	28	toxicities	toxicity	NOUN
dpc-3884	193	29	.	.	PUNCT
dpc-3884	194	1	incorporation	incorporation	NOUN
dpc-3884	194	2	of	of	ADP
dpc-3884	194	3	dermatology	dermatology	NOUN
dpc-3884	194	4	qol	qol	NOUN
dpc-3884	194	5	indexes	index	NOUN
dpc-3884	194	6	in	in	ADP
dpc-3884	194	7	the	the	DET
dpc-3884	194	8	context	context	NOUN
dpc-3884	194	9	of	of	ADP
dpc-3884	194	10	icis	icis	PROPN
dpc-3884	194	11	treated	treat	VERB
dpc-3884	194	12	individuals	individual	NOUN
dpc-3884	194	13	is	be	AUX
dpc-3884	194	14	expected	expect	VERB
dpc-3884	194	15	to	to	PART
dpc-3884	194	16	better	well	ADV
dpc-3884	194	17	serve	serve	VERB
dpc-3884	194	18	towards	towards	ADP
dpc-3884	194	19	improved	improved	ADJ
dpc-3884	194	20	identification	identification	NOUN
dpc-3884	194	21	of	of	ADP
dpc-3884	194	22	diraes	diraes	NOUN
dpc-3884	194	23	impact	impact	NOUN
dpc-3884	194	24	on	on	ADP
dpc-3884	194	25	patients	patient	NOUN
dpc-3884	194	26	qol	qol	VERB
dpc-3884	194	27	.	.	PUNCT
dpc-3884	195	1	references	reference	NOUN
dpc-3884	195	2	1	1	NUM
dpc-3884	195	3	.	.	PUNCT
dpc-3884	196	1	weber	weber	PROPN
dpc-3884	196	2	js	js	PROPN
dpc-3884	196	3	,	,	PUNCT
dpc-3884	196	4	hodi	hodi	PROPN
dpc-3884	196	5	fs	fs	PROPN
dpc-3884	196	6	,	,	PUNCT
dpc-3884	196	7	wolchok	wolchok	PROPN
dpc-3884	196	8	jd	jd	PROPN
dpc-3884	196	9	,	,	PUNCT
dpc-3884	196	10	et	et	PROPN
dpc-3884	196	11	al	al	PROPN
dpc-3884	196	12	.	.	PUNCT
dpc-3884	196	13	safety	safety	NOUN
dpc-3884	196	14	profile	profile	NOUN
dpc-3884	196	15	of	of	ADP
dpc-3884	196	16	nivolumab	nivolumab	NOUN
dpc-3884	196	17	monotherapy	monotherapy	NOUN
dpc-3884	196	18	:	:	PUNCT
dpc-3884	196	19	a	a	DET
dpc-3884	196	20	pooled	pooled	ADJ
dpc-3884	196	21	analysis	analysis	NOUN
dpc-3884	196	22	of	of	ADP
dpc-3884	196	23	patients	patient	NOUN
dpc-3884	196	24	with	with	ADP
dpc-3884	196	25	advanced	advanced	ADJ
dpc-3884	196	26	melanoma	melanoma	NOUN
dpc-3884	196	27	.	.	PUNCT
dpc-3884	197	1	j	j	PROPN
dpc-3884	197	2	clin	clin	PROPN
dpc-3884	197	3	oncol	oncol	PROPN
dpc-3884	197	4	.	.	PUNCT
dpc-3884	198	1	2017;35(7):785–792	2017;35(7):785–792	NUM
dpc-3884	198	2	.	.	NOUN
dpc-3884	198	3	2	2	NUM
dpc-3884	198	4	.	.	X
dpc-3884	198	5	haanen	haanen	PROPN
dpc-3884	198	6	j	j	PROPN
dpc-3884	198	7	,	,	PUNCT
dpc-3884	198	8	carbonnel	carbonnel	PROPN
dpc-3884	198	9	f	f	NOUN
dpc-3884	198	10	,	,	PUNCT
dpc-3884	198	11	robert	robert	PROPN
dpc-3884	198	12	c	c	PROPN
dpc-3884	198	13	et	et	PROPN
dpc-3884	198	14	al	al	PROPN
dpc-3884	198	15	.	.	PUNCT
dpc-3884	198	16	management	management	NOUN
dpc-3884	198	17	of	of	ADP
dpc-3884	198	18	toxicities	toxicity	NOUN
dpc-3884	198	19	from	from	ADP
dpc-3884	198	20	immunotherapy	immunotherapy	NOUN
dpc-3884	198	21	:	:	PUNCT
dpc-3884	198	22	esmo	esmo	VERB
dpc-3884	198	23	clinical	clinical	ADJ
dpc-3884	198	24	practice	practice	NOUN
dpc-3884	198	25	guidelines	guideline	NOUN
dpc-3884	198	26	for	for	ADP
dpc-3884	198	27	diagnosis	diagnosis	NOUN
dpc-3884	198	28	,	,	PUNCT
dpc-3884	198	29	treatment	treatment	NOUN
dpc-3884	198	30	and	and	CCONJ
dpc-3884	198	31	follow	follow	NOUN
dpc-3884	198	32	-	-	PUNCT
dpc-3884	198	33	up	up	NOUN
dpc-3884	198	34	.	.	PUNCT
dpc-3884	199	1	ann	ann	PROPN
dpc-3884	199	2	oncol	oncol	PROPN
dpc-3884	199	3	2017	2017	NUM
dpc-3884	199	4	;	;	PUNCT
dpc-3884	199	5	28	28	NUM
dpc-3884	199	6	:	:	PUNCT
dpc-3884	199	7	119–42	119–42	NUM
dpc-3884	199	8	.	.	X
dpc-3884	200	1	3	3	X
dpc-3884	200	2	.	.	PUNCT
dpc-3884	200	3	belum	belum	PROPN
dpc-3884	200	4	vr	vr	PROPN
dpc-3884	200	5	,	,	PUNCT
dpc-3884	200	6	benhuri	benhuri	PROPN
dpc-3884	200	7	b	b	PROPN
dpc-3884	200	8	,	,	PUNCT
dpc-3884	200	9	postow	postow	PROPN
dpc-3884	200	10	ma	ma	PROPN
dpc-3884	200	11	et	et	PROPN
dpc-3884	200	12	al	al	PROPN
dpc-3884	200	13	.	.	PROPN
dpc-3884	200	14	characterisation	characterisation	NOUN
dpc-3884	200	15	and	and	CCONJ
dpc-3884	200	16	management	management	NOUN
dpc-3884	200	17	of	of	ADP
dpc-3884	200	18	dermatologic	dermatologic	ADJ
dpc-3884	200	19	adverse	adverse	ADJ
dpc-3884	200	20	events	event	NOUN
dpc-3884	200	21	to	to	ADP
dpc-3884	200	22	agents	agent	NOUN
dpc-3884	200	23	targeting	target	VERB
dpc-3884	200	24	the	the	DET
dpc-3884	200	25	pd-1	pd-1	ADJ
dpc-3884	200	26	receptor	receptor	NOUN
dpc-3884	200	27	.	.	PUNCT
dpc-3884	201	1	eur	eur	PROPN
dpc-3884	201	2	j	j	PROPN
dpc-3884	201	3	cancer	cancer	PROPN
dpc-3884	201	4	2016	2016	NUM
dpc-3884	201	5	;	;	PUNCT
dpc-3884	201	6	60	60	NUM
dpc-3884	201	7	:	:	PUNCT
dpc-3884	201	8	12–25	12–25	NUM
dpc-3884	201	9	.	.	PUNCT
dpc-3884	201	10	4	4	X
dpc-3884	201	11	.	.	PUNCT
dpc-3884	201	12	robert	robert	PROPN
dpc-3884	201	13	c	c	PROPN
dpc-3884	201	14	,	,	PUNCT
dpc-3884	201	15	schachter	schachter	PROPN
dpc-3884	201	16	j	j	PROPN
dpc-3884	201	17	,	,	PUNCT
dpc-3884	201	18	long	long	ADV
dpc-3884	201	19	gv	gv	ADP
dpc-3884	201	20	,	,	PUNCT
dpc-3884	201	21	et	et	PROPN
dpc-3884	201	22	al	al	PROPN
dpc-3884	201	23	.	.	PROPN
dpc-3884	201	24	pembrolizumab	pembrolizumab	NOUN
dpc-3884	201	25	versus	versus	ADP
dpc-3884	201	26	ipilimumab	ipilimumab	NOUN
dpc-3884	201	27	in	in	ADP
dpc-3884	201	28	advanced	advanced	ADJ
dpc-3884	201	29	melanoma	melanoma	NOUN
dpc-3884	201	30	.	.	PUNCT
dpc-3884	202	1	n	n	PRON
dpc-3884	202	2	engl	engl	PROPN
dpc-3884	202	3	j	j	PROPN
dpc-3884	202	4	med	med	PROPN
dpc-3884	202	5	2015	2015	NUM
dpc-3884	202	6	;	;	PUNCT
dpc-3884	202	7	372	372	NUM
dpc-3884	202	8	:	:	SYM
dpc-3884	202	9	2521–32	2521–32	NUM
dpc-3884	202	10	.	.	PUNCT
dpc-3884	203	1	5	5	X
dpc-3884	203	2	.	.	X
dpc-3884	203	3	sibaud	sibaud	PROPN
dpc-3884	203	4	v	v	PROPN
dpc-3884	203	5	,	,	PUNCT
dpc-3884	203	6	meyer	meyer	PROPN
dpc-3884	203	7	n	n	CCONJ
dpc-3884	203	8	,	,	PUNCT
dpc-3884	203	9	lamant	lamant	PROPN
dpc-3884	203	10	l	l	NOUN
dpc-3884	203	11	,	,	PUNCT
dpc-3884	203	12	vigarios	vigarios	PROPN
dpc-3884	203	13	e	e	NOUN
dpc-3884	203	14	,	,	PUNCT
dpc-3884	203	15	mazieres	mazieres	PROPN
dpc-3884	203	16	j	j	PROPN
dpc-3884	203	17	,	,	PUNCT
dpc-3884	203	18	delord	delord	PROPN
dpc-3884	203	19	jp	jp	NOUN
dpc-3884	203	20	.	.	PUNCT
dpc-3884	204	1	dermatologic	dermatologic	ADJ
dpc-3884	204	2	complications	complication	NOUN
dpc-3884	204	3	of	of	ADP
dpc-3884	204	4	anti	anti	ADJ
dpc-3884	204	5	-	-	ADJ
dpc-3884	204	6	pd-1	pd-1	ADJ
dpc-3884	204	7	/	/	SYM
dpc-3884	204	8	pd	pd	ADJ
dpc-3884	204	9	-	-	PUNCT
dpc-3884	204	10	l1	l1	PROPN
dpc-3884	204	11	immune	immune	ADJ
dpc-3884	204	12	checkpoint	checkpoint	NOUN
dpc-3884	204	13	antibodies	antibodie	VERB
dpc-3884	204	14	.	.	PUNCT
dpc-3884	205	1	curr	curr	PROPN
dpc-3884	205	2	opin	opin	PROPN
dpc-3884	205	3	oncol	oncol	ADJ
dpc-3884	205	4	2016	2016	NUM
dpc-3884	205	5	;	;	PUNCT
dpc-3884	205	6	28	28	NUM
dpc-3884	205	7	:	:	PUNCT
dpc-3884	205	8	254–63	254–63	NUM
dpc-3884	205	9	.	.	X
dpc-3884	206	1	6	6	X
dpc-3884	206	2	.	.	X
dpc-3884	206	3	merli	merli	PROPN
dpc-3884	206	4	m	m	PROPN
dpc-3884	206	5	,	,	PUNCT
dpc-3884	206	6	accorinti	accorinti	PROPN
dpc-3884	206	7	m	m	PROPN
dpc-3884	206	8	,	,	PUNCT
dpc-3884	206	9	romagnuolo	romagnuolo	PROPN
dpc-3884	206	10	m	m	PROPN
dpc-3884	206	11	,	,	PUNCT
dpc-3884	206	12	et	et	PROPN
dpc-3884	206	13	al	al	PROPN
dpc-3884	206	14	.	.	PROPN
dpc-3884	206	15	autoimmune	autoimmune	PROPN
dpc-3884	206	16	bullous	bullous	ADJ
dpc-3884	206	17	dermatoses	dermatosis	NOUN
dpc-3884	206	18	in	in	ADP
dpc-3884	206	19	cancer	cancer	NOUN
dpc-3884	206	20	patients	patient	NOUN
dpc-3884	206	21	treated	treat	VERB
dpc-3884	206	22	by	by	ADP
dpc-3884	206	23	immunotherapy	immunotherapy	NOUN
dpc-3884	206	24	:	:	PUNCT
dpc-3884	206	25	a	a	DET
dpc-3884	206	26	literature	literature	NOUN
dpc-3884	206	27	review	review	NOUN
dpc-3884	206	28	and	and	CCONJ
dpc-3884	206	29	italian	italian	ADJ
dpc-3884	206	30	multicentric	multicentric	ADJ
dpc-3884	206	31	experience	experience	NOUN
dpc-3884	206	32	.	.	PUNCT
dpc-3884	207	1	front	front	ADJ
dpc-3884	207	2	med	med	PROPN
dpc-3884	207	3	(	(	PUNCT
dpc-3884	207	4	lausanne	lausanne	PROPN
dpc-3884	207	5	)	)	PUNCT
dpc-3884	207	6	.	.	PUNCT
dpc-3884	208	1	2023;10:1208418	2023;10:1208418	NUM
dpc-3884	208	2	.	.	X
dpc-3884	208	3	7	7	X
dpc-3884	208	4	.	.	X
dpc-3884	208	5	dika	dika	X
dpc-3884	208	6	e	e	NOUN
dpc-3884	208	7	,	,	PUNCT
dpc-3884	208	8	lambertini	lambertini	PROPN
dpc-3884	208	9	m	m	PROPN
dpc-3884	208	10	,	,	PUNCT
dpc-3884	208	11	gouveia	gouveia	PROPN
dpc-3884	208	12	b	b	PROPN
dpc-3884	208	13	,	,	PUNCT
dpc-3884	208	14	et	et	PROPN
dpc-3884	208	15	al	al	PROPN
dpc-3884	208	16	.	.	PUNCT
dpc-3884	208	17	oral	oral	ADJ
dpc-3884	208	18	manifestations	manifestation	NOUN
dpc-3884	208	19	in	in	ADP
dpc-3884	208	20	melanoma	melanoma	NOUN
dpc-3884	208	21	patients	patient	NOUN
dpc-3884	208	22	treated	treat	VERB
dpc-3884	208	23	with	with	ADP
dpc-3884	208	24	target	target	NOUN
dpc-3884	208	25	or	or	CCONJ
dpc-3884	208	26	immunomodulatory	immunomodulatory	ADJ
dpc-3884	208	27	therapies	therapy	NOUN
dpc-3884	208	28	.	.	PUNCT
dpc-3884	209	1	j	j	PROPN
dpc-3884	209	2	clin	clin	PROPN
dpc-3884	209	3	med	med	PROPN
dpc-3884	209	4	.	.	PUNCT
dpc-3884	210	1	2021;10(6):1283	2021;10(6):1283	NUM
dpc-3884	210	2	.	.	NOUN
dpc-3884	211	1	8	8	NUM
dpc-3884	211	2	.	.	PUNCT
dpc-3884	212	1	hua	hua	PROPN
dpc-3884	212	2	c	c	PROPN
dpc-3884	212	3	,	,	PUNCT
dpc-3884	212	4	boussemart	boussemart	PROPN
dpc-3884	212	5	l	l	PROPN
dpc-3884	212	6	,	,	PUNCT
dpc-3884	212	7	mateus	mateus	PROPN
dpc-3884	212	8	c	c	PROPN
dpc-3884	212	9	et	et	PROPN
dpc-3884	212	10	al	al	PROPN
dpc-3884	212	11	.	.	PROPN
dpc-3884	212	12	association	association	PROPN
dpc-3884	212	13	of	of	ADP
dpc-3884	212	14	vitiligo	vitiligo	PROPN
dpc-3884	212	15	with	with	ADP
dpc-3884	212	16	tumor	tumor	NOUN
dpc-3884	212	17	response	response	NOUN
dpc-3884	212	18	in	in	ADP
dpc-3884	212	19	patients	patient	NOUN
dpc-3884	212	20	with	with	ADP
dpc-3884	212	21	metastatic	metastatic	ADJ
dpc-3884	212	22	melanoma	melanoma	NOUN
dpc-3884	212	23	treated	treat	VERB
dpc-3884	212	24	with	with	ADP
dpc-3884	212	25	pembrolizumab	pembrolizumab	NOUN
dpc-3884	212	26	.	.	PUNCT
dpc-3884	213	1	jama	jama	PROPN
dpc-3884	213	2	dermatol	dermatol	NOUN
dpc-3884	213	3	2016	2016	NUM
dpc-3884	213	4	;	;	PUNCT
dpc-3884	213	5	152	152	NUM
dpc-3884	213	6	:	:	PUNCT
dpc-3884	213	7	45–51	45–51	NUM
dpc-3884	213	8	.	.	NOUN
dpc-3884	213	9	9	9	NUM
dpc-3884	213	10	.	.	X
dpc-3884	213	11	sanlorenzo	sanlorenzo	NOUN
dpc-3884	213	12	m	m	PROPN
dpc-3884	213	13	,	,	PUNCT
dpc-3884	213	14	vujic	vujic	PROPN
dpc-3884	213	15	i	i	PROPN
dpc-3884	213	16	,	,	PUNCT
dpc-3884	213	17	daud	daud	VERB
dpc-3884	213	18	a	a	PRON
dpc-3884	213	19	et	et	PROPN
dpc-3884	213	20	al	al	PROPN
dpc-3884	213	21	.	.	PROPN
dpc-3884	213	22	pembrolizumab	pembrolizumab	NOUN
dpc-3884	213	23	cutaneous	cutaneous	ADJ
dpc-3884	213	24	adverse	adverse	ADJ
dpc-3884	213	25	events	event	NOUN
dpc-3884	213	26	and	and	CCONJ
dpc-3884	213	27	their	their	PRON
dpc-3884	213	28	association	association	NOUN
dpc-3884	213	29	with	with	ADP
dpc-3884	213	30	disease	disease	NOUN
dpc-3884	213	31	progression	progression	NOUN
dpc-3884	213	32	.	.	PUNCT
dpc-3884	214	1	jama	jama	PROPN
dpc-3884	214	2	dermatol	dermatol	NOUN
dpc-3884	214	3	2015	2015	NUM
dpc-3884	214	4	;	;	PUNCT
dpc-3884	214	5	151	151	NUM
dpc-3884	214	6	:	:	PUNCT
dpc-3884	214	7	1206–12	1206–12	NUM
dpc-3884	214	8	.	.	PUNCT
dpc-3884	215	1	10	10	NUM
dpc-3884	215	2	.	.	X
dpc-3884	216	1	freeman	freeman	PROPN
dpc-3884	216	2	-	-	PUNCT
dpc-3884	216	3	keller	keller	PROPN
dpc-3884	216	4	m	m	PROPN
dpc-3884	216	5	,	,	PUNCT
dpc-3884	216	6	kim	kim	PROPN
dpc-3884	216	7	y	y	PROPN
dpc-3884	216	8	,	,	PUNCT
dpc-3884	216	9	cronin	cronin	PROPN
dpc-3884	216	10	h	h	PROPN
dpc-3884	216	11	,	,	PUNCT
dpc-3884	216	12	richards	richards	PROPN
dpc-3884	216	13	a	a	PROPN
dpc-3884	216	14	,	,	PUNCT
dpc-3884	216	15	gibney	gibney	PROPN
dpc-3884	216	16	g	g	PROPN
dpc-3884	216	17	,	,	PUNCT
dpc-3884	216	18	weber	weber	PROPN
dpc-3884	216	19	js	js	PROPN
dpc-3884	216	20	.	.	PROPN
dpc-3884	216	21	nivolumab	nivolumab	NOUN
dpc-3884	216	22	in	in	ADP
dpc-3884	216	23	resected	resected	ADJ
dpc-3884	216	24	and	and	CCONJ
dpc-3884	216	25	unresectable	unresectable	ADJ
dpc-3884	216	26	metastatic	metastatic	ADJ
dpc-3884	216	27	8	8	NUM
dpc-3884	216	28	original	original	ADJ
dpc-3884	216	29	article	article	NOUN
dpc-3884	216	30	|	|	ADV
dpc-3884	216	31	dermatol	dermatol	ADJ
dpc-3884	216	32	pract	pract	NOUN
dpc-3884	216	33	concept	concept	NOUN
dpc-3884	216	34	.	.	PUNCT
dpc-3884	217	1	2024;14(3):e2024118	2024;14(3):e2024118	NUM
dpc-3884	217	2	27	27	NUM
dpc-3884	217	3	.	.	PUNCT
dpc-3884	218	1	naidoo	naidoo	PROPN
dpc-3884	218	2	j	j	PROPN
dpc-3884	218	3	,	,	PUNCT
dpc-3884	218	4	page	page	NOUN
dpc-3884	218	5	db	db	PROPN
dpc-3884	218	6	,	,	PUNCT
dpc-3884	218	7	li	li	PROPN
dpc-3884	218	8	bt	bt	PROPN
dpc-3884	218	9	et	et	PROPN
dpc-3884	218	10	al	al	PROPN
dpc-3884	218	11	.	.	PUNCT
dpc-3884	219	1	toxicities	toxicity	NOUN
dpc-3884	219	2	of	of	ADP
dpc-3884	219	3	the	the	DET
dpc-3884	219	4	anti	anti	NOUN
dpc-3884	219	5	-	-	ADJ
dpc-3884	219	6	pd-1	pd-1	ADJ
dpc-3884	219	7	and	and	CCONJ
dpc-3884	219	8	anti	anti	ADJ
dpc-3884	219	9	-	-	ADJ
dpc-3884	219	10	pd	pd	ADJ
dpc-3884	219	11	-	-	ADJ
dpc-3884	219	12	l1	l1	PROPN
dpc-3884	219	13	immune	immune	ADJ
dpc-3884	219	14	checkpoint	checkpoint	NOUN
dpc-3884	219	15	antibodies	antibodie	VERB
dpc-3884	219	16	.	.	PUNCT
dpc-3884	220	1	ann	ann	PROPN
dpc-3884	220	2	oncol	oncol	PROPN
dpc-3884	220	3	2015	2015	NUM
dpc-3884	220	4	;	;	PUNCT
dpc-3884	220	5	26	26	NUM
dpc-3884	220	6	:	:	SYM
dpc-3884	220	7	2375–91	2375–91	NUM
dpc-3884	220	8	.	.	PUNCT
dpc-3884	221	1	28	28	NUM
dpc-3884	221	2	.	.	PUNCT
dpc-3884	222	1	basch	basch	PROPN
dpc-3884	222	2	e	e	PROPN
dpc-3884	222	3	,	,	PUNCT
dpc-3884	222	4	deal	deal	NOUN
dpc-3884	222	5	am	am	NOUN
dpc-3884	222	6	,	,	PUNCT
dpc-3884	222	7	kris	kris	PROPN
dpc-3884	222	8	mg	mg	PROPN
dpc-3884	223	1	et	et	PROPN
dpc-3884	223	2	al	al	PROPN
dpc-3884	223	3	.	.	PROPN
dpc-3884	223	4	symptom	symptom	NOUN
dpc-3884	223	5	monitoring	monitoring	NOUN
dpc-3884	223	6	with	with	ADP
dpc-3884	223	7	patient	patient	NOUN
dpc-3884	223	8	-	-	PUNCT
dpc-3884	223	9	reported	report	VERB
dpc-3884	223	10	outcomes	outcome	NOUN
dpc-3884	223	11	during	during	ADP
dpc-3884	223	12	routine	routine	ADJ
dpc-3884	223	13	cancer	cancer	NOUN
dpc-3884	223	14	treatment	treatment	NOUN
dpc-3884	223	15	:	:	PUNCT
dpc-3884	223	16	a	a	DET
dpc-3884	223	17	randomized	randomized	ADJ
dpc-3884	223	18	controlled	control	VERB
dpc-3884	223	19	trial	trial	NOUN
dpc-3884	223	20	.	.	PUNCT
dpc-3884	224	1	j	j	PROPN
dpc-3884	224	2	clin	clin	PROPN
dpc-3884	224	3	oncol	oncol	PROPN
dpc-3884	224	4	off	off	ADP
dpc-3884	224	5	j	j	PROPN
dpc-3884	224	6	am	be	AUX
dpc-3884	224	7	soc	soc	PROPN
dpc-3884	224	8	clin	clin	PROPN
dpc-3884	224	9	oncol	oncol	PROPN
dpc-3884	224	10	2016	2016	NUM
dpc-3884	224	11	;	;	PUNCT
dpc-3884	224	12	34	34	NUM
dpc-3884	224	13	:	:	SYM
dpc-3884	224	14	557–65	557–65	NUM
dpc-3884	224	15	.	.	PUNCT
dpc-3884	225	1	29	29	NUM
dpc-3884	225	2	.	.	PUNCT
dpc-3884	226	1	basch	basch	PROPN
dpc-3884	226	2	e	e	PROPN
dpc-3884	226	3	,	,	PUNCT
dpc-3884	226	4	deal	deal	NOUN
dpc-3884	226	5	am	am	NOUN
dpc-3884	226	6	,	,	PUNCT
dpc-3884	226	7	dueck	dueck	PROPN
dpc-3884	226	8	ac	ac	PROPN
dpc-3884	226	9	et	et	PROPN
dpc-3884	226	10	al	al	PROPN
dpc-3884	226	11	.	.	PUNCT
dpc-3884	227	1	overall	overall	ADJ
dpc-3884	227	2	survival	survival	NOUN
dpc-3884	227	3	results	result	NOUN
dpc-3884	227	4	of	of	ADP
dpc-3884	227	5	a	a	DET
dpc-3884	227	6	trial	trial	NOUN
dpc-3884	227	7	assessing	assess	VERB
dpc-3884	227	8	patient	patient	NOUN
dpc-3884	227	9	-	-	PUNCT
dpc-3884	227	10	reported	report	VERB
dpc-3884	227	11	outcomes	outcome	NOUN
dpc-3884	227	12	for	for	ADP
dpc-3884	227	13	symptom	symptom	NOUN
dpc-3884	227	14	monitoring	monitoring	NOUN
dpc-3884	227	15	during	during	ADP
dpc-3884	227	16	routine	routine	ADJ
dpc-3884	227	17	cancer	cancer	NOUN
dpc-3884	227	18	treatment	treatment	NOUN
dpc-3884	227	19	.	.	PUNCT
dpc-3884	228	1	jama	jama	PROPN
dpc-3884	228	2	2017	2017	NUM
dpc-3884	228	3	;	;	PUNCT
dpc-3884	228	4	318	318	NUM
dpc-3884	228	5	:	:	SYM
dpc-3884	228	6	197–8	197–8	NUM
dpc-3884	228	7	.	.	X
dpc-3884	228	8	24	24	NUM
dpc-3884	228	9	.	.	PUNCT
dpc-3884	229	1	boutros	boutros	PROPN
dpc-3884	229	2	a	a	PRON
dpc-3884	229	3	,	,	PUNCT
dpc-3884	229	4	bruzzone	bruzzone	NOUN
dpc-3884	229	5	m	m	PROPN
dpc-3884	229	6	,	,	PUNCT
dpc-3884	229	7	tanda	tanda	PROPN
dpc-3884	229	8	et	et	PROPN
dpc-3884	229	9	et	et	PROPN
dpc-3884	229	10	al	al	PROPN
dpc-3884	229	11	.	.	PUNCT
dpc-3884	230	1	health	health	NOUN
dpc-3884	230	2	-	-	PUNCT
dpc-3884	230	3	related	relate	VERB
dpc-3884	230	4	quality	quality	NOUN
dpc-3884	230	5	of	of	ADP
dpc-3884	230	6	life	life	NOUN
dpc-3884	230	7	in	in	ADP
dpc-3884	230	8	cancer	cancer	NOUN
dpc-3884	230	9	patients	patient	NOUN
dpc-3884	230	10	treated	treat	VERB
dpc-3884	230	11	with	with	ADP
dpc-3884	230	12	immune	immune	ADJ
dpc-3884	230	13	checkpoint	checkpoint	NOUN
dpc-3884	230	14	inhibitors	inhibitor	NOUN
dpc-3884	230	15	in	in	ADP
dpc-3884	230	16	andomized	andomize	VERB
dpc-3884	230	17	controlled	control	VERB
dpc-3884	230	18	trials	trial	NOUN
dpc-3884	230	19	:	:	PUNCT
dpc-3884	230	20	a	a	DET
dpc-3884	230	21	systematic	systematic	ADJ
dpc-3884	230	22	review	review	NOUN
dpc-3884	230	23	and	and	CCONJ
dpc-3884	230	24	meta	meta	ADJ
dpc-3884	230	25	-	-	PUNCT
dpc-3884	230	26	analysis	analysis	NOUN
dpc-3884	230	27	.	.	PUNCT
dpc-3884	231	1	eur	eur	PROPN
dpc-3884	231	2	j	j	PROPN
dpc-3884	231	3	cancer	cancer	NOUN
dpc-3884	231	4	2021	2021	NUM
dpc-3884	231	5	;	;	PUNCT
dpc-3884	231	6	159	159	NUM
dpc-3884	231	7	:	:	PUNCT
dpc-3884	231	8	154–66	154–66	NUM
dpc-3884	231	9	.	.	X
dpc-3884	231	10	25	25	NUM
dpc-3884	231	11	.	.	PUNCT
dpc-3884	231	12	rapoport	rapoport	NOUN
dpc-3884	231	13	bl	bl	PROPN
dpc-3884	231	14	,	,	PUNCT
dpc-3884	231	15	van	van	PROPN
dpc-3884	231	16	eeden	eeden	PROPN
dpc-3884	231	17	r	r	NOUN
dpc-3884	231	18	,	,	PUNCT
dpc-3884	231	19	sibaud	sibaud	NOUN
dpc-3884	231	20	v	v	ADP
dpc-3884	231	21	et	et	PROPN
dpc-3884	231	22	al	al	PROPN
dpc-3884	231	23	.	.	PROPN
dpc-3884	231	24	supportive	supportive	ADJ
dpc-3884	231	25	care	care	NOUN
dpc-3884	231	26	for	for	ADP
dpc-3884	231	27	patients	patient	NOUN
dpc-3884	231	28	undergoing	undergo	VERB
dpc-3884	231	29	immunotherapy	immunotherapy	NOUN
dpc-3884	231	30	.	.	PUNCT
dpc-3884	232	1	support	support	NOUN
dpc-3884	232	2	care	care	NOUN
dpc-3884	232	3	cancer	cancer	NOUN
dpc-3884	232	4	2017	2017	NUM
dpc-3884	232	5	;	;	PUNCT
dpc-3884	232	6	25	25	NUM
dpc-3884	232	7	:	:	SYM
dpc-3884	232	8	3017–030	3017–030	NUM
dpc-3884	232	9	.	.	PUNCT
dpc-3884	233	1	26	26	NUM
dpc-3884	233	2	.	.	X
dpc-3884	233	3	27	27	NUM
dpc-3884	233	4	postow	postow	NOUN
dpc-3884	233	5	ma	ma	PROPN
dpc-3884	233	6	,	,	PUNCT
dpc-3884	233	7	callahan	callahan	PROPN
dpc-3884	233	8	mk	mk	PROPN
dpc-3884	233	9	,	,	PUNCT
dpc-3884	233	10	wolchok	wolchok	PROPN
dpc-3884	233	11	jd	jd	PROPN
dpc-3884	233	12	.	.	PROPN
dpc-3884	233	13	immune	immune	ADJ
dpc-3884	233	14	checkpoint	checkpoint	NOUN
dpc-3884	233	15	blockade	blockade	NOUN
dpc-3884	233	16	in	in	ADP
dpc-3884	233	17	cancer	cancer	NOUN
dpc-3884	233	18	therapy	therapy	NOUN
dpc-3884	233	19	.	.	PUNCT
dpc-3884	234	1	j	j	PROPN
dpc-3884	234	2	clin	clin	PROPN
dpc-3884	234	3	oncol	oncol	PROPN
dpc-3884	234	4	2015	2015	NUM
dpc-3884	234	5	;	;	PUNCT
dpc-3884	234	6	33	33	NUM
dpc-3884	234	7	:	:	SYM
dpc-3884	234	8	1974–1982	1974–1982	NUM
dpc-3884	234	9	.	.	PUNCT